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This section provides a medium through which Canadian
surgeons can declare themselves, briefly and informally, on
the day-to-day affairs of surgery.

Perforated Peptic Ulcer
The incidence of peptic ulcer disease and,
therefore, of perforation has declined
steadily in much of the western world
over the past 30 years. The reasons for
this are obscure, but the result is a new
generation of physicians who may rarely
see a patient with perforated peptic ulcer.
They need to be reminded of the words
of Lord Moynihan that “ perforation is
one of the most serious and most over
whelming catastrophes that can befall a
human being” . The overall mortality for
perforated peptic ulcer remains at about
20% despite advances in anesthesia, in
tensive care, parenteral nutrition and an
tibiotic therapy. The reasons for this are
clear: the diagnosis is often missed, the
true condition being recognized only at
autopsy, and the delay in operating is
often greater than 24 hours. In a large
Canadian series, delay of more than 24
hours after perforation was associated
with an overall mortality of 25% .' Delay
in diagnosis is particularly hazardous in
the elderly in whom the condition is just
as likely to occur as in younger patients.
Death from perforation is rare under the
age of 40 years. The diagnosis of perfora
tion must be considered in any sudden
painful illness in the elderly, even if the
most likely explanation seems to be
myocardial infarction. Narcotics must not
be given until the patient has been
The Canadian Journal of
Surgery
Le journal canadien de
chirurgie
(613) 731-9331

The Canadian Journal o f Surgery is pub
lished by the Canadian Medical Association
and sponsored by the Royal College of
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tives of the Journal endorsed by the Coun
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dian surgeons with an effective vehicle for
the dissemination of their observations in the
area of clinical research.
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assessed by an experienced surgeon. If a
patient with a perforation is admitted
initially to a nonsurgical service, the out
come is almost always fatal.
The paper by Fong in this issue (pages
370-2) reminds us of these facts. In his
series, the overall mortality for a 15-year
period ending 1980 was 19.2%. In 5% of
the patients the perforation was recog
nized only at autopsy and 28% were
operated upon more than 24 hours after
perforation. The mortality in the latter
group was 43%. Most of the deaths were
due to sepsis and Fong points out that the
organisms were frequently anaerobes or
coliforms. He recommends routine
peritoneal fluid culture and administra
tion of antibiotics if there is a delay in
diagnosis of more than 24 hours. Unfor
tunately, he does not tell us how the pa
tients in his series were managed surgical
ly or whether antibiotics were employed,
so it is difficult to understand on what he
bases his recom m endations. Most
surgeons would feel that he has not gone
far enough.
Surgeons have long known that for the
first 6 hours after perforation, the
peritonitis is chemical rather than
bacterial and that bacterial peritonitis
becomes inevitable after 12 hours. The
bacterial content of stomach is related to
the length of time since the previous meal.
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each, back issues at $6.00 each.
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the January 1983 issue.
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Food buffers gastric acid and introduces
fresh bacteria. The use of antibiotics
should be routine. This is therapeutic, not
prophylactic. Elective surgery for un
complicated duodenal ulcer probably re
quires no antibiotic prophylaxis but
emergency surgery for peritonitis makes
antibiotic treatment mandatory. A n
tibiotics should be given in the emergen
cy room as soon as the diagnosis is
made.2 It is unwise to delay treatment
until peritoneal cultures have been taken;
most surgeons agree that a combination
of antibiotics effective against both
anaerobes and gram-negative bacilli
should be given.
Increasingly, patients with perforation
are being treated by definitive ulcer opera
tions. The very high morbidity and m or
tality associated with late operations for
perforation, reported by Fong, serves as
a timely warning. Even the most vigorous
proponents of definitive surgery concede
it should not be performed if the perfora
tion is more than 24 hours old or if there
is substantial co n tam in atio n .3 If,
however, the perforation is recent, there
is not much peritoneal soiling, the ulcer
is chronic and the patient is in reasonable
condition, then it is best to deal definitive
ly with the ulcer. The correct choice of
operation will depend on the experience
of the surgeon. This is not the time to try
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a new operation. However, for those
surgeons who are adept at highly selec
tive vagotomy, this may be the best in
dication. It is relatively free of the sideeffects associated with truncal vagotomy
and drainage and if 20% of the patients
have recurrent ulceration, they are still
better off than if the ulcer had been
patched, because 50% of ulcers so treated
recur.4 There has been only one con
trolled prospective trial comparing
definitive surgery with simple closure in
the surgical treatment of perforation.5
This small trial from Hong Kong sug
gested that both truncal vagotomy and
highly selective vagotomy are safe and ef
fective in carefully selected patients.
Selection is the key; few surgeons ad
vocate definitive surgery for all comers.

For the inexperienced gastric surgeon,
working at night under less than ideal
conditions, the safest course probably re
mains the classic Roscoe Graham closure
of the perforation.6
A small number of British surgeons still
follow the teaching of Hermon-Taylor
and successfully manage selected patients
without an operation.7 Most Canadian
surgeons are convinced that early
laparotomy is the safest course.
M.M. Cohen , mb, frcsic], frcs(edin )
Member,
Editorial Board.
Head, Division of general surgery,
Mount Sinai Hospital,
Toronto, Ont.
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Controversy in the Surgical Management of Melanoma

In 1982 a working group comprising
representatives o f seven regional
cooperative oncology groups met to con
sider prospective trials in the treatment of
melanoma. The members agreed that
large-scale trials of adjuvant therapy were
not indicated because no effective agents,
chem otherapeutic, im m unologic or
others, were available. It was also ap
parent that there are genuine controver
sies about appropriate surgical manage
ment. A trend towards resecting narrower
margins of normal tissue, especially for
thin lesions, has clearly begun, but this
idea has never been tested rationally.
Similarly, controversy about the role of
elective node dissection continues despite
many retrospective series and two pro
spective series. A review article by Lopez
in the March 1983 issue of the Journal
(pages 105-11) identified these areas of
controversy and made recommendations
based on a consensus from the available
surgical literature. Such compromises
may not provide the best solution.
Margin of Excision
Although wide local excision has long
been accepted as standard primary
therapy, it is clear that recurrence rates
are more a function of thickness of the
tumour than extent of excision, as shown
in the WHO study,1 in node-negative pa
tients. The problem is that in most reviews
of lesions excised with narrow margins of
normal tissue, the patients tend to be

young, female and have a preponderance
of head and neck lesions. With such
selected populations, valid comparisons
are impossible.
A recent survey of Canadian practices
indicates that most surgeons are perform
ing classic wide resections with margins
of 3 to 5 cm (Quirt I: Personal com
munication, 1982). It is, therefore, ap
propriate to find out, through a prospec
tive trial, whether lesser surgical pro
cedures would achieve the same
therapeutic results.
Elective Node Dissection
The number of publications about elec
tive node dissection testifies to the con
troversy and underscores the classic cliche
about the lack of association between
quantity and quality of data. In the
biologic sense, the question comes down
to the concept of tumour burden and
curability. The advantage of operating on
someone with nodal micrometastases is
that the tumour burden may be small and
a surgical procedure can increase the cure
rate; the disadvantage is that many pa
tients undergo an unnecessary operation.
If the node dissection is delayed, the ad
vantage is that only those patients who
need the operation will undergo it; the
disadvantage is that the chance for cure
is lost in some patients. A decision to per
form elective node dissection depends on
the biologic rationale that there are three
groups of patients: one with local disease,

one with local disease and distant
metastases and an intermediate group
with local and micrometastatic regional
disease.
Curiously, the findings in the literature
have fallen into two distinct groups. The
retrospective studies2'5 indicated that elec
tive node dissection was beneficial but the
two prospectively controlled trials1'6 fail
ed to ratify this; both showed no signifi
cant difference between elective and
delayed node dissection. But there are
problems in accepting these findings too
literally. The WHO study1 did not
stratify for thickness and ulceration,
variables that are known to be important,
and this imbalance could distort the con
clusions. In the Mayo Clinic study,6 two
thirds of the patients had lesions less than
1.5 mm thick, indicating a favourable
prognosis. This is not representative of
average melanoma patients. Moreover,
the combined Clark-Breslow staging is
confusing.7 When the data were re
arranged by thickness of lesion alone,
there appeared to be a significant dif
ference in the intermediate group of pa
tients whose lesions ranged from 1.5 to
3.99 mm in thickness, who underwent
elective node dissection. Also, there are
geographic as well as genetic and etiologic
differences between the European and
North American populations. These pro
blems prevent a simple interpretation of
results.
Because these are controlled studies
and the methodology is presented, it is
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possible for us to examine the details and
offer criticisms of the design. Lopez
argued th a t the large num ber of
retrospective studies should not be
disregarded on statistical grounds alone.
Because retrospective studies do not have
methodologic details, we cannot be as
specific in criticizing them but there must
be many unevaluable events or details. In
short, we really have no useful guidelines.
The compromise suggested by Lopez to
adopt elective node dissection has no bet
ter basis despite large numbers (retrospec
tive series) than has the opposite point of
view (prospective studies). What is there
in our prejudices that we identify faults
and reasons to disregard prospective
studies, but are always willing to accept
retrospective series? To attempt to find
a solution to the melanoma problem we
can draw some parallels with the evolu
tion of conceptual thinking in breast
cancer therapy.
Protocol B-04 of the National Surgical
Adjuvant Breast Project was one of the
most important and definitive studies in
cancer surgery. In this study, patients
whose axillary lymph nodes were un
treated had the same relapse-free survival
and ultimate survival as those who had
radical mastectomy.8 Coming after 15
years of controversy about the relative
role of the Halsted radical mastectomy
and the modified radical mastectomy, this
study has refuted the classic teaching of
an en-bloc lymph-node dissection and, in
deed, has shown that regional lymphnode dissection is not a determinant of
survival. Furthermore, after decades in
which teachers cited retrospective series
testifying to the superiority of the classic
radical mastectomy, it has been shown
that this operation may be abandoned for
all patients.
Obviously, we cannot draw conclusions
for melanoma from results in breast
cancer. The point is that well-controlled
prospective studies can offer insights that
may contradict accepted teachings and
should provoke thoughtful reconsidera
tion of traditional ideas. One of the
arguments for elective node dissection is
th a t th e presence of lym ph-node
metastases alters the prognosis. The
biologic truth is probably the reverse. The
prognosis isn’t bad because the patient
has involved nodes; rather, the nodes are
involved because the patient has a bad
disease with a poor prognosis. In other
words, the presence of tumour cells in
lymph nodes implies the existence of a
state of tumour aggressiveness or lack of
host defence, permitting metastases to
become established. The difference in sur
vival for node-negative and node-positive
patients does not necessarily mean that
early node dissection is advantageous. It
would be incorrect to reject the two pro
spective studies, which indicate no advan
tage for elective node dissection, simply

because of some methodologic faults that
have been identified. If we did so, we
would be accepting the large retrospective
series without any real discussion of their
methodologic faults. Therefore, the on
ly course is to conduct a better-designed
prospective, controlled study to answer
these questions. The National Cancer In
stitute of Canada will be a participant in
the Intergroup Melanoma Study, which
will also include representation from each
geographic region of the United States.
This study will be activated before the end
of 1983 and will evaluate the optimal
margins of resection of normal tissue
around the primary melanoma and
evaluate the role of elective regional
lymph-node dissection in patients whose
melanomas range from 1.0 to 3.99 mm
thick. Patients will be randomly assigned
to undergo excision with 2- or 4-cm
margins around the primary melanoma
and then will be randomized again to
undergo immediate or delayed lymphnode dissection. A second group of pa
tients with lesions less than 1.0 mm thick
will be randomized to 1- or 3-cm margins
but will not undergo lymph-node
dissection.
We all agree that modern treatment
should be based on a clear understanding
of the biology and natural history of the
disease. Since this information is not
available, it is not scientifically reasonable
to make binding recommendations. All
surgeons who treat melanoma have a
serious obligation to consider associating
themselves with the National Cancer In
stitute study in order to assure an ade
quate number of patients and rapid
availability of data to help solve these
surgical dilemmas.
R ichard G. M argolese , md, frcs[ci
Associate director,
McGill Cancer Centre,
Director, Division o f oncology,
Department o f surgery,
The Sir Mortimer B. DavisJewish General Hospital,
Montreal, PQ
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Treatment for
Localized Carcinoma of the Prostate
Three modalities of treatment have been
used to treat localized carcinoma of the
prostate: radical prostatectomy, inter
stitial radiation (iodine or gold seed im
plant) and external radiation. The gold
seed (l98Au) implant is supplemented by
external radiation as recommended by
Carlton and colleagues.1
Although the results of radical prosta
tectomy are excellent, only a few selected
patients are suitable for this type of treat
ment. Moreover, the high incidence of
impotence and of urinary incontinence
postoperatively makes this procedure less
than ideal.
Interstitial radiotherapy with iodine 125
implant has, unfortunately, given less
than optimal results and is quickly fall
ing from favour. The 88% rate of biop
sies positive for malignant cells following
treatm ent reported by Wilson and col
leagues in this issue (pages 363-5) is
obviously worrisome and will probably be
reflected in the long-term survival of their
patients. It is likely just a matter of time
before a positive biopsy manifests itself
as a metastasis. On the other hand,
198Au implant (supplemented by external
radiation) appears to give a lower in

cidence (33%) of positive biopsies.2
Also, because of the prolonged half-life
of 125I (60 days), the addition of external
radiotherapy may produce a high fre
quency of rectal and bladder complica
tions. In contrast, the half-life of 198Au
is only 2Vi days. Gold 198 has a greater
degree of penetration that makes an even
distribution of the effect of the isotope
in the gland more likely.
External radiotherapy has been used
for longer and has the advantage of be
ing noninvasive. It is a useful method for
poor-risk patients with cancer of the pros
tate. However, this has created a prob
lem in interpreting results, because pa
tients who have been treated by external
radiation often have not been staged by
pelvic lymphadenectomy. In one ran
domized prospective trial where patients
were staged, it was shown that the 5-year
survival after radical prostatectomy is
superior to that after external radiation.3
Experience will probably show that
there is no single method of treatment
that is best for all cases of localized pros
tatic carcinoma. In some cases, radical
prostatectomy is the appropriate treat
ment, while in others, the best result may

well be by 198Au implant with external
radiation or external radiation alone,
depending on the local characteristics of
the tumour, and the general condition
and to some extent the preference of the
patient. With the high rate of positive
biopsies after interstitial radiation with
,25I, it is difficult to justify its further
use.
S aid A. A w a d ,
Member,
Editorial Board.

m d , frcsic ]

Head, Department of urology,
Dalhousie University,
Halifax, NS
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SESAP IV Question
13.

Which of the following statements about gastroduodenal stress ulcers is TRUE?
(A)

More than 50% occur in the duodenum

(B)

Bleeding is effectively prevented with antacids guided by pH monitoring

(C)

85% of patients requiring operation are successfully managed with truncal vagotomy and emptying procedure

(D)

The incidence is increasing in major trauma centers

(E)

Intravenous H2 receptor antagonists (eg, cimetidine) are the most effective means of prevention

For the question above select the one answer that is best of the five given. For the critique of Item 13 see page 309.
(Reproduced by permission from SESAP IV Syllabus: Surgical Education and Self-Assessment Program No. 4. For
enrolment in the Surgical Education and Self-Assessment Program No. 4, please apply to the American College of
Surgeons, 55 East Erie St., Chicago, IL 60611.)
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A Modified Technique for
Long-Term Transverse Colostomy
To the editors.—Standard transverse loop
colostomy as a temporary defunctioning
procedure is generally simple and safe to
perform. However, there are situations in
which a transverse colostomy may be re
quired either as a permanent stoma or for
a prolonged period. Examples include
cases of radiation stricture of the rectum
and rectovaginal fistula. The use of
a standard loop colostomy for a pro

longed period has the highest complica
tion rate (31%) of any colostomy.1
Prolapse and necrosis of the stoma are
the most common complications, ac
counting for 25% and 17% respectively.1
Furthermore, it is often more difficult to
look after and to apply a device to a loop
colostomy.
We have devised a simple modification
of the loop colostomy (Fig. 1, A-E) to
reduce complications and improve patient
comfort. The usual upper abdominal
transverse incision is made and a suitable

segment of colon mobilized (Fig. 1A).
The bowel is then stapled with the TA-55
stapler (Auto Suture Company, Division
of US Surgical Corp., Norwalk, Conn.)
and divided (Fig. 1, B and C). The distal
end is sutured to the posterior sheath (Fig.
ID). The proximal end is matured
primarily, as a functional end-colostomy
(Fig. IE).
Care should be taken to ensure that the
matured end is indeed the proximal end.
This can be confusing in some cases; we
performed a barium stomagram in the
operating room to check this in one
patient.
We have performed this procedure in
five patients. There have been no com
plications of prolapse, hernia or necrosis
in a 3-year follow-up.
We accept that it may be more difficult
to take down this colostomy than the
standard type. However, the need to per
form a formal anastomosis, as opposed
to an “ edge-trimming anastomosis” , does
not appear to add morbidity to the
procedure.2'3 Given the proper indica
tions, any potential disadvantages of our
modification are outweighed by the lack
of complications and ease of caring for
this stoma.
H . S. Ster n , m d , frcsicj
E.D. M yers , m d , frcsjci
Department of surgery,
Mount Sinai Hospital,
600 University Ave.,
Toronto, Ont.
M5G 1X5
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Actinomyces and the IUD
FIG. 1—Modified technique for transverse colostomy. A: isolation of loop of transverse
colon; B and C: division of loop with TA-55 stapler; D: suture of distal limb to peritoneum
and proximal limb to skin; E: finished stoma.

To the editors.—Over the past 4 years at
the University Health Services, Edmon
ton, Alberta, routine cultures were taken
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of all intrauterine devices (IUDs) re
moved to study the incidence of Actino
myces sp.
During the first year of the study, 48
IUDs were removed, but none of the
cultures grew Actinomyces organisms. In
1980, of 85 IUDs removed, 9 (10.5%)
gave a culture positive for Actinomyces
sp. In 1981, 59 IUDs were removed and
25 (42.4%) had cultures positive for Acti
nomyces sp. and in 1982, of 90 IUDs
removed, 51 cultures (56.7%) grew A c
tinomyces organisms. Although the dif
ference in the incidence of positive
cultures between the first and second year
may be attributed to technician inex
perience, these findings appear to be im
portant and should not be ignored.
It is interesting that, traditionally, acti
nomycosis is a disease more prevalent in
adult males, with a peak incidence be
tween 15 and 30 years of age. Although
clinical actinomycosis has become ex
tremely rare with the advent of antibiotic
therapy, our findings merit serious con
sid e ra tio n because a p articu larly
vulnerable group of young women are af
fected. Actinomycosis of the pelvis in
volving fallopian tubes,1 ovaries2 and
urinary bladder3 has been reported, and
in all cases the condition was associated
with the use of IUDs.
In the past, pelvic actinomycosis has
been attributed to secondary infection
from the cecum or the appendix or by in
fection from other areas through the
blood stream. However, more recently,
IUDs have been implicated.4
In a recent study, Duguid and
associates5 from Dundee, Scotland,
re p o rte d finding actinom yces-like
organisms in cervical smears from women
using IUDs. They attributed this infection
to the fact that the IUDs were plastic or
that their use was prolonged. In our ex
perience at the University of Alberta,
there is no correlation between infection
and the type of IUD or the duration of
its use. Indeed, the majority of the IUDs
removed were copper 7s or copper Ts.
Dr. Daniel Mishell, professor and
chairman of the department of research
in gynecology at the University of
Southern California, believed that the
reports of actinomycosis in the endome
trial cavity and cervical canal of patients
who used an IUD were mainly of those
who had retained the IUD for 5 years or
longer.6 However, in our cases, A c
tinomyces organisms were present in
some patients whose IUD had been in
place for only a few months.
Dr. Waldemar Schmidt of the Univer
sity of Texas presented a theory that the
IUD, a foreign body in the uterine cavi
ty, becomes coated with a crust of
calcium that allows certain organisms,
particularly Actinomyces sp., to multi
ply where they are not normally found.4
He believes that certain sexual practices
308

such as orogenital and anogenital sex may
introduce these organisms into the vaginal
canal.
In our 4-year study, 30% of 282 cultures
were positive for Actinomyces organisms.
More important is the fact that the
percentage of positive cultures has been
increasing, cultures of the last 90 IUDs
removed in 1982 showing 56.7% positive
for Actinomyces organisms. More recent
ly, all subjects have also had high endocervical cultures taken before removal
of the IUD. Of the eight in whom both
the IUD and high endocervical cultures
were made, four had positive endocervical
and IUD cultures. We have not yet en
countered symptomatic or clinically ap
parent pelvic actinomycosis accompany
ing the use of the IUD. All subjects with
positive cultures were given a course of
tetracycline and had a follow-up endocer
vical culture after 4 weeks. To date, all
these cultures have been negative.
Because of the increasing occurrence of
pelvic actinomycosis reported in the
literature and the results of our studies,
we have adopted the following routine:
high endocervical culture is done before
the IUD is inserted; follow-up examina
tions include high endocervical cultures
done after 1 month, after 4 months and
then every 6 months up to 3 years, at
which time the IUD is removed and re
placed only after a culture has given
negative results.
Y . YONEDA, MD, FRCS[C], FACS

Obstetrics and gynecology,
University Health Services,
University of Alberta,
Edmonton, Alta.
T6G 2E2
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Antibiotics in Surgery for
Perforated Peptic Ulcer
To the editors.—Dr. Cohen in his
editorial (page 301) recommends that an
tibiotics be given in all cases of perforated
peptic ulcer, irrespective of the duration
of perforation. My contention is that
when surgery is performed within 12
hours of acute perforation, antibiotics

may not be necessary. As stated by Dr.
Cohen, the peritonitis in these cir
cumstances is primarily chemical and
peritoneal cultures taken at this stage are
frequently negative. Moreover, from the
results of my study (pages 370-2), infection
rates in these patients are very low. In
itially, I did not compare the effect of an
tibiotics and no antibiotics given
perioperatively to patients who underwent
operation less than 24 hours after perfora
tion. The reason is that the results of
such comparisons are difficult to interpret
in retrospective studies, especially when
different antibiotic regimens are used.
Despite these drawbacks, on reviewing
my data in patients with early peptic per
foration (within 24 hours), I found that
55 had not received antibiotics and 71
received various antibiotics varying from
three doses to 7-day courses. Six serious
abdominal infections occurred in patients
receiving no antibiotics, and six in those
receiving antibiotics. Most infections were
in patients operated on between 12 and
24 hours of their perforation. These find
ings tend to support my contention that
it may not be necessary to give antibiotics
perioperatively in very early peptic per
foration because infectious complications
do not develop in the majority of patients
treated by operation alone. Proof that
there is no difference in the rate of ab
dominal infection between patients who
receive antibiotics and those who do not
would require a randomized prospective
study, which may not be feasible with the
declining incidence of perforated peptic
ulcer.
I.W . F o n g ,

m d , f r c p ic j

St. Michael’s Hospital,
University of Toronto,
30 Bond St.,
Toronto, Ont.
M5B 1W8
Surgical Management
of Malignant Melanoma
To the editors.—One of the most reward
ing aspects of writing a paper on a con
troversial subject is that it is thoughtprovoking and stimulates discussion.
Margolese, in his editorial that appears
in this issue of the Journal (page 303)), em
phasizes that the controversies are
legitimate and agrees that despite volu
minous literature on the subject, both the
retrospective and prospective data do not
provide all the answers. I agree whole
heartedly that the answers to these con
troversies will be obtained only through
clinical trials that are well designed, pro
spective and randomized, and 1 join him
in his plea for participation in such studies
from every surgeon who deals with mela
noma.
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We also are participants in the NSABP
trials and other multicentre studies and
there is nothing wrong with conservative
cancer surgery when the methodology and
data are valid. Indeed, we may be aban
doning modified radical mastectomy for
lesser procedures in selected breast
cancers when the data support it.
Although both breast cancer and mela
noma are capricious tumours, their
biologic characteristics are not com
parable. Moreover, adjuvant treatment
and long-term management of local re
currences without surgery may be effec
tive in the former but not in the latter.
Although the discussions of controver
sial issues in the management of mela
noma are quite legitimate, surgeons out
side the academic environment may be
confused. What do we advise them to do?
What do we teach our surgical residents?
Today, hundreds of surgeons who do not
wish to refer their patients to specialized
centres treat melanoma and many do not
have access to prospective clinical trials.
In my opinion, the controversy has pro
vided some answers. Wide excision of less
than 5 cm of normal tissue has become
acceptable. Prophylactic lymphadenectomy for thin melanomas is no longer ad
vocated, but is beneficial for thick lesions
or for Clark’s level V lesions, and the
WHO melanoma group found apparent
benefit in subgroups with level IV and
melanomas 1.6 to 4.5 mm thick. Where
the controversy continues is in the treat
ment of lesions of intermediate thickness.
In my paper (Can J Surg 1983; 26:

105-11), I did not make “ binding recom
mendations” . I merely suggested that in
lesions of intermediate thickness other
factors, affecting the incidence of lymphnode metastases and prognosis, are now
Call for Abstracts,
known that permit what I see as a
Second International Conference
selective-elective lymphadenectomy in
on Clinical Factors
high-risk groups.
and Mechanisms Influencing
Whereas this compromise may not pro
Bone Growth
vide the best solution when valid data
become available, at present these
guidelines give the practising surgeon a This second international interdisciplinary
better alternative to the all-or-none conference to be held at the University of
policy, yet sound surgical judgement is re California, Los Angeles, in early January
quired to select the proper candidates for 1985 will be a follow-up to the basic
aggressive surgery. Some of the biologic 1science one held in January 1982 but will
features of melanoma are understandable emphasize clinical sciences aspects of
and the natural history is clearer but the bone growth. A primary objective of the
biologic truth may well be the reverse, as conference again is to update and in
pointed out by Margolese; however, this tegrate our understanding of the growth
truth cannot be found in individual cases of bone with new knowledge and to of
without the lymph-node specimen in the fer directions for future clinical research.
pathologist’s hands. Let’s also not forget The content will cover factors and
that statistical conclusions never take in mechanisms that influence both normal
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recurrence following inadequate excision bone growth, both general and
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continued on page 365

SESAP IV Critique
ITEM 13

Stress ulcers are generally considered to be a variant or extreme of diffuse hemorrhagic gastritis. They do not usually
occur in the duodenum. The incidence of stress ulcers is decreasing in most centers, probably because effective pro
phylactic measures are becoming routine. Maintaining gastric pH at greater than 3.5 appears to be the most important
factor in preventing bleeding from stress ulcers. Because some patients do not demonstrate these pH changes with the
usual dosage, or even higher doses, of cimetidine, antacids controlled with frequent pH monitoring are more effective.
Intragastric pH monitoring is important to gauge the effect of either means of prophylaxis.
Patients who do bleed and ultimately require operation have a poor prognosis because of hemorrhage and the
predisposing conditions that stimulated bleeding. Most reports indicate an operative mortality of at least 20% for any
operation. Truncal vagotomy and pyloroplasty is associated with a rebleeding rate of more than 30%.

E
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v aminoglycosides.
Usage During Pregancy or Lactation: Safety of PIPRACIL* use in pregnant women has not been determined. Because
animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy
only if clearly needed. It has been found to cross the placenta in rats. Caution should be exercised when PIPRACIL*
is administered to nursing mothers. It is excreted in low concentrations in milk.
Pediatric Use: Dosages for children under the age of 12 have not been established.
ADVERSE REACTIONS: PIPRACIL* is generally well tolerated.The most common adverse reactions have been local in
nature, following intravenous or intramuscular injection. The following adverse reactions may occur:
Local Reactions - In clinical trials thrombophlebitis was noted in 3.8% of patients. Pain, erythema, and/or indura
tion at the injection site in 1.9% of patients. Less frequent reactions: ecchymosis, deep vein thrombosis and
hematomas.
^
Hypersensitivity Reactions-Rash was noted in 1.9% of patients. Drug fever 2.1%. Less frequent findings; pruitis,
vesicular eruptions, positive Coombs tests.
Gastrointestinal - Diarrhea and loose stools were noted in 2.8% of patients. Less frequent reactions: vomiting,
nausea, bloody diarrhea.
Hepatic - Increases in liver enzymes (LDH, SGOT, SGPT), hyperbilirubinemia. Rarely, cholestatic hepatitis.
Renal-Elevations of creatinine or BUN.
Central Nervous System - Headache, dizziness, fatigue.
Hemic and Lymphatic - Reversible leukopenia, neutropenia, thrombocytopenia and/or eosinophilia, bleeding and
decreases in prothrombin time have been reported. Reversible leukopenia (neutropenia) is more apt to occur in
patients receiving prolonged therapy at high dosages or in association with drugs known to cause this reaction.
Serum Electrolytes - Individuals with liver disease or individuals receiving cytotoxic therapy or diuretics, were
reported rarely to demonstrate a decrease in serum potassium concentrations with high doses of PIPRACILr
r
Musculo-Skeletal - Rarely, prolonged muscle relaxation.
Other - Superinfection, including candidiasis.
DOSAGE AND ADMINISTRATION: PIPRACIL* may be administered by the intramuscular route or intravenously by injec
tion or infusion. Dosage and route of administration should be determined by the severity of the infection and
condition of the patient. The usual dosage for serious infections is 3 to 4 grams given every 4 to 6 hours as a 20 to 30
minute infusion administered intravenously.
The maximum daily dose usually administered to adults is 24 g/day, although higher doses have been used.

DOSAGE
Type of Infection
Serious infections such as septicemia, nosocomial pneumonia, intra abdominal infections, aerobic and anaerobic gynecologic infections,
and skin soft-tissue infections.
Complicated urinary tract infections.
Uncomplicated urinary tract infections and most community-acquired
pneumonia.
Uncomplicated gonococcal urethritis.

Usual Total
Daily Dosage
12-18 g I V.
(200-300 mg/kg)

Frequency of
Administration

8-16 g I V.
(125-200 mg/kg)
6-8 g IM . or I V
(100-125 mg/kg)
2 g I.M*

Every 6 to
8 hours
Every 6 to
12 hours
Single dose

*0 ne gram of probenecid given orally 1/2 hour prior to injection.
Dosage In Renal Impairment
Urinary Tract
Urinary Tract
Creatinine
Infection
Infection
Clearance
(complicated)
(uncomplicated)
mL/min.
>40
20-40
<20

Every 4 to
6 hours

Serious Systemic
Infection

No dosage adjustment necessary
No dosage adjustment necessary 9 g/day 3 g every 8 hrs.
6 g/day 3 g every 12hrs.
6 g/day 3 g every 12 hrs.
Hemodialysis removes 30-50% of piperacillin in 4 hours;
6
1 g additional dose should be administered following each dialysis

12 g/day 4 g every 8 hrs.
8 g/day 4 g every 12 hrs.

g/day 2 g every 8 hrs.
Patients on
period.
Hemodialysis*
For patients with renal failure and hepatic insufficiency, measurement of serum levels of PIPRACIL* will provide
additional guidance for adjusting dosage.
Infants and Children - Dosages in infants and children under 12 years of age have not been established
The average duration of PIPRACIL* treatment is from 7 to 10 days, except for gynecologic infections, in which
it is from 3 to 10 days; the duration should be guided by the patient’s clinical and bacteriological progress. For most
acute infections, treatment should be continued for at least 48 to 72 hours after the patient becomes asympto
matic. Therapy for Group A beta-hemolytic streptococcal infections should be maintained for at least 10 days to
reduce the risk of rheumatic fever of glomerulonephritis.
ADMINISTRATION
Intramuscular: When indicated by clinical and bacteriological findings, intramuscular administration of 6 to 8 g. daily
of PIPRACIL* in divided doses, may be utilized for initiation of therapy and this route may be considered for m ainte
nance therapy after clinical and bacteriologic improvement has been obtained with intravenous piperacillin sodium
treatment. Administration should not exceed 2 g. per injection at any one site. This route has been used primarily in
the treatment of patients with uncomplicated gonorrhea and urinary tract infections.
Adults and Children More Than 12 Years of Age: The reconstituted solution is given by deep intramuscular injection. The
preferred site of injection is the upper outer quadrant of the buttock (i.e. gluteus maximus). Also may be given in the
mid-lateral muscles of the thigh. The deltoid area should be used only if well developed, and then only with caution
to avoid radial nerve injury. Intramuscular injection should not be made into the lower or mid-third of the upper arm.
Intravenous: The intravenous route should be used in the treatment of serious infections.
Direcf Intravenous (Bolus) Injection: The vials should be reconstituted with 5 mL of suitable diluent listed below
and the resulting solution should be injected slowly over a period of 3 to 5 minutes to help avoid vein irritation.
Intravenous Infusion: A dilution of at least 15 mL per gram is recommended to reduce potential for vein irritation.
The reconstituted and diluted solution may be administered by intermittent or continuous drip. Intermittent infusion
should be administered over a period of about 30 minutes. During intermittent infusion it is desirable to discontinue
the primary intravenous solution. Any unused portion must be discarded. For continuous infusion the solution may
be administered over a longer period of time.
RECONSTITUTION
For Intramuscular Use: Solutions for Reconstitution: Sterile Water for Injection, or if required
'Bacteriostatic Water for Injection,
"Lidocaine HC1 0.5 or 1% (without epinephrine)-For Intramuscular Use Only.
For Intravenous Use: Solutions for Reconstitution: Sterile Water for Injection, or if required,
'Bacteriostatic Water for Injection.
‘ Either parabens or benzyl alcohol.
"Lidocaine HC1 is contraindicated in patients with a known history of hypersensitivity to local anesthetics of
the amide type.
RECONSTITUTION TABLE
Approximate
Approximate
VOLUME OF
Product
Average Concentration
Available Volume
Diluent to be added
Size
1 g/2.5 mL
5.0 mL
4.0 mL
Vials 2 g
1 g/2.5 mL
7.5 mL
6.0 mL
3g
1 g/2.5 mL
10.0 mL
7.8 mL
4g
Infusion Bottles
17 mL
15 mL
3g
23 mL
20 mL
4g
The prepared solution may be further diluted to the desired volume with any of the solutions for intravenous
infusion listed below.
The contents of the 3 and 4 g infusion bottles should be diluted to at least 15 mL per gram.
The appropriate quantity of reconstituted solution may be added to an intravenous bottle or bag containing
any of the solutions for intravenous infusion listed below.
Solutions for Intravenous Infusion:
Intravenous Admixtures:
Intravenous Solutions:
Normal Saline (+KCL 40 mEq).
5% Dextrose in Water [D5W]
5% Dextrose/Water [D5W] (+KCL 40 mEq).
0.9% Sodium Chloride (Normal Saline) [NS].
5% Dextrose/Normal Saline [D5NS] (+KCL 40 mEq).
Dextrose 5% and 0.9% Sodium Chloride [D5NS].
Ringer’s Injection, U.S.P. (+KCL 40 mEq).
Lactated Ringer's Injection, U.S.P.
Lactated Ringer’s Injection, U.S.P. (+KCL 40 mEq).
Dextran 6% in 0.9% Sodium Chloride.
STABILITY OF SOLUTIONS: PIPRACIL* is stable in both glass and plastic containers when reconstituted with recom
mended diluents and further diluted with the indicated intravenous solution and intravenous admixtures.
Stability studies have demonstrated chemical stability (pH, potency and clarity) through 24 hours at room
temperature and up to 72 hours refrigerated. Appropriate consideration of aseptic technique, however, recom
mends discarding unused portions after storage for 24 hours at room temperature or 48 hours refrigerated. If used
as a multi-dose container, the vials must be reconstituted only with the bacteriostatic diluents noted above.
INCOMPATIBILITY: Because of chemical instability, PIPRACIL* should not be used for intravenous administration with
solutions containing sodium bicarbonate
PIPRACIL* should not be added to blood products, protein hydrolysates or amino acids.
When PIPRACIL* is given concurrently with aminoglycosides, it is recommended that both drugs be used in full
therapeutic doses, but administered separately. PIPRACIL* should not be mixed with an aminoglycoside in a
syringe or infusion bottle, since this can result in inactivation of the aminoglycoside.
DOSAGE FORMS: PIPRACIL* (sterile, lyophilized piperacillin sodium) is available in vials containing amounts of pipera
cillin sodium equivalent to 2, 3 and 4 grams of piperacillin. Available in boxes of 12 vials.
Product Numbers: 2 g /v ia l-3879-48 3 g/vial-38 8 2 -4 9 4 g /v ia l-3880-50
Available in 100 mL size infusion ("piggyback") bottles, containing sterile, freeze-dried piperacillin sodium
powder equivalent to 3 and 4 grams of piperacillin. Boxes of 12 infusion bottles.
Product Numbers: 3 g/bottles- 3882-41 4 g /b o ttle s -3880-42
Piperacillin Sensitivity Discs impregnated with 100 ug of piperacillin are also available.
Storage:
PIPRACIL* vials and infusion bottles should be stored at controlled room temperatures of 15-30°C (59-86°F).
Piperacillin Sensitivity Discs should be refrigerated upon receipt. Product Monograph available on request. __
'PIPRACIL is a trade mark of Lederle Piperacillin, Inc.
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REVIEW ARTICLE
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Cimetidine 6 Years Later:
a Review
Over 1 5 million people have been treated
with cimetidine since its introduction 6
years ago. Although the drug was
thoroughly investigated before release,
through its use more information has
become available on the side-effects and
the way cimetidine has altered the
natural history of peptic ulcer disease.
Initially, the drug decreased the number
of operations performed for peptic ulcer
and we have now developed a clearer
understanding of the indications for
surgery.
This review puts together old and new
data that may be of value to physicians
prescribing cimetidine. The development
of cimetidine as an agent for treating
peptic ulcer, its side-effects and indica
tions for use and the introduction of
other H2 antagonists are discussed.
Some data are included on why patients
do not respond to H2 blockade and how
these patients should be managed.
Plus de 15 millions d'individus ont ete
traites a la cimetidine depuis son
apparition, il y a 6 ans. Bien que le
medicament ait ete etudie a fond avant
son lancement, son usage a permis
d'obtenir davantage d'information sur
ses effets secondaires et sur la facon
dont la cimetidine a modifie I'histoire
naturelle de I'ulcere gastro duodenal. Au
debut, le medicament a reduit le nombre
des operations pratiquees dans les cas
d'ulceres gastro-duodenaux et nous
avons maintenant acquis une meilleure
connaissance des indications
chirurgicales.
Cette revue rassemble des donnees
anciennes et nouvelles susceptibles
d'etre d'interet pour les medecins qui
prescrivent la cimetidine. On commente
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le developpement de la cimetidine
comme agent therapeutique de I'ulcere
gastro duodenal, ses effets secondaires
et ses indications, ainsi que I'arrivee de
nouveaux inhibiteurs des recepteurs
histaminiques H2. Des donnees sont
fournies expliquant pourquoi certains
patients ne repondent pas aux anti-H2 et
indiquent comment ces patients doivent
etre traites.

Histamine

Histamine was first synthesized in
1907,8 but it was not until 1922 that it
was shown to be a potent stimulant of
gastric acid release in man.9 It was found
to be present in gastric mucosa, sug
gesting that it was intimately related to
gastric secretion. However, the exact role
of histamine has remained an enigma.
Emmelin and Kahlson10 were the first to
suggest that histamine is the final common
Duodenal ulceration occurs because of an
pathway in gastric secretion and soon
imbalance between excess secretion of
afterwards Code" proposed that no other
acid and impaired mucosal resistance.
chemostimulator is interpaired between
Although measures that theoretically pro
histamine and the parietal cell and that
mote mucosal resistance are known, the
histamine is the final common local
aim of both medical and surgical therapy
chemostimulator of the parietal cells of
for peptic ulcer has been to decrease acid
the gastric mucosa. Although this theory
secretion. Before the Hr receptor an
has had immense support, not all workers
tagonists were introduced, there was no
are in agreement.12
really effective medical therapy for
Most recent work, using isolated
duodenal ulcer. Antacids decrease inparietal cells, has demonstrated separate
tragastric acidity over a 24-hour period1
receptors on the parietal cell for gastrin,
and have been shown to heal duodenal
acetylcholine and histamine that interact
ulcers when given in large doses.2 An
but are histamine-dependent.13 There
ticholinergic drugs also decrease acid
have been many attempts to antagonize
secretion, but both agents are associated
gastric secretion with conventional an
with unacceptable side-effects when used
tihistamines but all have failed.14' 16 In
in therapeutic doses.3,4
1948, a leading article in the British
When cimetidine, an H,-receptor an
Medical Journal'1 stated: “ It is strange
tagonist, was introduced in 1976, it that on gastric secretion alone, there has
became possible to decrease effectively all till now been no suggestion of antagonism
forms of basal and stimulated acid out between substances (histamine and anti
put without resorting to surgery. Within histamines) which are antagonists every
5 years, cimetidine had been given to over
where else. It is likely that there is one
15 million people throughout the world
simple explanation of this anomaly which
and was an enormous commercial
would well repay exploration” . Ash and
success.
Schild18 suggested that the effects of
Over the past 20 years the number of histamine antagonized by antihistamines
operations performed for duodenal ulcer be called “ H, effects” , but it was not
has declined gradually;--6 the introduc
until 1972 that the H2 receptor was
tion of cimetidine dramatically ac defined.
celerated this fall. The drug was also
responsible for decreasing the number of Cimetidine
working days lost by those with duodenal
ulcers. Cimetidine, however, is thought Introduction
to have no effect on the natural history
of this disease7 and may merely postpone
The concept of a receptor is rather like
surgery. Few drugs have been so widely a keyhole. Any hormone or drug with a
evaluated and it is time to reassess the predetermined chemical configuration
value of treatment with H2 blockade.
may activate or inactivate a receptor site
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as a key locks or unlocks a door.
Histamine behaves like a master key by
activating different types of receptor.
Black and colleagues19 defined the
H, receptors after systematically in
vestigating more than 700 compounds
with a chemical structure similar to that
of histamine. They discovered that methyl
substitutions at different sites on the im
idazole ring gave rise to two separate
types of compound, each with single
receptor specificity: four methyl substitu
tions resulted in H2 effects while two
methyl substitutions resulted in H, ef
fects. Their test systems included contrac
tion of isolated guinea pig ileum and rat
stomach (both of which are antagonized
by conventional antihistamines) to define
H, effects, and acid secretion in per
fused rat stomach and contraction fre
quency of both isolated guinea pig heart
muscle and rat uterus to define H2
effects.
Soon after these elementary dis
coveries, burimamide, the first hista
mine H;-receptor antagonist, was syn
thesized. It inhibited histamine and
pentagastrin-stimulated acid secretion by
57% .19 The absorption of the drug was
unreliable in experimental animals and this
compound was not evaluated in man.
Slight alteration in the chemical structure
of burimamide resulted in a compound
with improved solubility and ionization,
hence providing better absorption. The
resulting compound, metiamide, was
more potent than burimamide in decreas
ing stimulated acid secretion and reached
the stage of clinical trials to assess heal
ing in duodenal ulceration. Unfortunate
ly, although it was efficacious in healing
duodenal ulcer, seven cases of bone mar
row depression were reported with one
death. Metiamide was therefore no longer
used in man.
Cimetidine was the third H2-receptor
antagonist to be synthesized and was
found to be without side-effects or
adverse reactions in experim ental
animals. It was shown to inhibit effective
ly all forms of basal and stimulated acid
secretion in m an,20'24 and numerous
clinical trials have confirmed its effec
tiveness in both relieving symptoms and
healing duodenal ulceration.25,26 Few
drugs are used as widely as cimetidine. In
dications for its use include esopha
gitis,27 gastric erosions,28 emergency
anesthesia,29 renal transplantation,30
pancreatic insufficiency and ileal resec
tion.31
Although cimetidine has been effective
in healing gastric and duodenal ulcera
tion, it has not been as successful in
treating their complications. One report
demonstrated an increased incidence of
perforated ulcers since the introduction
of cimetidine and suggested that although
H2 blockade may heal an ulcer, it does
not protect against perforation.32 The

drug is o f no proven benefit in
gastrointestinal bleeding,33 although it
may be of use when combined with
a n tacid s.34 Early experience with
ra n itid in e , a new, more p o tent
H2-receptor antagonist, suggests this
may be of benefit in preventing rebleeding
in duodenal ulceration.35
Initially, the recommended dose of
cimetidine was 200 mg three times daily
and 400 mg at bedtime (1 g/d) in the
United Kingdom, and 300 mg four times
daily (1.2 g/d) in North America, but it
was shown that twice daily doses of 400
mg (UK) and 600 mg (US) were just as
effective in decreasing intragastric acidi
ty over a 24-hour period36,37 and in heal
ing duodenal ulceration.38,39 The twice
daily doses are now the recommended
form of treatment. More recently, it has
been shown that a single large night-time
dose of an H2-receptor antagonist is as
effective as a twice daily dose in decreas
ing 24-hour intragastric acidity and has
led the authors to suggest that a large
night-time dose should be evaluated by
clinical trial as a primary therapy for pep
tic ulcer.40
The use of cimetidine is indicated for
reflux esophagitis as demonstrated by a
review of 11 controlled trials involving
more than 450 patients.41 The results in
nine of these trials showed a significant
improvement in symptoms and the other
two demonstrated a trend in the same
direction that was not significant because
of the small numbers involved. However,
cimetidine was not superior to placebo in
preventing stricture recurrence or in
reversing m etaplasia of B a rre tt’s
esophagus.41
Cimetidine’s other main use has been
to prevent upper gastrointestinal bleeding
from stress lesions in high-risk patients.
After reviewing the literature, Speranza
and colleagues42 concluded that
cimetidine and antacids were equally ef
fective in diminishing the incidence of
bleeding in these patients, but the advan
tage of cimetidine is that it can be given
parenterally. The prophylactic use of
cimetidine in patients with sepsis was not
very effective although the benefits of
cimetidine combined with antacids in
these patients have yet to be evaluated.
Side-Effects
Cimetidine is relatively safe. In short
term clinical trials of 2182 patients with
peptic ulcer, 24 had untoward side-effects
compared with 10 of 844 patients treated
with placebo.43 Mental confusion may
occur in the elderly or very ill44 in whom
cimetidine may cross the blood-brain bar
rier. Cimetidine has mild antiandrogenic
side-effects in animals in much larger
doses than are used clinically.44 It causes
an increase in the serum prolactin level

when given as an intravenous bolus in
man and has been shown to elevate serum
luteinizing hormone and testosterone
levels.45 It also decreases the response of
aldosterone to angiotensin, inhibits
vasopressin release and causes an exag
gerated response of thyroid-stimulating
hormone to a thyrotropic-releasing hor
mone stimulation test. Reported sideeffects have included gynecomastia, im
potence and loss of libido. It has also been
shown that cimetidine interferes with
hepatic metabolism of other drugs such
as warfarin, diazepam, phenytoin and
antipyrine.46 More recently, there have
been reports of arthropathy and renal
failure associated with cimetidine therapy.
Early experience with ranitidine suggests
that this, the latest H2-receptor an
tagonist, is without most of these pro
blems, although two reports47,48 have
shown an increase in serum prolactin
levels with ranitidine.
Cimetidine can suppress the symptoms
of, or even heal, an early intramucosal
gastric carcinoma or lymphoma and thus
seriously delay diagnosis. Even an ex
perienced endoscopist can miss small le
sions on the lesser curvature. It seems
likely that a missed carcinoma was pre
sent before cimetidine treatment in all of
the 21 patients with gastric carcinoma,
found in association with cimetidine
therapy, reported to the Committee of
Safety of Medicines up to January
1981 . 49

A fu rth e r association betw een
cimetidine and gastric cancer has been
suggested by two hypothetical mech
anisms. The first suggests that by
raising intragastric pH, colonization of
the stomach by nitrate-reducing bacteria
might increase intragastric nitrite and
subsequently nitrosamines and nitrosam ides th a t might be associated
with an increased risk o f gastric
carcinoma.50 Gledhill and associates,51
however, have shown that vagotomy may
raise pH more than cimetidine, and
Stalsberg and Taksdal52 have shown a
sixfold increase in the risk of gastric
carcinoma following gastric surgery.
Moreover, recent work53 casts doubt on
this theoretical risk by showing that in
normal subjects on a normal diet, cime
tidine (1 g/d) does not alter the gastric
pH sufficiently to produce bacterial col
onization, and there are no consistent
changes in nitrate-reducing bacteria,
nitrite or nitrosamine levels.
A more worrying hypothesis is that in
tragastric nitrite may combine with
cimetidine, resulting in nitrosocimetidine,
which is of similar chemical structure to
N-methyl-N-nitroso-N-nitrosoguanidine,
a known potent gastric carcinogen in ani
mals.54 Nitrosocimetidine, however, has
never been isolated from the human
stomach. Many other drugs such as chlorpromazine, chlordiazepoxide, tetracy-
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cline and oxytetracycline also undergo
nitrosation, producing theoretically
carcinogenic metabolites, yet occurrence
o f a malignant tumour has not been
reported in association with any of these
drugs.
With all these theoretical risks, it must
be stressed that cimetidine should not be
given as a trial of therapy for dyspepsia
without adequate diagnosis by barium
meal or endoscopy. Treatment should be
for a 6-week period to induce ulcer heal
ing. If symptoms return then a further
course of cimetidine may be given without
additional investigations provided a
malignant tumour is not suspected. Fre
quent exacerbations are, however, an in
dication for operation, which should be
offered to patients in preference to
maintenance therapy. Nonsurgical treat
ment results in a high relapse rate55 and
does not alter the natural history of this
disease.7 Cimetidine is still the initial
treatment of choice for duodenal and
gastric ulcer.
The Nonresponder
It is increasingly recognized that
cimetidine will heal only 57% to 87% of
duodenal ulcers after a 6-week course of
therapy.56 Although in most cases con
tinued treatment will ultimately result in
healing, it is predictable that 7% of pa
tients will have more than three attacks
a year.57 One possible explanation for
lack of response is poor compliance.
Boyd and associates58 monitored com
pliance by counting tablets and measur
ing drug metabolites in early morning
urine samples. They concluded that com
pliance did not differ between patients
whose ulcer remained healed and those
who had a relapse. Patients with active
ulcer disease experience pain which gives
them an incentive to take their medica
tion. Once symptoms disappear, com
pliance may be less important because a
recent study has shown that the number
of ulcers endoscopically healed 3 months
after presentation is independent of the
length of treatment, as long as the pa
tients take their medication until symp
toms disappear.59
Boyd and associates58 have shown that
patients who have a relapse while on
maintenance therapy do not differ in age,
sex, duration of symptoms, smoking
habits and alcohol consumption from
those who do not have a relapse. These
findings have been confirm ed by
Bardhan,60 who called the cimetidineresistant ulcer a “ refractory ulcer” . Bar
dhan also showed that there were no ap
preciable differences in endoscopic
features, acid and pepsin outputs and
serum gastrin levels between patients with
refractory and those with healing ulcer.
Peden and associates61 found that
ulcers in women were less likely to heal,
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but Sonnenberg and colleagues62 found
an increased incidence of healing in
women. The latter group also found
moderate alcohol intake, abstinence from
smoking and youth were good prognostic
indicators whereas concomitant disease,
number and total area of peptic lesions,
family history and duration of symptoms
had little influence on the response of the
ulcer to treatm ent. Dragstedt and
Owens63 suggested that the most impor
tant etiologic factor in the pathogenesis
of duodenal ulcer was increased vagal
tone manifested by nocturnal hypersecre
tion. More recently, Hunt64 noted that
although individual responses to cime
tidine were similar during the day, over
night there were two patterns of response:
one group of patients with little or no
decrease in intragastric acidity when
receiving cimetidine, and a second group
who were relatively anacidic. The former
group were noted to have a poorer
response to treatment than the latter.
Venables and associates,65 using a com
bined pentagastrin-insulin test, showed
that, after insulin stimulation, those
whose ulcers failed to heal had differing
acid to pepsin secretion ratios. They sug
gested that such patients are more respon
sive to vagal stimulation than those whose
ulcer healed. This suggestion is supported
by their findings that in patients who ran
domly received either cimetidine and an
anticholinergic agent or cimetidine alone,
all who received the combined therapy
had healed ulcers, whereas healing
occurred in only 60% of those taking
cimetidine alone. Thjodleifsson and
Wormsley66 have suggested that when
nocturnal acidity is not controlled by H,
blockade, control of acid secretion may
be improved by the addition of atropine.
This has been noted by others.67 The use
of cimetidine with pirenzepine, a new
locally acting antimuscarinic agent
similar to atropine, has resulted in better
acid inhibition than with cimetidine
alone.68 This combination has also im
proved the healing rates of duodenal ulcer
compared with those for each drug used
alone.69
Of particular interest to surgeons is the
possibility that failure to respond to
cimetidine might predict a poor response
to vagotomy. Venables,70 before the in
troduction of cimetidine, found a 5%
recurrence rate with truncal vagotomy.
More recently, since selecting cimetidine
nonresponders for surgery, recurrence
rates have risen to 16.6%, which he sug
gests is cause for concern. This high recur
rence rate is similar to the 15% recurrence
rate after proximal gastric vagotomy
reported by Blackett and Johnson.71
They had previously noted a 14% recur
rence with proximal gastric vagotomy
before the introduction of cimetidine.
These high recurrence rates in non
responders may be due to more ac

curate diagnosis with the widespread use
of endoscopy to document recurrence, or
perhaps to poor results with highly selec
tive vagotomy, when compared with trun
cal vagotomy and drainage. Recently,
proximal gastric vagotomy has been
shown to provide substantially better con
trol of acid secretion than cimetidine in
patients who prospectively meet criteria
of poor clinical response to H 2
antagonists.51 This report concluded that
proximal gastric vagotomy should pro
vide adequate therapy for nonresponders,
making more radical surgical procedures
unnecessary.
The Future
At present, several other H2 an 
tagonists are being developed and the
market will soon become saturated with
these compounds as has occurred with
13-blockers and cephalosporins. Most of
these new compounds, like cimetidine, are
competitive Hr receptor antagonists,
although some are noncompetitive and
have a longer duration of action.
Tiotidine (ICI Pharmaceuticals) and
SKF/93479 were both promising com
pounds, but there were problems during
development. Oxmetidine (Smith, Kline
& French), and ranitidine (Glaxo
Laboratories) are more potent com
pounds and both have reached the stage
of clinical trials. The latter drug is now
available on open prescription in several
European countries and was put on the
Canadian market in November 1982. The
chemical structure of ranitidine is based
on a furan ring, rather than the imidazole
ring of cimetidine and may explain why
ranitidine has few of the side-effects of
cimetidine. However, it must be stressed
that the side-effects of cimetidine were
not recognized until 2 years after its in
troduction. Although ranitidine appears
to be a more potent, safer compound, it
should not be recommended as a superior
treatment until it has been as well tried
as cimetidine.
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arteriovenous fistulas and in one patient
with a large peripheral aneurysm. The
results were satisfactory. The clinical
presentation and treatment course in
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and the role of this form of therapy is
discussed. This method of endovascular
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treating pulmonary arteriovenous fistulas
and aneurysms because placement of
the balloon is precise, permanent and
localized and the flow of the balloon in
the fistula or aneurysm can be directed.
Les auteurs decrivent leur technique
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The technique o f embolization using a
detachable balloon to produce endo
vascular o cclu sio n was originally
developed to manage cerebral arterio
venous malformations and fistulas.1 It
has also been used at more peripheral
sites for vascular occlusion in the manage
ment of hemorrhage, tumours and arterio
venous fistulas.2
We present a number o f case reports
to show how this technique can be used
to occlude pulmonary arteriovenous
fistulas and to obliterate a large internal
iliac aneurysm. We discuss the role o f this
technique in such situations.

Case Reports
Case 1
A 57-year-old housewife was referred for
assessment of cyanosis to the chest diseases
unit of the University Hospital in London, On
tario. She had experienced shortness of breath
for 15 years. Her effort tolerance had
deteriorated progressively and was about 50 m
at the time of assessment. She had a history
of recurrent chest infections with a chronic
cough productive of clear sputum. She smoked
two to three cigarettes daily. As child she
had frequent sore throats and recurrent
epistaxis. She suffered from migraines and
decreased vision in the right eye. The family
history was noncontributory.
On physical examination, central cyanosis
and clubbing of the fingers and toes were evi
dent. No telangiectasia was present. Chest
auscultation indicated a localized bruit at the
base of the left lung. There was decreased
visual acuity in the right eye, with macular
degeneration.
Laboratory findings were as follows:
hemoglobin level 21.1 g/dl; leukocyte count 6.3
x 109/l with a normal differential count;
platelet and reticulocyte counts, prothrombin
time, partial thromboplastin time and serum ■
electrolytes, blood urea nitrogen, creatinine,
albumin, calcium, phosphate, urate and
bilirubin levels were all normal. Blood-gas
analysis with the patient breathing room air
showed: arterial oxygen tension (Pao2) of 49
mm Hg, arterial carbon dioxide tension
(Paco2) of 30 mm Hg, pH 7.45, bicarbonate
23 mmol/1 and arterial oxygen saturation
86.7%. Pulmonary function tests showed nor

mal flow, normal lung volume and a normal
diffusing capacity.
A chest roentgenogram showed pulmonary
arteriovenous fistulas in both lungs. Two large
fistulas were demonstrated angiographically in
the left lower lobe and one in the right lower
lobe (Fig. 1). Two smaller fistulas were also
present, one in each lower lobe. A computer
ized tomogram of the head showed an old
infarct of the left occipital lobe.
On perfusion study following injection of
technetium 99m labelled with macroaggregated
albumin, there was substantial activity within
the brain and the kidneys. The right to left
shunt was estimated to divert 35% of the car
diac output. The four arteriovenous fistulas
were occluded under angiographic control with
detachable latex balloons, at two sessions,
without any complications (Fig. 2). A roent
genogram obtained after the procedure showed
the seven occluding balloons in position.
The mass lesions created by the varices had
disappeared.
The patient’s symptoms lessened and arterial
blood-gas values returned to normal (Table I).
She remains well 18 months after the
procedure.
Case 2
A 29-year-old woman was referred to the
chest diseases unit for balloon embolization of
multiple pulmonary arteriovenous fistulas. A
diagnosis of Osler-Weber-Rendu disease was
made when she was 15 years old. Since then,
her condition had deteriorated progressively.
She suffered from shortness of breath, fatigue,
dizziness, headaches and chest pain. She was
hospitalized on numerous occasions for com
plications secondary to her Osler-WeberRendu disease. These included recurrent
hemoptysis, gastrointestinal bleeding, iron
deficiency and a cerebral abscess. At the time
of admission, her daily activities were severe
ly restricted. She had been confined to a
wheelchair for 2 years and was using oxygen
intermittently at home. Surgical therapy was
not considered appropriate because she had
multiple large arteriovenous fistulas in both
lungs.
She was cyanosed and clubbing of fingers
and toes was present. Telangiectasia was pre
sent on her tongue and lips. A large
arteriovenous fistula, secondary to a previous
cardiac catheterization, was present in the right
antecubital fossa. There were flow murmurs
at both lung bases. The jugular venous pressure
was mildly elevated and cardiomegaly was pre-
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sent. The liver was palpable with a span of 12
cm. Examination of the central nervous system
gave normal findings. Laboratory data were:
hemoglobin level 13.0 g/dl, leukocyte count 3.9
x 109/1 with a normal differential count and
red cell indices o f hypochrom ia and
microcytosis, serum iron 3.56 /unol/l (normal
11.59 to 31.33 ^mol/1), saturation of transfer
rin 6% (normal 20% to 55%), platelets 173 x
109/1 and reticulocytes 6.8%; values were nor
mal for the prothrombin and partial throm
boplastin times, urinalysis and serum elec
trolytes, albumin, calcium, phosphate, urate,
glutamic oxaloacetic transaminase, glutamic
pyruvic transaminase and alkaline phos
phatase. The total lactic dehydrogenase
was 367 1U/1 (normal 203 to 378 1U/1) with
the LD| fraction 28.7% (normal 14% to
26%). Total serum bilirubin value was 27.36
fimol/1 (normal 3.42 to 17.1 ^irnol/1) and the
direct bilirubin value was 6.84 jtmol/1.
The electrocardiogram was normal. The
electroencephalogram showed a focal abnor
mality in the left occipital lobe secondary to
the cerebral abscess. C om puterized
to m o g rap h y of the head
showed
encephalomalacia of the left occipital lobe.
Blood-gas analysis with the patient breathing
room air showed: Pao2 35 mm Hg, Paco2 31
mm Hg, pH 7.45, oxygen saturation 69.3%.
The chest roentgenogram showed cardiomegaly with right-sided prominence and
multiple arteriovenous fistulas in both lungs.
A pulm onary angiogram dem onstrated
numerous arteriovenous malformations in both
lungs with the largest in the bases. Many of
the largest malformations were occluded, us
ing a total of 32 balloons and two coils at six
different angiographic sessions. The procedures
were uncomplicated apart from a grand mal
seizure that developed during the sixth session.
This seizure was thought to be secondary to
the cerebral abscess scar.
A postembolization chest roentgenogram
showed a decrease in the heart size to within
normal limits and multiple balloons and
markers in fistulas. Several varices were still
present.
The patient improved clinically with an in
crease in Pao2 and oxygen saturation (Table
1) and had a marked improvement in effort
tolerance; she no longer used her wheelchair.
Fifteen months after her treatment she is still
well, with a Pao2 o f 47 mm Hg. Further em
bolization of the pulmonary arteriovenous
fistulas and occlusion of the right arm
arteriovenous fistula are planned.

Case 3
A 29-year-old housewife was referred for
evaluation of polycythemia. Her symptoms of

Fig. lb

Fig. 2b

FIG. 1—Case 1. (a) Anteroposterior right
pulmonary arteriogram before treatment.
Large pulmonary arteriovenous fistula is in
lower lobe with small one distal to it. (b) Left
pulmonary arteriogram shows two large
fistulas in lower lobe. All three large fistulas
are large venous varices supplied by up to three
fistulas per varix.

FIG. 2—Case 1. (a) Right pulmonary
arteriogram immediately after embolization.
Large fistulas are no longer present. Occluding
balloons are indicated by arrows, (b) Left
pulmonary arteriogram after embolizatioir.
Large fistulas are not visible. Occluding
balloons are indicated by arrows.

Table -Arterial Blood-Gas (mm Hg) and Shunt Values before and after Embolization
Breathing
room air
Patient
no.
1

2
3

318

Pao2 Paco2, pH
49
30
7.45
35
31
7.45
48
32
7.42

Before embolization
Breathing
100% 02
%
sat. Pa02, Paco2, pH
86.7
70
24
7.50
69.3
42
33
7.45
83.9
79
32
7.42

Breathing
room air
% Shunt,
sat.
%
Pa02, Paco2, pH
95.6
38
68
36
7.42
44
79.8
52
27
7.40
95.9
35
68
28
7.47

After embolization
Breathing
100% 02
%
sat. Pa02, PaC02, pH
94.3 484
30
7.48
79.4
65
28
7.40
93.3 169
36
7.40

% Shunt,
sat.
%
100
11
92.7 38
99.5 24
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fatigue, fainting, headaches and mild shortness
of breath had been present for 4 years and she
had also noticed a bluish discoloration of her
lips, fingers and toes since childhood. An
elevated hemoglobin level was noted 2 years
earlier and she underwent phlebotomy on six
occasions. Apart from frequent epistaxis, there
was no history of blood loss and no family
history of cardiorespiratory or hematologic
illnesses.
She was cyanosed and her fingers and toes
were clubbed. Telangiectasia was present on
her lips. There was a bruit over the middle zone
of the right lung, which was accentuated
during Mueller’s maneuver.
Laboratory findings were: hemoglobin level
17.9 g/dl; leukocyte count 5 x 109/1 with a
normal differential count; values for serum
electrolytes, calcium, phosphate, urate and
bilirubin and urinalysis were normal. Bloodgas analysis with the patient breathing room
air showed a Pao2 of 48.0 mm Hg, Paco2 32.0
mm Hg, pH 7.42, bicarbonate 21 mmol/1 and
oxygen saturation 83.9%. Pulmonary function
testing showed that lung volume, flow and dif
fusing capacity were normal. The electrocar
diogram was normal.
A chest roentgenogram showed an
arteriovenous fistula peripherally in the mid
dle lobe of the right lung and a smaller nodule
in the lower lobe.
Pulmonary angiography demonstrated five
small arteriovenous fistulas in the lower lobe
of the left lung. One large arteriovenous fistula
was present in the right middle lobe and 11
smaller ones were scattered throughout the
right lung.
Directly after the pulmonary angiogram was
obtained, a detachable latex balloon was used
to occlude the large fistula. The procedure was
uncomplicated. Arterial blood-gas values
measured after the procedure showed notable
improvement (Table 1). The patient remains
well 1 year after the embolization. The Pao2

has increased to 57 mm Hg, the chest film
shows no change in the embolized fistula but
slight enlargement of a right lower lobe fistula.
She will undergo digital p u lm onary
angiography to check this.

FIG. 3—Case 4. Pelvic arteriogram shows
large right internal iliac aneurysm. There is
calcification in its wall (curved arrows), lumen
is trilobar (straight arrows) and neck is
posterior and slightly superior to common il
iac bifurcation (open arrow).

FIG. 4—Case 4. Angiogram 3 months after
embolization. Balloons are in aneurysm.
Balloon in neck of aneurysm was filled with
radiolucent silicone material. There is no
filling of aneurysm and no visualization of
neck.

Case 4
A 65-year-old man had had right pelvic and
hip pain for 3 years. The pain increased in
severity during the day and was particularly ag
gravated by bowel movement. There were no
neurologic signs and no clinical evidence of
peripheral vascular occlusive disease. Investiga
tions, including plain pelvic films and aor
tography (Fig. 3), showed an aneurysm of the
right internal iliac artery measuring 8 cm with
calcification in its walls. There was also dif
fuse ectasia of the entire aorta from the distal
thoracic arch to the common iliac bifurcations.
In view of the size and location of the aneurysm
and the evidence of diffuse aortic disease, a
nonoperative attempt to occlude the aneurysm
was appropriate.
Initially, 8-mm Gianturco coils were put in
to the neck of the aneurysm, but these would
not maintain their position due to the short
aneurysm neck, which quickly widened into the
aneurysm, and they simply fell into the lumen
of the aneurysm. The aneurysm was therefore
catheterized and five detachable balloons were
inserted through the catheter. The intent was
to fill the aneurysm with balloons so that
thrombosis would take place. However, it was
possible to occlude the outflow and stenose the
inflow to the aneurysm by selective balloon
placement, creating stasis and encouraging
thrombosis to take place. The patient tolerated
the procedure well and was discharged 2 days
later.
On follow-up at 3 months, an angiogram
showed that the aneurysm remained throm
bosed (Fig. 4). The patient’s hip and pelvic
pain had resolved.

Discussion
Pulmonary Arteriovenous Fistulas
Pulmonary arteriovenous fistulas are
rare and the majority are asymptomatic,
although the complications associated
with them are often severe and may be
life-threatening. Surgical therapy has been
the mainstay of active treatment for
symptomatic fistulas.3 According to the
review of Dines and associates,3 only
44% are symptomatic and one third are
multiple. Of the 63 patients reviewed, 38
were treated surgically, the resection be
ing conservative whenever possible. Even
then, 15 (40%) underwent a lobectomy,
9 (24%) a segmentectomy and 7 (18%) a
wedge resection. In only 5 (13%) was a
pure fistula resection accomplished. The
fistula can be resected even in difficult
cases as illustrated recently,4 but the
review of Dines and associates3 indicates
that this is the exception rather than the
rule. Surgical advances may, however,
lead to greater success in resecting
fistulas.
Isolated reports over the last few years
have indicated successful treatment of
these fistulas by various embolization
techniques.5'8 The most satisfactory ap
pear to have been those using a
detachable balloon to occlude the
fistula.9,10 This method is ideal for
treating arteriovenous fistulas because of
the precise, permanent and localized
nature of the occlusion and the flow
direction of the balloon into the fistula.
Infarction of small segments of normal
lung occurs infrequently10 and is less
likely with balloon occlusion than with
other methods because balloon placement
is precise. If the malformation is of the
rare diffuse type, then loss of lung paren
chyma will occur both with excision and
embolization.8
Pulmonary arteriovenous fistulas are
also particularly suited to this method of
therapy as they are generally supplied by
one or only a few vessels with no prox
imal connections to the fistula.10 Occlu
sion of the feeding vessel therefore
abolishes the fistula, unlike congenital
arteriovenous malformations in other
viscera.
Pulmonary hypertension has been
described in association with pulmonary
arteriovenous fistulas and, as a sequel to
occlusion of the fistula, worsening of the
hypertension.11 This association is rare,
having been documented in only seven
cases; however, transcatheter balloon oc
clusion affords the possibility of record
ing pulmonary arterial pressures at the
time of occlusion and before balloon
release. Pulmonary hypertension thus can
be avoided. None of our cases showed
pulmonary artery hypertension, and there
was no notable change in pulmonary and
right ventricular pressures after emboliza-
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tion in our cases or those of others.410
Serious complications related to the oc
clusion procedure are rare and should oc
cur less frequently with balloon occlusion
than with other techniques. Displacement
of the occluder has been described,8 but
this was when Gianturco coils were used;
it should not occur with detachable
balloons unless there is very early defla
tion. We have encountered no major pro
blems with the technique. One patient
suffered a seizure during an embolization
session, but there is no evidence to
associate this with the embolization; the
electroencephalogram indicated an epilep
togenic focus related to the left occipital
lobe scar from a previous brain abscess.
Dines and associates3 suggest that
there are four indications for operation
in pulmonary arteriovenous fistulas: for
symptomatic fistulas with large shunts,
for enlarging fistulas, for shunt reduction
in multiple bilateral fistulas and for
fistulas with systemic blood supply. Con
sidering the age range of their patients (4
to 70 years, mean 41 years) and the fact
that 44% were symptomatic at the time
of study, most patients with pulmonary
arteriovenous fistulas will likely become
symptomatic. On the basis of our small
experience, we suggest that embolization
of fistulas with detachable balloons
should be considered as a primary method
of therapy for pulmonary arteriovenous
fistulas in Dines’ first three categories,3
and that all such fistulas be considered for
treatment to avoid the life-threatening
complications that may ensue.
Aneurysm s
Operative treatment of our patient with
an internal iliac aneurysm (case no. 4)
would have been a major undertaking.
The size o f the aneurysm and its short
neck would have made proximal ligation
extremely difficult.
The detachable balloon method of en
dovascular occlusion is likely the one
most suited to aneurysmal control in this
situation because of the variety of balloon
sizes available, the precision possible in
locating the vascular occlusion, its local
ized nature and the ability to direct the flow
o f the embolus and to manipulate its
placement by a coaxial system such as
that developed by Debrun and asso
ciates.1
The technique of endovascular occlu
sion has been used as a method of em
bolization in many circumstances, in
cluding control of hemorrhage, tumour
and presurgically for flow control and for
th ro m b o sis of a few intracran ial
aneurysms. Embolization techniques have
also been attempted as an adjunct to
operation for controlling abdominal aor
tic aneurysms.12;13 However, in a few in
stances it has been used for more
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peripheral aneurysm control, either as an
ad ju n ct or
an
alternative to
o p eratio n .14’15 We believe that this
method of aneurysm control merits
serious consideration, particularly in the
patient who is a poor operative risk or
when the aneurysm is in a surgically dif
ficult location.

"STEMETIL®
(prochlorperazine)
stops nausea, helps keep
the patient calm and alert

11. Rodan BA, G o d w in JD, C h e n JTT, Ra vin CE:
Worsening pulmonary hypertension after resection of
arteriovenous fistula. A JR 1981; 137: 864-6

Indications: nausea and vomiting of various
etiologies: gastrointestinal disorders, drug
intolerance, motion and radiation sickness,
post-operative conditions, pregnancy, vertigo and
migraines.
Dosage: Adults, oral route - Usual effective
dosage is 5 to 10 mg, 3 or 4 times daily; in very
mild cases, a single dose of 5 to 10 mg is often
adequate. This dosage may be increased as
required by increments of 10 mg every 2 or 3 days
until symptoms are controlled. For maintenance
therapy the dosage should be reduced to the
minimum effective dose. Rectal route - The
suggested adult dose is 20 to 50 mg daily.
Children: oral and rectal routes - up to 10 mg
per day in divided doses according to body weight.
Parenteral route (not to exceed 40 mg per day) In general practice: 5 to 10 mg I.M., 2 or 3 times a
day. In surgery: 5 to 10 mg I.M., 1 to 2 hours
before anesthesia. Repeat once during surgery if
necessary. Post-operatively, same dose of 5 to 10
mg I.M., repeated every 3 to 4 hours. Maybe
given I.V. during and after surgery in the infusion
solution at a concentration of 20 mg per litre. In
obstetrics: 10 mg I.M. during first stage of labor;
subsequent 10 mg doses as needed. Postpartum:
the usual total daily dose is 15 to 30 mg orally or
1. M.
Contraindications: comatose or deeply de
pressed states of the CNS due to hypnotics,
analgesics, narcotics, alcohol, etc.;
hypersensitivity to phenothiazines; blood
dyscrasias; bone marrow depression; liver
damage.
Warnings and precautions: etiology of vomiting
should be established before using the drug as its
antiemetic action may mask symptoms of
intracranial pressure or intestinal obstruction.
Patients with a history of convulsive disorders
should be given an appropriate anticonvulsant
while on therapy. Tardive dyskinesia may occur in
patients on long-term therapy. If used with CNS
depressants, the possibility of an additive effect
should be considered. Use with great caution in
patients with glaucoma or prostatic hypertrophy.
The drug may impair the mental and/or physical
abilities required for the performance of potentially
hazardous tasks such as driving a car or operating
machinery, especially during the first few days of
therapy. Keep in mind that all medications should
be used cautiously in pregnant patients, especially
during the first trimester.
Side effects: extrapyramidal reactions, disturbed
temperature regulation and seizures have been
encountered. Other side effects due to
phenothiazine derivatives should be borne in mind;
for complete list, see product monograph.
Overdosage: no specific antidote; symptomatic
treatment. If a pressor agent is required,
norepinephrine may be given (not epinephrine as it
may further depress the blood pressure).
Dosage forms: tablets 5 and 10 mg; ampoules
2 mL/10 mg; liquid 5 mg per teaspoonful (5 m lj;
suppositories 5 and 10 mg.
Full prescribing information available on
request.

12. C arrasco H, P arry CE: Transcatheter embolization
o f abdominal aortic aneurysms. A J R 1982; 138: 729-33

References: 1. Int. Rec. Med., 170; 469, 1957.
2. Curr. Ther. Res., 14 (9): 590-598, 1972
3. Today's Drugs, Brit. Med. J., 481, 1970.
4. Antiseptic, 73: 16, 1976.

References
l . D ebrun G, L a c o u r P, C a ro n JP, H u r t h , M, C om OY J, Keravel Y: Detachable balloon and calibratedleak balloon techniques in the treatment o f cerebral
vascular lesions. J Neurosurg 1978; 49: 635-49

2. w h it e Rl jr . Ba rth KH, Ka u f m a n SL, D e C a pin o v ,
STRANDBERG JD: Therapeutic em bolization with
detachable balloons. Cardiovasc Intervent Radiol 1980;
3: 229-41

3. D ines DE, A rms RA, B e rn at z PE, G om es MR:
Pulmonary arteriovenous fistula. M avo Clin Proc 1 974*
49: 460-5

4. B rown SE, W righ t PW , Ren n er JW, riker JB:
Staged bilateral thoracotomies for multiple pulmonary
arteriovenous malformations complicating hereditary
hemorrhagic telangiectasia. J Thorac Cardiovasc Surg
1982; 83: 285-9

5. T aylor BG, C ockerill EM, M a nfre d i F, Klatte
EC: Therapeutic embolization o f the pulmonary artery
in pulmonary arteriovenous fistula. A m J M ed 1978; 64:
360-5

6. JONSSON K HELLEKAUT C, OLSSONO, Holen O: Per
cutaneous transcatheter occlusion o f pulmonary arterio
venous malformation. Ann Radiol (Paris) 1980; 23: 335-7

7. C a st a n e d a -Zu n ig a w , E pstein M, Zollikofer C,
N ath PH, Form anek A , B en -Sha c h a r G, A m platz
K: Embolization o f multiple pulmonary artery fistulas,
Radiology 1980; 134: 309-10

!
;
j

8. H atfield DR, F ried AM: Therapeutic embolization o f
diffuse pulmonary arteriovenous malformations. A JR
1981; 137: 861-3

!
I

9. T erry PB, Ba rth KH, Ka u f m a n SL, W hite Rl j r :
Balloon embolization for treatment o f pulmonary
arteriovenous fistulas. N Engl J M ed 1980; 302: 1189-90

j

10. Barth KH, w h it e Rl jr . Ka u f m a n SL, T erry PB,
Ro l a n d JM: E m boloth erapy o f pulm onary
arteriovenous malformations with detachable balloons.
Radiology 1982; 142: 599-606

13. G oldm an ML, P hilip p k , Sarrafizadeh M, Marar
HG, SINGH N: Transcatheter em bolization with
Bucrylate (in 100 patients). Radiographics 1982; 3: 340-75

i

RHONEPOULENC PHARMA Inc.
8580 Esplanade
Montreal, Quebec
^authorized user

14. Rankin RN, Yo u n g so n GG. Mc Kenzie FN: Manage
ment o f superior gluteal artery aneurysm by percutaneous
balloon catheter occlusion: a case report. Surgerv 1979;
85: 235-7

15. REUTER SR, CARSON SN: Thrombosis o f a common il
iac artery aneurysm by selective embolization and extraanatomic bypass. A JR 1980; 134: 1248-50

VOLUME 26, NO. 4, JU L Y 1983 / THE CANADIAN JOURNAL OF SURGERY

One antiem etic m ay be all it takes
to stop nausea in the w ard

□Anaesthesia □ Surgery
□ Chemotherapy □ Radiation therapy
Stemetil rapidly controls nausea in
m ost hospitalized patients
A single dose of Stemetil usually stops
nausea in just 30-45 minutes,1and keeps
working for up to four hours.

Stemetil helps keep surgical
patients comfortable and alert
Stemetil does not cause excessive sedation,2
so vital signs can be taken without delay. The
mild anxiolytic effect helps keep patients
calm and co-operative.2 Stemetil is well
tolerated, and remarkably free from toxic
side effects.34

A dosage form for every need
Ampoules 2 mL/10 mg (i.m./i.v. inf.)
Tablets 5 and 10 mg
Suppositories 5 and 10 mg
Liquid 5 mg/5 mL

STEMETIE

prochlorperazine

stops nausea, helps keep the patient
calm and alert
RHONE POULENC PHARMA Inc.
8580 Esplanade
Montreal, Quebec
®authorized user

A lain Verdant , md , frcsicj;* Robert C ossette, md, frcsicj;* Leon Dontigny , md, frcsicj;*
C laude Mercier , md, m sc;* A rthur P age , md, frcsicj!

Resultats ameliores dans la chirurgie non urgente
des anevrismes de I'aorte thoracique descendante
Les a u te u rs p re se n te rs 3 5 cas d'anevrism e de I'ao rte th o ra ciq u e descendante
soum is a un tra ite m e n t chirurg ica l non
urg e n t. Les m alades fu re n t divises en
deux g ro u p e s e tiologiques. Le groupe 1
c o m p re n a it 16 m alades (age m oyen de
3 5 ans) p o rte u rs d 'u n anevrism e traum atiq u e c h ro n iq u e d e c o u ve rt entre 4 m ois
e t 4 3 ans apres I'a c c id e n t. Le groupe 2
in c lu a it 1 9 malades (age m oyen de 65
ans) d o n t I'an e vrism e e ta it principale
m en t d 'o rig in e a rte rio scle ro tiq u e ou
s y p h ilitiq u e .
D u ra n t le clam page aortique, la circu la 
tio n fu t assuree grace a une derivation
e xte rn e inseree p ro xim a le m en t au niveau
de I'a o rte ascendante et dista le m e n t
dans I'a o rte descendante ou la fem orale
gauche. C e tte d e riva tio n tem poraire
(shunt de G ott) ne necessite pas d'heparin is a tio n syste m iq u e et assure, a la fois,
une d e co m p re ssio n du segm ent aortique
p ro xim a l e t une pe rfu sio n op tim a le du
se g m e n t ao rtiq u e dista l. Dans certains
cas, une so lu tio n de n itro g lyce rin e ou de
n itro p ru s s ia te est infusee pour assurer
une d e co m p re ssio n proxim ale optim ale.
Les p rin c ip a u x p o in ts a surveiller sont: a)
la m esure co n tin u e lle de la pression arterielle e t des gas sanguins series par I’ inte rm e d ia ire d une canule arterielle inseree
dans la radiate d ro ite ; b) une ve n tila tio n
m axim ale par I'in te rm ed ia ire d 'u n tube
e n d o tra ch e a l standard; et c) le retablissem en t rapide du vo lu m e sanguin en cas
de p e rte s im p o rta n te s a I'aide d 'u n appareil a a u to tra n s fu s io n . Cet appareil perm et e g a le m e n t de conserver les pertes
sanguines dans un reservoir avec I'alterna tive de ne retransfuser q u 'a u m om ent
du declam page a ortique.
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Dans la p lu p a rt des cas, un clam page
aortique e n tre la ca ro tid e et la sousclaviere gauches fa c ilite I'anastom ose
proxim ale. N ous fa vo riso n s une dissec
tio n transversale com plete du collet
proxim al et d ista l pour bien s'assurer que
I'ad ve n tice e st incluse circonferentiellem en t dans les anastom oses aortiques.
Ce system e de p ro te ctio n organique est
excellent. Un seul m alade est decede, ce
qui donne une m o rta lite operatoire de
2 .8 % . A ucun cas de defaillance cardiaque, d 'in s u ffis a n c e renale ou de paraplegie ne fu t observe.
T h irty -fiv e p a tie n ts w ere operated upon
e le ctive ly fo r a descending th o ra cic aor
tic aneurysm . S ixteen pa tie nts (mean age
3 5 years) in g ro u p 1 had a chronic
tra u m a tic aneurysm , fo u n d betw een 4
m onths and 4 3 years a fte r th e ir a cci
d ent. In g ro u p 2 w ere 19 patients (mean
age 6 5 years) w ith aneurysm s caused
m ainly by a rte rio scle ro sis or syphilis.
During th e period o f a o rtic cross
clam ping, a o rtic flo w w a s diverted
th ro u g h an e xte rn a l G o tt heparin-coated
sh u n t, placed b e tw e en the ascending
aorta p ro xim a lly and the descending aor
ta or le ft fe m o ra l artery d istally. No
syste m ic hep arin iza tio n w as required.
T his m ethod provides excellent proxim al
decom pression and o p tim a l distal p e rfu 
sion. In som e cases, a drip o f
n itro g lyce rin o r nitro p ru ssid e solution
w a s necessary to obtain com plete aortic
decom pression p ro xim a lly. Three points
relating to m o n ito rin g are im p orta n t: (a)
blood pressure should be recorded co n 
tin u o usly and blood samples fo r m easur
ing blood gases are obtained th rough a
rig h t radial a rte ry line; (b) a standard
endotracheal tu b e is preferred fo r m ax
im al o xyg e n a tio n during a o rtic cross
clam ping; and (c) an autotra n sfusion
system is used. This a llo w s large
am ounts o f lo s t blood to be returned to
th e pa tie nt to m aintain a stable co n d i
tio n . W hen losses are m inor, blood is
saved in a rese rvo ir and is retransfused
o n ly w hen norm al a o rtic circulation is
restored.
Better exp o sure fo r th e proxim al
anastom osis can be obtained by clam p
ing the a o rtic arch b etw een the le ft

ca ro tid and th e le ft subclavian arteries.
C om plete tra n se ctio n o f th e aorta at the
a n a sto m o tic sites is advised to ensure
th a t th e a d ve n titia is circu m fe re n tia lly in 
cluded in th e su tu re line. The authors
sh o w th a t th is sh u n t te chnique has pro
vided safe circ u la to ry su p p ort and good
organ p ro te ctio n . One p a tie nt died, g iv 
ing an overall op e ra tive m o rta lity o f
2 .8 % . A m o n g su rvivors, no heart failure,
paraplegia or renal failure occurred.

L’aorte thoracique descendante occupe le
deuxieme rang, apres I’aorte abdominale
sous-renale, pour Tincidence des anevris
mes aortiques. L’arteriosclerose ou la
syphilis n ’en sont plus les causes principales. En effet, dans notre serie de 68
malades operes, plus de la moitie, soit 36
cas, etaient des anevrismes traumatiques
secondaires a des accidents de la route.
Quelle qu’en soit l’etioiogie, leur evolu
tion naturelle est maligne et ils doivent
etre reseques avant que ne surviennent les
complications spontanees qu’on leur connait: a) La rupture dont les symptomes
miment souvent les urgences coronariennes. b) La compression des structures
mediastinales, notamment de la bronche
souche gauche au point de compromettre serieusement la respiration dans cer
tains cas. c) L’embolie peripherique originant du materiel thrombotique qui
borde les parois internes et qui a l’occasion peut meme se surinfecter.

Depuis le debut de notre experience
dans ce domaine, nous avons rode une
technique chirurgicale que nous avons
rigoureusement appliquee chez tous les
malades traites en urgence ou en
differe.1 Pour bien demontrer la securite
de cette technique, nous ne presenterons
que les 35 cas operes de faqon non
urgente, eliminant 33 autres malades ope
res en catastrophe ou en etat de choc et
dont la mortalite operatoire un peu plus
elevee n ’est que directement reliee a la
condition precaire du malade avant l’intervention et non pas a la technique ellememe.
Ces 35 cas soumis a un traitement chi
rurgical non urgent ont ete divises en deux
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groupes etiologiques: un premier groupe
de 16 malades porteurs d ’un anevrisme
traumatique chronique decouvert entre 4
mois et 43 ans apres l’accident, leur age
variait de 18 ans a 60 ans avec une
moyenne de 35 ans; un deuxieme groupe
dont l’anevrisme etait d’origine principaIement arteriosclerotique ou encore syphilitique et dont l’age s’echelonnait de 41
ans a 78 ans avec une moyenne de 65 ans.
T echnique

La reparation de l’aorte thoracique descendante necessite un clampage aortique
total dont les consequences physiologiques sont serieuses. En effet, dans 1’etage
superieur au clampage, il se produit une
hypertension soudaine pouvant atteindre
200 a 250 mm Hg et dont les effets se
repercutent sur deux organes cibles
importants: le cerveau et le coeur. Au
niveau cerebral, un oedeme, une hemorragie ou une hypoxie par vasospasme
reactionnel diffus peuvent en resulter. Au
niveau cardiaque, une surcharge aigue
s’ensuit, se manifestant d ’abord par de
l’arythmie ventriculaire puis de la bradycardie et finalement, par un arret cardia
que du a la distension des fibres
ventriculaires.
Dans 1’etage inferieur au clampage aor
tique, la pression arterielle s’effondre provoquant une hypotension de tous les orga
nes et engendrant une acidose metabolique exageree par une insuffisance renale,
faute de perfusion adequate des arteres
renales.
Cette acidose metabolique ajoutee aux
effets nocifs de la surcharge cardiaque
peut conduire rapidement a l’arret cardia
que. L’hypoperfusion distale touche egalement la moelle epiniere avec les risques
toujours constants de paraplegie.
Pour eviter ces perturbations physiologiques graves, nous avons opte pour une
technique de protection organique
excluant la circulation extra-corporelle
dont les risques hemorragiques relies a
l’heparinisation systemique sont bien connus. Notre technique chirurgicale est

FIG. 1—Protection des organes durant le
clampage aortique. Derivation externe inseree
entre I'aorte ascendante et I’aorte descendanle
assurant a la fois une decompression du coeur
et des vaisseaux cerebraux et une perfusion des
organes distaux. En normovolemie, une per
fusion de nitroglycerine ou de nitroprussiate
s’avere parfois un complement necessaire pour
une decompression proximale optimale.

basee sur [’utilisation d’une derivation
externe inseree proximalement au niveau
de l’aorte ascendante et, distalement, au
niveau de I’aorte descendante (fig. 1).
Cette derivation (shunt de Gott; Sher
wood Medical Industries, St. Louis, Mo.)
est un tube de chlorure de polyvinyle
transparent dont les parois internes sont
enduites d ’un complexe heparinique qui
em peche toute coagulation in tra luminale. Aucune heparinisation systemi
que n’est done requise.
Selon notre experience, cette derivation

FIG. 2—Technique chirurgicale. 1) Clam 
page aortique entre la carotide et la sousclaviere gauches. 2) Transection complete du
collet aortique proximal et distal. 3) Verifica
tion de I’etancheite de [’anastomose proximale.
4) Declampage selectif de I'aorte proximale et
distale et de la sous-claviere gauche pour
extraire tout debris thrombotique. 5) Declam
page de I’aorte descendante et exteriorisation
de Fair residuel contenue dans la prothese de
Dacron. 6) Declampage de la cross aortique et
exteriorisation de Fair residuel a la base de la
sous-claviere gauche. 7) Declampage de la sousclaviere gauche. 8) La prothese de Dacron est
recouverte de I’ancienne paroie anevrismale
dans le but de I'isoler des structures
mediastinales.

assure a la fois une excellente decompres
sion aortique proximale, alors que la pres
sion de I’aorte ascendante se maintient
entre 125 et 150 mm Hg. La pression de
perfusion distale reste generalement audessus de 70 mm Hg alors qu’un debit urinaire conserve en est le reflet direct.
Chez les malades plus ages et hypertendus de longue date dont la compliance
vasculaire est alteree, il est parfois neces
saire d ’ajouter une perfusion de nitrogly
cerine ou de nitroprussiate si l’on veut
assurer une decompression proximale
adequate.
Le monitoring est de premiere impor
tance pour le bon deroulement de cette
intervention.
• Contrairement a certains auteurs qui
favorisent l’emploi d ’un tube de Carlens
pour collaber selectivement le poumon
gauche et obtenir une meilleure exposi
tion, nous utilisons un tube endotracheal
standard. Ceci nous permet d ’assurer une
oxygenation optimale tout au long de l’intervention, mais surtout au moment du
clampage aortique.
• Une canule arterielle introduite dans
la radiale droite sert a l’enregistrement
continu de la pression arterielle et au prelevement d ’echantillons sanguins pour la
rnesure des gaz arteriels avant et pendant
le clampage aortique de meme qu’au
declampage.
• Une tension veineuse centrale est
essentielle po u r le rem placem ent
liquidien.
• La pression auriculaire gauche n ’est
mesuree que dans les cas a haut risque
cardiaque, soit par l’intermediaire d ’un
Swan-Ganz insere avant l’operation, soit
par canulation peroperatoire de l’artere
pulmonaire.
• L’utilisation d ’un autotransfuseur
permet en cas de perte sanguine majeure
de retransfuser rapidement et d ’eviter de
graves fluctuations de pression arterielle.
Cet appareil est particulierement apprecie lorsqu’a 1’ouverture de l’anevrisme,
plusieurs arteres intercostales donnent a
plein debit. Le sang recueilli dans un
reservoir peut etre conserve et retransfuse
seulement au moment du declampage
aortique. Cette hypovolemie relative per
met un meilleur controle de la pression
arterielle proximale dans certains cas ou
malgre l’utilisation du nitroprussiate, elle
demeure trop elevee.
• Une solution de mannitol est amorcee peu avant le clampage aortique.
Quelques points nous semblent impor
tants dans la technique de resection qui
par ailleurs a ete bien standardisee depuis
plusieurs annees. Pour les anevrismes
dont l’origine interesse les premiers cen
timetres distaux a la sous-claviere gauche,
nous clampons la crosse aortique entre la
carotide gauche et la sous-claviere gauche,
ce qui nous donne une meilleure exposi
tion pour l’anastomose proximale (fig. 2,
no. 1).
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La section du ligament arteriel permet
une meilleure mobilisation de la partie
posterieure de l’aorte. Contrairement a
certains auteurs qui gardent la paroi pos
terieure intacte, nous sectionnons completement le collet aortique proximal et dis
tal, seule fagon de s’assurer de l’incorporation indispensable de 1’adventice dans
les anastomoses (fig. 2, no. 2).
De plus, comme le minimum de dissec
tion est pratique, la plevre recouvrant
1’aorte sur sa face anterieure et laterale
est egalement incluse dans les anastomo
ses. Avant de completer 1’anastomose dis
tale, l’aorte proximale et distale et la sousclaviere gauche sont ouvertes tour a tour
et irriguees avec du serum physiologique
pour en extraire tout materiel thrombotique residuel (fig. 2, no. 4). Le clamp
aortique distal est d ’abord relache et la
prothese de Dacron est piquee a plusieurs
reprises pour en evacuer completement
Pair residuel (fig. 2, no. 5). Alors seulement la pince aortique proximale est relachee en s’assurant que la derivation a
d’abord ete clampee de maniere a eviter
toute embolie aerienne a rebours dans
l’aorte ascendante.

Enfin, avant de liberer la sous-claviere
gauche, l’aiguille est repiquee a sa base
car tout air residuel emprisonne non evacue pourrait avoir comme consequence
une embolie cerebrale via la vertebrale
gauche (fig. 2, no. 6).

Resultats
Des 35 malades operes, un seul est
decede secondairement a une embolie pulmonaire 8 jours postoperatoire. Notre
mortalite operatoire est done de 2.8%.
Aucun cas d’insuffisance cardiaque ne
fut note. Les seules complications cardiaques mineures rencontrees furent la tachycardie sinusale et 1’hypertension paradoxale, phenomenes reflexes maintenant
bien connus survenant frequemment dans
la chirurgie de l’aorte thoracique et dont
l’incidence dans notre serie a ete de pres
de 80%.
Les mesures pre- et postoperatoires de
Puree et de la creatinine nous permettent
d ’affirmer qu’aucun cas d’insuffisance
renale ne fut note. Aucune paraplegie
n ’est survenue.

Conclusions
Les succes de la chirurgie moderne ne
se mesurent plus seulement en termes de
mortalite diminuee, mais aussi en termes
de morbidite minimale. Nous sommes
done partisans d’une protection optimale
des organes durant le clampage aortique.
Notre technique de derivation a bien
demontre son efficacite dans sa double
fonction de decompression proximale et
de perfusion distale. Grace a cette
methode, la chirurgie de Paorte thoraci
que descendante peut etre faite en toute
securite pour le malade.

Addendum
Depuis l’acceptation de ce manuscrit pour
publication, 10 autres nouveaux cas d’anevrisme de l’aorte thoracique descendante ont
ete operes avec cette technique. Trois malades
ont ete soumis a une chirurgie non urgente avec
une survie sans complication chez tous.
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BOOK REVIEWS
COMPLEX FOOT DEFORMITIES IN
CHILDREN. Sherman S. Coleman. 301 pp.
Illust. Lea & Febiger, Philadelphia, 1983.
$65.75 (Can.). ISBN 0-8121-0857-4.
Dr. Coleman, professor of orthopedic surgery
at the University of Utah College of Medicine,
has produced a clear and definitive work on
foot deformities in children. Not all deformities
are complex, and he has given proper weight
to each. Most of the book is properly devoted
to talipes equinovarus. The text is presented
in such an orderly and clear manner, it is
difficult to find any fault. The illustrations,
including the roentgenograms, are clear and
crisp. The book is printed on quality paper,
the type is large and the composition is
expansive with wide margins, giving a sense of
non-crowding.
One of the major complicating factors of
foot deformities in children is the growth
potential, which adds to the problem and
presents an ever-changing picture requiring
constant vigilance and possible changes of
treatm ent. Early recognition, continued
treatment and long-term follow-up are all em
phasized in the book. The etiology and patho
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genesis, the probable evolution of the problem
at hand and the possibilities of treatment are
presented clearly and accurately. The list of
conditions is short but well chosen. Some
illustrations are repeated; however, instead of
detracting from the readability, this adds to it.
One gets the feeling that the author luxuriated
a little in his presentation; the wide borders and
large format add to this feeling. Yet, the price
for this type of book has been kept relatively
low.
The author has been meticulous in his choice
of words and methods. He is comfortable to
be with in this book and he gives the feeling
that he and the book can be trusted.

GENITOURINARY CANCER SURGERY.
Edited by E. David Crawford and Thomas
A. Borden. 575 pp. Illust. Lea & Febiger,
Philadelphia, 1982. $144. (Can.). ISBN
0-8121-0812-4.

is presented as a complete text on urologic
oncology. Although it deals primarily with
surgery of urologic malignant tumours, other
related aspects are included such as radio
therapy and chemotherapy.
The text is thorough and the chapters have
been carefully selected. The contributors are
experts in their fields and have written from
personal experience. The book reads easily and
the illustrations are generous and clear. At the
beginning of each chapter, a short historical
introduction gives an elegant background to
the topic. Although the surgical techniques
occupy most of the text, anatomy, pathology,
patient selection and pre- and postoperative
care are also well presented in a logical manner.
The editors have described the various
approaches to the treatment of urologic
malignant tumours and have shown good
judgement in their references.
This book is a useful reference text for both
residents and practising urologists. The idea of
covering all aspects of urologic oncology in one
text makes it easier for the residents to acquire
the necessary knowledge on the subject and for
the surgeon to obtain updated information in

With contributions by 57 authors, this book

continued on page 382
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Effect of Femoral Profundaplasty on Blood Flow
The effect of femoral profundaplasty on
blood flow in the lower limb was
examined. In 15 patients with signs and
symptoms of femoropopliteal artery
occlusion, the following measurements
were made before and after profun
daplasty with vein-patch graft: ankle
pressure index, muscle blood flow at rest
and with maximal exercise (xenon
clearance technique), and blood flow in
the calf and in the great toe (venous oc
clusion plethysmography). No significant
change was found in resting muscle
blood flow, or in the results of calf or
toe plethysmography. Muscle blood flow
was significantly (p < 0.01) increased 1
minute after maximal ischemic exercise
(6.3 ± 2.0 ml/100 g*min 1 before
operation and 10.4 ± 3.9 after) and the
time to reach peak muscle blood flow
after tourniquet release was significantly
reduced (p < 0.01) after operation, from
149 ± 52 to 102 ± 46 seconds. Ankle
pressure index was unchanged by pro
fundaplasty (0.63 ± 0.17). All of the six
patients with claudication were subjec
tively improved, and in seven of the nine
patients with foot ischemia the limb was
saved. The changes in blood flow help to
explain the clinical improvement noted
after profundaplasty.
Les effets de la plastie de I'artere
femorale profonde sur la circulation
sanguine dans les membres inferieurs ont
ete etudies. Chez 15 patients presentant
les signes et symptomes d'une
obliteration femoropoplitee, les
evaluations suivantes ont ete faites
avant et apres une plastie profonde par
greffe de tissu veineux: indice de
pression a la cheville, le debit sanguin
musculaire au repos et a I'effort
maximum (par la technique de la
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clairance du xenon), et le debit sanguin
dans le mollet et le gros orteil (par
plethysmographie avec occlusion
veineuse). Aucun changement significatif
n'a ete observe sur le debit sanguin
musculaire au repos ou sur les resultats
de la plethysmographie du mollet ou de
I'orteil. La circulation sanguine etait
significativement augmentee (p < 0.01)
1 minute apres un exercice ischemiant
maximum (6.3 ± 2.0 ml/100 g-min 1
avant I'operation contre 10.4 ± 3.9
apres) et le temps necessaire pour
atteindre un debit sanguin musculaire
maximum apres relachement d'un garrot
etait significativement reduit (p < 0.01)
apres I'operation, passant de 149 ± 52
a 102 ± 46 secondes. L'indice de
pression a la cheville n'a pas ete modifie
par la plastie (0.63 ± 0.17). Les six
patients qui souffraient de claudication
ont ete subjectivement ameliores et sept
des neuf patients ayant une ischemie du
pied ont vu leur membre etre sauve. Les
modifications du debit sanguin aident a
expliquer I'amelioration clinique observee
apres plastie d'une artere femorale
profonde.

Since femoral profundaplasty, or deep
femoral angioplasty, was introduced 15
years ago,1 enthusiasm for this pro
cedure has waxed and waned. The impor
tance of revascularization of the deep
femoral artery was first recognized in
relation to “ run-off” at the lower end of
aortofemoral bypass grafts;2,3 then pro
fundaplasty became popular in the
m anagem ent o f fem oropopliteal
disease.4'7 At one time it was suggested
that it was the procedure of choice even
when the more traditional femoropop
liteal bypass grafting procedure was
technically possible.8
The hemodynamic data available on
the results of femoral profundaplasty are
limited. This study was designed to
measure limb blood flow' and its distribu
tion before and after profundaplasty, in
o rd er to evaluate the procedure
objectively.
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Patients and Methods

Reprint requests to: Dr. C.J. Wright,
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Patients
Fifteen patients (age range from 52 to

74 years) with symptomatic femoropop
liteal disease were studied. Six had in
capacitating calf claudication and nine
had rest pain or pregangrenous changes
in the foot. Arteriography showed com
plete occlusion of the superficial femoral
artery in every case, together with distal
obstruction of varying severity. Four pa
tients had maturity-onset diabetes. In six
patients the angiogram suggested that
femoropopliteal bypass grafting would
have been technically possible, whereas in
the remainder no adequate popliteal
artery could be seen. There was no
evidence of stenosis at the orifice of the
deep femoral artery, although lateral
angiograms of the artery were not
obtained.
Experimental Procedure
Patients were studied supine in an airconditioned room 1 to 3 days before
operation. After 30 minutes of rest with
the leg in a foam cradle, the following
measurements were made: ankle and
brachial systolic pressures, measured by
Doppler stethoscope and blood pressure
cuff on the lower calf and arm respective
ly; ankle pressure index, expressed as
ankle systolic pressure (mm Fig) divided
by brachial systolic pressure (mm Fig), the
normal value being in the range of 1.0 to
1.15.
Blood Flow Measurements
Muscle blood flow in the anterior tibial
muscle compartment was measured by the
xenon-133 clearance technique described
by Lassen and colleagues.9 Each
measurement followed the injection of 0.1
ml o f xenon-133 in saline.
Venous occlusion plethysmography us
ing mercury strain-gauges measured
blood flow in the midcalf region and in
the great toe, with a rapid-inflation
venous tourniquet around the thigh and
the lower calf respectively.
Muscle Exercise Model
After measurements at rest were made,
the thigh tourniquet was inflated to a level
exceeding systolic pressure and the patient
exercised the ankle as vigorously as possi
ble. This was continued to the limits of
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patient tolerance, which in no case was
less than 2 minutes. Following release of
the tourniquet, muscle blood flow was
measured at intervals of 1 minute and the
time lapse from tourniquet release to
maximal muscle blood flow was record
ed. The plethysmographic measurements
were made only at rest because of
technical constraints.
Operative Procedure
U nder
general an esth esia,
a
longitudinal incision was made at the
groin to expose the common, superficial
and deep fem oral arteries. An
arteriotomy was made extending from the
common femoral down the deep femoral
artery until at least the first major branch
was reached (Figs. 1 and 2). In some cases
local endarterectomy was performed and
in all cases the arteriotomy was closed
with an elliptical patch of saphenous vein,
using a continuous 4-0 polypropylene
suture (Fig. 3).
Postoperative Measurements
The measurements of blood flow and
pressure as already described were
repeated in identical fashion 8 to 10 days
after operation.
Statistical Analysis
The results for each parameter were
compared before and after profundaplasty using Student’s t-test for paired data.

FIG. 1—Incision for arteriotomy.
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Results
The results are summarized in Table I.
There was no change in the ankle pressure
index after profundaplasty. Similarly,
resting total-limb blood flow as measured
by plethysmography and resting muscle
blood flow measured by xenon clearance
were unchanged.
There was a significant (p < 0.01) in
crease, however, in muscle blood flow 1
minute after ischemic muscle exercise,
from 6.3 ± 2.0 ml/100 g'm in 1 before
profundaplasty, to 10.4 ± 3.9 ml/100
g'm in 1 after. The changes in muscle
blood flow with maximal exercise and
with profundaplasty are demonstrated in
Fig. 4. In this group of patients with
arterial disease, it can be seen that the

development of maximal blood flow is
delayed, but profundaplasty caused a
reduction in the time lapse from tourni
quet release to the maximal blood flow
recorded, from 149 ± 52 to 102 ± 46
seconds.
All of the patients treated for claudica
tion claimed to have improved walking
distance after operation. Of the nine pa
tients who underwent the operation for
limb salvage, there was a good immediate
clinical result in seven, but in two patients
there was no subjective or objective
benefit and below-knee amputation was
performed.
Discussion
The operation of femoral profun-

Table 1--Blood Pressure and Flow Measurements
before and after Profundaplasty
Measurement
Ankle pressure index
Total calf blood flow,
ml/dl •min-1
Toe blood flow,
ml/dl ■min-'
Resting muscle blood flow,
ml/100 g •min-'
Muscle blood flow 1 min
after ischemic excercise,
ml/100 g ■min“*
Time elapse to peak
flow, s

Before

After

p value

0.63 ± 0.17

0.65 ± 0.17

NS

3.0 ± 1.2

2.7 ± 0.9

NS

4.5 ± 4.1

4.7 ± 4.5

NS

2.5 ± 1.1

2.6 ± 1.1

NS

6.3 ± 2.0

10.4 ± 3.9

<0.01

149 ± 52

102 ± 46

<0.01

FIG. 2—Arteriotomy in common and deep
femoral arteries.

FIG. 3—Closure of arteriotomy with patch
of saphenous vein.
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daplasty was described as an alternative
to the more standard femoropopliteal by
pass grafting operation in patients with
inadequate run-off below the knee as
shown by aortography. The operation has
several variations in technical detail, but
the principle is to ensure good blood flow
into the deep femoral artery and enlarge
the calibre of its proximal 4 to 5 cm.
Martin,4 Berguer5 and Welsh7 and their
colleagues have reported clinical success
in 70% to 90% of cases. In many patients
limb salvage was achieved with profundaplasty when femoropopliteal bypass
grafting was considered technically im
possible. In a series of 209 patients recent
ly reported,10 however, the limb salvage
rate fell to 23% after 5 years. In those
who underw ent the operation for
claudication, good results were main
tained for 5 years in 77%. Data are lack
ing on the hemodynamic effects of profundaplasty. A significant rise in ankle
pressure index following profundaplasty
has been reported, both at rest,11-12 and
with exercise.13 Martin and Jamieson14
reported a 100% increase in lower limb
blood flow during exercise after profun
daplasty, and Baron and colleagues15
found that the increased blood flow
caused by intra-arterial injection of
papaverine was further increased by 50%
after the operation.
In this study, the resting hemodynamic
measurements were not increased by pro
fundaplasty, but the distal arterial
disease, as measured by the resting ankle
pressure index (0.63 ± 0.17), was not as
severe as reported by some.12-13 Venous
occlusion plethysmography measures the
total limb blood flow in the area
underneath the strain-gauge and it is,
therefore, usually assumed that in the calf
the result reflects muscle blood flow
whereas in the great toe it is skin blood
flow that is measured. The calf blood
flow as measured by plethysmography,
3.0 ± 1.2 m l/d E m in '1 compares with
2.5 ± 1.1. ml/100 g*min 1 for mus
cle blood flow alone as measured by
xenon clearance.
The normal response to maximal
ischemic exercise is a 40-fold increase in
leg muscle blood flow within a few

seconds of tourniquet release (up to 80
ml/100 g*min- ‘).16 In this group of pa
tients with arterial disease, the maximal
blood flow was less than 20 ml/100
g-min ', and the time lapse to reach the
maximal level was greatly prolonged (149
± 52 seconds). After profundaplasty,
however, there was significant improve
ment (Table I, Fig. 4).
There is no doubt from this and from
the previous reports that the operation
brings subjective benefit to patients with
claudication and rest pain, and objective
evidence from the hemodynamic results
is accumulating. It might be suspected
that the degree of sympatholysis in
evitably caused by the femoral vessel
dissection is responsible for the results,
but it has been shown that sympathec
tomy alone causes no change in the
hemodynamics of exercising muscle.16
Enthusiasm for femoropopliteal bypass
grafting has moderated and it has been
convincingly demonstrated that a failed
femoropopliteal bypass graft renders the
subsequent amputation less satisfac
tory.17 Distal bypass techniques have
received more attention recently, but the
results to date do not encourage wide
application.18 The role of profundaplas
ty as part of the distal reconstruction in
aortofemoral bypass grafting or in the
relief of demonstrable stenosis at the
orifice of the deep femoral artery is well
understood and accepted,19-20 but when
such stenosis is not demonstrable, profun
daplasty remains an operation with
limited indications. For femoropopliteal
disease, the vascular surgeon may select
bypass grafting, femoral profundaplasty
or transluminal angioplasty, according to
the special circumstances in each patient.
When femoropopliteal arterial obstruc
tion coexists with severe distal disease,
contraindicating bypass grafting, then
femoral profundaplasty is a reasonable
option. The results of this study help to
explain, in hemodynamic terms, the
clinical improvement noted after profun
daplasty in patients with symptomatic
femoropopliteal artery occlusion.
The expert technical assistance of Mr. Ed.
Weber is greatly appreciated.
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Graft Infections in Aortoiliac Arterial Reconstructions
T w e n ty-fo u r patients with 2 5 infected
p rosth etic grafts have been treated at
the H ealth S cie n ce s Centre in W innipeg
over the p ast 20 years. Ninteen prim ary
operations were done for aorto illiac o c 
clu siv e disease and 6 for abdom inal aor
tic an eu rysm s. Th e patients presented
from 2 w e eks to 9 years after the first
operation. In 16 of the graft in fe ctio n s
there w a s a groin a b sc e ss, a draining
sin u s or a false aneurysm . Th e co m 
m onest method of treatm ent w a s e x c i
sion of the entire graft with im m ediate
extra-an atom ic arterial reconstruction.
S ix p atien ts died. Early d ia g n o sis and
a g g re ssiv e surgical treatm ent are
em phasized.
A u co u rs des 20 dernieres an ne e s, 2 5
in fe ctio n s de greffons prosthetiques
surven an t ch ez 2 4 patients ont ete
traitees au Health S c ie n c e s Centre de
W in nip eg. Dix-neuf operations prim aires
avaie nt ete pratiquees pour des
o b stru ctio n s aorto-iliaques et 6 pour des
a n e v rism e s de I'aorte abdom inale. Les
patients ont ete re cu s de nouveau de 2
sem ain e s a 9 ans apres la prem iere
operation. Dans 16 ca s d 'in fection du
g re ffo n , on observait un a b ce s d ans
I'ain e, un sin u s de drainage ou un faux
anevrism e. La m ethode de traitem ent la
plus frequente fut I'e xcisio n du greffon
co m p let a v e c reconstruction arterielle
extra-anatom ique im m ediate. S ix patients
son t decedes. On souligne I'im portance
d 'u n d ia g n o stic precoce et d'un
traitem ent chirurgical agressif.

Prosthetic graft infection remains the sin
gle most serious complication of arterial
reconstructive surgery. The frequency of
infection as a result of aortoiliac
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reconstruction in reported series ranges
from 1.6% to 6% with an associated mor
tality ranging from 25% to 75% .'~4 The
morbidity, including amputation, recur
rent infection and persistent symptoms,
is virtually 100%. We have reviewed our
experience of the past 20 years and report
our management methods and results.

Patients
Twenty-four patients (23 men, 1
woman) with 25 infected prosthetic grafts
have been treated at the Health Sciences
Centre (formerly Winnipeg General
Hospital) in the past 20 years. Fifteen pa
tients had their original operation in our
institution and 9 were referred from other
hospitals. Nineteen primary operations
were for aortoiliac occlusive disease and
6 for abdominal aortic aneurysms (Table
I). At the original operation, at least one
groin incision and usually two were made
in 23 instances. The modes of presentation

of the graft infections are listed in Table
II. Sixteen graft infections were associated
with an abscess, a draining sinus or false
aneurysm at the groin. The two patients
with aortoduodenal fistulas presented
with manifestations of infection, one of
which was a groin abscess. Four patients
presented with infection 1 month after the
first operation, 12 patients between 1 and
12 months and 9 patients from 1 to 9
years. The organisms cultured at the time
of the second operation are listed in Table
III. Although the single most common
microorganism was Staphylococcus
aureus, the flora was often mixed.

Management
The mainstays of management were the
use of appropriate broad-spectrum an
tibiotics and removal of the prosthetic
graft. The graft was excised in 20 patients
Table III—Organisms Cultured
at Second Operation

Table 1—Primary Operation
Procedure

No. of
infections

Aortofetnoral bypass
Iliofemoral bypass
Axillofemoral bypass
Aortoiliac graft
Aorta tube graft

17
3
3
1
1

Total

25

Table II—Modes of Presentation
No. of
Presentation
infections
Groin
Abscess
13
Sinus with bleeding
3
False aneurysm
2
Abdominal signs
4
Aortoduodenal fistula
2
Ruptured proximal
false aneurysm
1
Septicemia
3
Perigraft seroma
2
Extruded graft
1
No signs
1
Total
32

Organism
Staphylococcus aureus
Staphylococcus epidermidis
Bacteroides sp
Enterobacter sp
Pseudomonas sp

Mixed
None
Total

No. of
infections
7
4
1
1
1
8
3
25

Table IV-Treatment of Infected Grafts
No. of
Treatment
infections
Graft removal alone
3
Graft removal and
17
reconstruction
Axillofemoral
11
Obturator
2
Cross-femoral
3
Aortofemorofemoral
1
Drainage, irrigation
2
Drainage, omental wrap
1
Graft replacement with
muscle transposition
1
No surgery
1
Total
25
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follow ed im m ediately by arterial
reconstruction using a remote bypass in
16 of 17 patients (Table IV). In one pa
tient, an autogenous aortoprofunda
cross-profunda vein graft was used. In
one patient, only the limbs of the graft
were removed, the body was wrapped
with omentum. The preferred method of
secondary reconstruction was axiliofemoral bypass; it was performed in
11 patients. Three grafts were removed
without revascularization. Three patients
had drainage and irrigation or omentum
wrapped around the prosthesis. One pa
tient had a segment of the graft removed
and replaced with a sartorius muscle
transposition for coverage.
Results
The graft infection was responsible for
the death of six patients, from 3 days to
2 years from the time of the second opera
tion, a mortality of 25%. Nine patients
were referred from other centres for
management of the infected graft; of
these, five (55%) died. In two patients,
late aortic stump blow-out was the cause
of death at 5 months and 7 months. Two
patients died of cerebral hemorrhage and
one of pneumonia and recurrent graft in
fection. Fifteen patients had the initial
operation at our institution, 1 died of
graft infection. This patient was untreated
because the graft infection was not
recognized before his sudden death,
which was due to disruption of the aor
tic anastomosis associated with infection.
All six patients who did not require secon
dary revascularization survived. Six
patients died of unrelated causes from 2
months to 11 years after their second
operation. There were six above-knee am
putations and two below-knee amputa
tions in seven patients. One patient re
quired bilateral above-knee amputation.
Both below-knee amputations were in
limbs that did not have secondary
revascularization procedures. Seven of
the eight amputations were done in pa
tients who originally presented with rest
pain. Four patients with axillofemoral
grafts required late thrombectomy and
two other patients had late infection of
the second graft.

postoperatively of bacteremia as possible
causes. At least one of these was iden
tified in 14 of the 25 primary operations.
In some series there appears to be no dif
ference between the incidence of infection
with or without the use of antibiotics prophylactically, although peer pressure
makes it mandatory to use them.'A5'6 We
give Keflin 1 hour preoperatively, intraoperatively and 1 to 2 days post
operatively. We think it is important to
avoid operation if possible in a patient
who has an infected foot lesion or skin
infection anywhere. Pulmonary and
urinary tract infections should be treated
aggressively before and after operation.
Excellent hemostasis and operative tech
nique are mandatory to avoid the need for
early reoperation. Wound irrigation and
meticulous closure of the groin wound are
essential. Good postoperative wound care
is also important. In spite of all these
measures, graft infection will continue to
occur. Successful management depends
upon early diagnosis and aggressive
surgical treatment. Although several
noninvasive tests have been used, in
cluding ultrasonography7 and radio
nuclide scanning,8 these are rarely
diagnostically conclusive.9 A groin
sinogram may outline the graft (Fig. 1).
Aortography may help to demonstrate a
false aneurysm. In most instances, the ex
tent of graft infection can only be deter
mined by operative exploration.9 Wound
drainage and irrigation may be used in
some circumstances but this is not often
successful. When the infection appears
late with no evidence of anastomotic in
volvement, drainage, irrigation and ap
propriate antibiotic therapy may be
attempted.3'10 It is important to continue
antibiotic therapy for at least 6 months.
If the body of the graft is involved, the
dangers associated with delay dictate an
aggressive approach, including graft
removal. Immediate revascularization is
usually necessary to save the lower ex
tremities. In some instances amputation

Discussion
The actual incidence of graft infection
is difficult to determine. In the period
from 1968 to 1979, in 192 aortofemoral
prosthetic reconstructions for aortoiliac
occlusive disease, our graft infection rate
was 1.6%. The most important considera
tion in graft infection is prevention. In
trying to identify predisposing causes in
our patients, we have considered pre
operative skin lesions, intraoperative con
tamination, early reoperation, postoper
ative hematoma, wound necrosis, lym
phatic drainage and the presence

FIG. 1—Sinogram from groin sinus
demonstrates perigraft contrast medium and
body of graft.

may be better than subjecting the patient
to a prolonged revascularization proce
dure. However, axillofemoral reconstruc
tion is a very effective method of
revascularization and can usually be per
formed successfully. We remove the graft
first then redrape the patient and carry
out the reconstruction. Two patients suf
fered limb paralysis associated with this
sequence; one recovered completely. If
the decision to remove the graft can be
made preoperatively and if the patient’s
condition is stable, it may be preferable
to do the revascularization procedure
first. Whichever sequence is used, we
recommend that it be at the same
operative procedure rather than later as
has been suggested by some.1'2 Early suc
cess in saving the patient’s life does not
signal the end of the management. Many
patients have suffered severe morbidity
with late aortic blow-out, recurrent infec
tion and amputation. Long-term an
tibiotic therapy may help prevent late sep
sis. Meticulous closure of the aortic stump
in normal aortic tissue with buttressing by
prevertebral fascia or an omental pedicle
is essential. In spite of these precautions,
late aortic stump blow-out may occur.
Conclusions
Every effort must be made to prevent
graft infection by proper patient selection
and meticulous operative technique. In
aneurysm repairs, groin anastomoses
should be avoided if possible. The pro
phylactic use of systemic antibiotics may
be useful. Early diagnosis with aggressive
surgical management is mandatory; pro
crastination will lead to disaster. Local in
fection with graft limb involvement and
intact anastomosis can be treated suc
cessfully with local drainage and irriga
tion. In most instances, graft removal
with concomitant remote revasculariza
tion is the treatment of choice.
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Why Remove an Infected Aortofemoral Graft?
The radical treatment of infected
vascular grafts is a major procedure with
a high mortality and loss of limb. The
authors review their experience with 13
consecutive cases of infected aorto
femoral grafts treated conservatively dur
ing an 1 1-year period. The treatment con
sisted of wide incision and drainage of
the infected area followed by assiduous
irrigation with an antiseptic or antibiotic
solution. In 10 patients the inguinal
wound healed and the prosthesis was
reincorporated; 8 of the 10 had a patent
prosthesis and the treatment was con
sidered successful, while 2 needed fur
ther surgery. Three patients died of
hemorrhage or sepsis. Follow-up ranged
from 8 to 144 months (mean 77
months). Two patients had a false
aneurysm 3 and 7 years after wound
healing.
The results compare favourably with
those of radical treatment. The authors
believe a conservative approach must
always be tried as the first step in the
management of infected vascular prostheses. The gratifying results observed in
their series, in both the short and long
term, support this conservative ap
proach, which is a satisfying alternative
to radical operations with their high mor
tality and morbidity.
Le traitement radical des infections de
greffes vasculaires est une intervention
majeure entachee d'une forte mortalite
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ou de la perte d'un membre. Les auteurs
passent en revue leur experience portant
sur 13 cas consecutifs d'infections de
greffons aorto-femoraux traites de facon
conservatrice durant une periode de 11
ans. Le traitement consistait en une exci
sion large et au drainage de la region
infectee suivi d'une irrigation assidue a
I'aide d'une solution antiseptique ou antibiotique. Chez 10 patients, la plaie ingui
nale guerit et la prothese fut reintroduite;
8 des 10 patients avaient une prothese
fonctionnelle et le traitement fut consi
der^ comme ayant reussi, alors que les 2
autres necessiterent une nouvelle inter
vention chirurgicale. Trois patients sont
morts d'hemorragie ou d'infection. La
surveillance des suites therapeutiques
s'echelonne de 8 a 144 mois (moyenne
de 77 mois). Deux patients ont eu un
faux anevrisme de 3 a 7 ans apres la
guerison de la plaie.
Ces resultats se comparent avantageusement a ceux du traitement radical. Les
auteurs croient qu'une approche conser
vatrice devrait toujours etre la premiere
etape du traitement des infections de
protheses vasculaires. Les resultats
encourageants observes dans cette serie,
a court comme a long terme, soutiennent
cette approche conservatrice qui constitue une alternative satisfaisante aux ope
rations radicales avec leurs fortes morta
lite et morbidity.

Graft infection remains one of the most
disastrous complications associated with
vascular surgery, often followed by loss
of limb or life. In spite of preventive mea
sures, prosthetic infection cannot be eli
minated. The incidence ranges from
0.25% to 6% .1-3
The classic approach, which consists of
removing all the infected material fol
lowed by extra-anatomic bypass grafting,
is a major procedure accompanied by
high mortality (25% to 75%) and ampu
tation rate (35% to 75%).4-6
Because of the almost prohibitive mor
tality and complication rate, we adopted
a more conservative approach several
years ago, using early drainage and debri
dement of the infected zone followed by
continuous irrigation with an antibiotic
or antiseptic solution.

We do not question the value of radical
treatment, which is particularly effective
if the whole graft is infected, but we want
to emphasize that if certain criteria are
respected, conservative treatment is less
dangerous and no less efficacious than
radical treatment.

Patients and Primary Procedure
At the Hopital Saint-Luc in Montreal,
between Jan. 1, 1970 and Mar. 1, 1981,
aortofemoral grafts were inserted in 605
patients; 12 patients (1.98%) had graft
infection. One other patient referred to
us with an infected graft is included in this
study.
The cases of graft infection were equal
ly distributed during the study period (a
mean of 1.2 cases per year). There were
nine men and four women who ranged in
age between 52 and 77 years (mean 63.7
years). Six were 52 to 60 years old, three
60 to 70 and four were over 70 years of
age. The general condition of nine pa
tients was good, while in four it was poor.
Atherosclerosis was the principal con
dition in 11 patients; the atherosclerotic
process was located in the aortoiliac area
in 10 but included the femoropopliteal
area in 1. One patient had an abdominal
aortic aneurysm and another had arterial
hypoplasia.
In addition to their primary disease,
five patients were diabetic, four were
hypertensive and one had primary
retroperitoneal fibrosis. Six patients had
other infected lesions: toe gangrene in five
and ischemic ulcer of the heel in one. All
the patients received cephalosporin in
travenously as pre- and peroperative
prophylaxis.
Bilateral aortofemoral bypass was the
primary procedure in all the patients.
Associated procedures were resection of
abdominal aortic aneurysm in one patient
and femoropopliteal bypass in another.
The prosthetic material used was
“ Weavenit” Dacron (Meadox Medicals
Inc., Oakland, NJ) in six patients,
“ Milliknit” (Golaski Laboratories Inc.,
Philadelphia, Pa.) in five and “ Lo-Por”
(Golaski Laboratories) in two. Double 0
Ti-cron (David & Geek, Willowdale,
Ont.) sutures were used for the aortic
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anastomosis and 5-0 Ti-cron for the
femoral anastomosis.
Results
Signs of graft infection showed be
tween 5 days and 5 years after operation
(mean 11.9 months). In four patients, the
infection was precocious, appearing ear
ly (less than 1 month), while in four others
there was a long latent period (exceeding
1 year). In four, signs of infection ap
peared between 1 and 6 months and in
one between 6 and 12 months after opera
tion. Signs of graft infection were as
follows: inguinal abscess nine, false
aneurysm seven, thrombosis four, hemor
rhage three, persistent sinus one and sep
ticemia one.
Bacteriologic data obtained from pus
or prosthetic material cultures showed
that the predominant organism responsi
ble was initially Staphylococcus aureus
(10 patients). Other bacteria cultured
from the graft site were Escherichia coli,
Proteus mirabilis and Streptococcus
viridans (one each).
In further cultures taken from infected
grafts, the bacteria were E. coli in four,
K lebsiella p n eu m o n ia e in three,
Pseudomonas in three, Staphylococcus
epidermidis in two and P. mirabilis in
two.
Twelve patients received antibiotic
therapy systemically. Cloxacillin alone or
in combination with gentamicin or
carbenicillin was given to eight patients
(60%). The other antibiotics used were:
ampicillin, penicillin G and cephazolin.
Conservative Approach
The conservative local approach con
sisted of surgical drainage with extensive
debridement of the infected area. The
unincorporated part of the graft was com
pletely exposed. An irrigation system with
soft rubber tubes was then inserted. The
irrigation solution contained multiple an
tibiotics: polybactrin (bacitracin, neo
mycin, polymyxin) in six and neomy
cin 1% in three; an antiseptic solution of
betadine 1% was used in three.
The irrigation time ranged from 3
weeks to 4 months (mean 1.7 months).
The dressing changes were meticulous and
were supervised by the surgical team.
Continous irrigation was used for the first
weeks and then was replaced by frequent
daily dressings moistened with the same
solution.
At first, this treatment was given only
to poor-risk patients, excluded from any
major surgical procedure. Later, we
extended our indications to include
almost all cases of graft infection.
In most cases, clean granulation tissue
covered the graft first and thickened
progressively. The graft became
incorporated in the wound, which was
reduced to a small fibrous scar.

In two patients we added other forms
of local treatment because of thrombosis
or persistent septicemia. This consisted in
removing part of the infected limb of the
graft.
Amputation was carried out in three
p a tie n ts. Two o f these p atien ts
subsequently died.
Results
Three of the 13 patients did not survive.
All were debilitated. One died of profuse
hemorrhage, the two others of septicemia
and bleeding.
In 10 patients the wound healed and the
graft became incorporated. In 8 of the 10
the graft remained patent and no other
form of treatment was added, but in 2
patients the infected limb of the prosthesis
was removed. Reconstruction was not
necessary in one, while in the other
patient revascularization was carried out.
It failed and the limb had to be amputated
above the knee.
The survival rate was 77%. The
amputation rate was 23% for the whole
series but was only 7.7% for survivors.
The follow-up was up to 12 years (mean
6.3 years). Two patients died of
m yocardial in farctio n during the
follow-up period. Seven patients are
doing well, without complications.
Complications
Two survivors subsequently had false
aneurysms, 3 and 7 years respectively,
after the healing of their wounds. They
were operated upon, and in both the graft
was found to be incorporated.
In a third patient, the graft was re
moved 4 years after implantation because
of a persistent inguinal sinus associated
with pain and fever. The aorta was closed
and no reconstruction was done. The
patient survived without amputation and
he is well 4 years after removal of the
graft.
Discussion
Conservative treatment of infected
grafts has long been a subject of
debate.7' 10 Results are contradictory.1114
Most of the series reported are hetero
geneous, including peripheral grafts and
vascular access prostheses.
Our study is original in that the series
was hom ogeneous, including only
aortofemoral grafts, and our approach to
the problem was systematic.
Three pertinent points emerged from
our study.
1.
In patients with concomitant
infected lesions, graft infection was on the
same side as the other lesion and the same
organisms were responsible for both
infections. In one patient, at the time of
grafting, enlarged inguinal nodes were
present. Staphylococcus grew on culture

of these lymph nodes and staphylococcal
graft infection developed later. It is,
therefore, important to treat and cure any
infected lesion before the grafting
procedure.
2. Serial bacteriologic studies of the
inguinal wounds showed three successive
waves o f bacteria. The first was
dominated by staphylococci, the second
by coliform organisms and the third by
Pseudom onas and fungi. It seems
important to adjust the antibiotic therapy
accordingly.
3. In our hands, the conservative
approach, when adequately applied and
when there are no septic thrombi or whole
graft infection, gives better results than
more aggressive methods.
In spite of its apparent and attractive
simplicity, the conservative approach
necessitates vigilance and considerable
effort on the part of the whole team to
provide the ideal conditions required for
its success.
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A new approach
to the endocrine m anagem ent
of m etastatic breast cancer.
C Y TA D R EN is in d ica te d for
p o stm e n o p a u sa l o r o o p h o re cto m iz e d
patients with m e tastatic b re a st c a r 
cin o m a. T h e fo llo w ing g ro u p s a re likely
to d erive the m ost im m e d ia te benefit:
□ p a tie n ts w ith e s tro g e n re c e p to r (ER)
p o s itiv e tu m o rs re q u irin g p a llia tive
therapy.
p a tie n ts w ith p a in fu l b o n e m e ta s ta s e s .3

C Y T A D R E N o ffers th e patient an
ad d itio n al p e rio d of re a s o n a b ly norm al
a m b u la to ry life.
C Y T A D R E N c a n p ro lo n g life fo r
re s p o n d in g p a tie n ts w ith m e ta s ta tic
b re a s t can ce r.
C Y T A D R E N p a tie n ts m o re fre q u e n tly
e x p e rie n c e re g re s s io n of b o n e m e ta s 
ta s e s a n d p a in relief.6

p a tie n ts s u ita b le fo r e n d o c r in e th e ra p y
y e t p rim a rily u n re s p o n s iv e to o th e r tre a t
m e n ts , e.g. ta m o x ife n .4

C Y T A D R E N p ro v id e s a n a lte rn a tive ,
un til n o w u n a v a ila b le , fo r p a tie n ts not
re s p o n d in g to ta m o x ife n .

□ p a tie n ts w h o in itia lly re s p o n d e d to
o th e r e n d o c rin e tre a tm e n t, e.g. ta m o x ife n ,

□ C Y T A D R E N p re s e rv e s q u a lity o f life
w ith re la tive ly fe w s id e effects.

b u t re la p s e d .4
p a tie n ts u n d e r c o n s id e ra tio n fo r m a jo r
a b la tiv e e n d o c r in e s u rg e ry .1

2h ",
C Y T A D R E N is
a m in o g lu te th im id e .

A n a drenal s u p p re s s a n t
a n d reversible in h ib ito r
o f p erip h e ra l
e s tro g e n syn th e sis.

1

\

n h :?

n

S tructure of a m in o g lu te th im id e
H

______

1 Adrenacorticotrophic
horm one(ACTH)
is released by
the pituitary gland.

CYTADREN blocks estrogen pro
duction in the peripheral tissues.

□ CYTADREN blocks the conversion of
cholesterol to pregnenolone, the
steroid which gives rise to pro
4 Cytadren suppresses
gesterone, androgens, the
the conversion of
androgens to estrogens
mineralocorticoids (aldo
and in turn diminishes
the effect of
sterone etc.) and the glu
estrogens on
breast tumor
cocorticoids (cortisol etc.)
growth.

□ CYTADREN blocks the formation
of steroids from cholesterol in
3 Estrogen stimulates the
growth of ER positive
the adrenals. At the same
breast
carcinoma
time it inhibits aromatase
tissue.
in the peripheral tissues,
thereby lowering plasma
estrogen to the same
extent as surgical adren
alectomy.1CYTADREN
maintains androgen levels
by not inhibiting the
formation of testosterone
2 A CTH stimulates steroidogenesis in the
and dehydrotestosterone.2

adrenals. Androgens produced are converted
into estrogens in the peripheral tissues.

\

□ Steroids escaping this
block are converted
|
directly to androgens,
which in turn are convert
ed to estrogens by the
aromatase enzyme in the
peripheral tissues. CYTADREN
inhibits this step as well.

The Cytadren efficacy profile.
CYTADREN provides a new option before initiating chemotherapy.

CYTADREN in patients previously treated with tamoxifen.
Patients resistant to tamoxifen
# of patients
evaluated

Investigator
SMITH, I.E., etal.
MURRAY, R.M.L., et al.
KAYE, S.B. etal.
HARVEY, H. A., etal.
RAGAZ, J., et al.
BUZDAR, A.U., etal.
INGLE, J.N., etal.
TOTAL

29
50
20
14
15

6
20
7
3
5

-

-

-

-

128

41

Cytadren in patients with
painful bone metastases.
CYTADREN improves regression of bone metastases
accompanied by bone healing and relief of bone pain.
Study
Cytadren
Tamoxifen
Num ber
evaluable

Number
responding

Num ber
evaluable

Objective
response

Num ber
responding

Smith etal.

31

11

(35%)

29

5

(17%)

Lipton et al.

13

7

(54%)

18

4

(22%)

Total

44

18 (40.9%)

47

9 (19.1%)

(21%)
(40%)
(35%)
(21%)
(33%)

Relapsed tamoxifen responders
# of patients
evaluated
20
41
21
18
-

46
35
(32%)

181

Objective
response
8
25
13
9
-

26
7

(40%)
(61 %)
(62%)
(50%)
-

(56%)
(20%)

88 (48.6%)

5

Safety & tolerability
CYTADREN is generally well tolerated at
recommended doses.
Transient drowsiness and lethargy, which
abate over a 6-8 week period, are the most
frequent side effects.
An itchy rash may appear. This normally
diminishes within 7-10 days without interrupting
therapy.

Cytadren respects the life it prolongs.
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To the Medical Profession:

13Cytadren™(aminoglutethimide)
Adrenal suppressant
Reversible inhibitor of peripheral estrogen synthesis
Description
Cushing's syndrome
Cytadren (aminoglutethimide) is a potent reversible inhibitor of adrenal
mineralocorticoid and glucocorticoid synthesis. It partially inhibits the
enzymatic conversion of cholesterol to pregnenolone, the reaction that
initiates steroidogenesis in the adrenal cortex; as well, Cytadren blocks the
Cu, C2i, and C]8 hydroxylation of steroids. In Cushing’s syndrome of all
etiologies other than drug-induced, the inhibition of cortisol biosynthesis by
Cytadren markedly reduces excessive plasma cortisol.
Breast carcinoma
In addition to the effect on the adrenal cortex, Cytadren also inhibits the
aromatization of androgens into estrogens in peripheral tissues. The
aromatase mediated conversion of androgens into estrogens is the source of
estrogen in the postmenopausal woman; the aromatase enzyme is present in
liver, muscle, fat, and breast tissue including breast carcinoma. Cytadren
does not inhibit the formation of testosterone or dehydrotestosterone. Thus,
maintenance of androgen level with relative suppression of estrogens may be
of potential benefit. In vitro studies have shown that the blockade of
aromatization occurs at 10 times lower concentrations of Cytadren than
those required to prevent steroidogenesis. It is believed that this extra
adrenal blockade of aromatization of androgens of adrenal origin into estro
gens by aminoglutethimide is of overriding therapeutic importance in the
treatment of breast carcinoma in the postmenopausal woman.
Inhibition of adrenal-cortisol production by Cytadren leads to a reflex rise in
adrenocorticotrophic hormone (ACTH) secretion from the pituitary. The latter
overcomes the cortisol-lowering effect of Cytadren, leading to the so-called
"adrenal escape phenomenon’’. The compensatory increase in ACTH
secretion can be suppressed by the simultaneous administration of a
glucocorticoid. Cytadren increases the rate of its own metabolism and that of
certain glucocorticoids, including dexamethasone, but not of hydrocortisone.
Hence, the latter is indicated as the glucocorticoid replacement therapy of
choice to maintain a long-lasting adrenal suppressant effect, i.e., to prevent
the "adrenal escape phenomenon".
Cytadren causes a rapid decrease in aldosterone secretion from the adrenal
cortex. In some patients, the signs and symptoms of hypoaldosteronemia,
such as hyponatremia, dizziness, hypotension and weakness, occur. This may
be treated by administration of a mineralocorticoid, such as fludrocortisone,
0. 1.mg orally daily or on alternate days.
Cytadren inhibits the synthesis of thyroxine by the thyroid gland. There is,
however, a compensatory increase in thyroid-stimulating hormone (TSH)
secretion which is usually of sufficient magnitude to overcome this blockade.
Thyroxine replacement therapy is therefore only occasionally required.
In spite of the TSH increase, Cytadren administration, for reasons which are
not entirely clear, has not been associated with an increase in prolactin
secretion.
Cytadren only minim ally inhibits estrogen production by the ovarian follicle
in the premenopausal woman. Hence, it is not feasible to produce a medical
oophorectomy in these women with this drug.
Indications and clinical use
Cushing's syndrome
Cytadren (aminoglutethimide) is indicated for the palliative treatment of
Cushing’s syndrome of all etiologies other than drug-induced. It is effective
in reducing elevated plasma cortisol levels to one half or less of pretreatment
levels in 30 to 60% of treated patients. A sustained response to Cytadren is
most frequently observed in patients with Cushing’s syndrome due to
adrenal adenoma or carcinoma. However, pituitary dependent adrenal
hyperplasia does respond initially to Cytadren in up to 60% of cases.
Cytadren has no effect on the disease processes that underlie Cushing’s
syndrome. It is useful in the control of hypercortisolism as an interim
measure until definitive therapy is instituted or where such therapy is not
appropriate. Therapy with Cytadren for longer than 3 months has been
studied only in a limited number of patients.
Metastatic breast carcinoma
Cytadren in combination with glucocorticoid replacement is indicated for the
palliative treatment of metastatic breast carcinoma in the postmenopausal
woman. Patients with estrogen receptor positive tumors are most likely to
benefit from Cytadren therapy. The remission rates appear to be the highest
in soft tissue and bone metastases; metastases in liver and lung rarely
respond to Cytadren.
Up to 30% of patients initially refractory to tamoxifen citrate may show an
objective response to Cytadren.
After remission and relapse on tamoxifen citrate, up to 48% of these patients
may experience an objective response to Cytadren.
Cytadren treatment should be continued only in those patients who have
demonstrated a response to it within the first three months.
Contraindications
Cytadren (aminoglutethimide) is contraindicated in those patients with
severe manifestations of hypersensitivity to glutethimide or aminoglutethi
mide and in premenopausal women with metastatic breast carcinoma.
Warnings
1. Cytadren (aminoglutethimide) may cause adrenocortical insufficiency
which will usually present after 24 to 48 hours of treatment. After the
initiation of Cytadren therapy and under conditions of stress, such as
surgery, trauma, or acute illness, patients should be carefully monitored
and given hydrocortisone or cortisone acetate and mineralocorticoid
supplements as indicated. Dexamethasone is not recommended because
its rate of metabolism is enhanced by Cytadren.
2. Cytadren may suppress aldosterone production by the adrenal cortex and
thereby cause orthostatic or persistent hypotension. The blood pressure
should be followed in all patients at appropriate intervals. Patients should
be advised of the possible occurrence of weakness and dizziness as
symptoms of hypotension, and of measures that could be taken should
they occur.
3. Cytadren may depress the central nervous system resulting in lethargy or
somnolence. Ataxia has been noted in some cases. These are usually
transient effects. (See Adverse reactions)
4. Cytadren can cause fetal abnormalities when administered during
pregnancy. In the earlier experience with the drug, two cases of
pseudohermaphroditism in 5000 pregnancies were reported in female
infants whose mothers took aminoglutethimide and other concomitant
anticonvulsants. When administered to rats at doses of # and
l >/4times the maximum human dose, Cytadren caused a decrease in fetal
implantation, increase in fetal deaths, and a variety of teratogenic effects.

The drug also caused pseudohermaphroditism in rats treated with
approximately three times the highest recommended human dose. If this
drug must be used during pregnancy, or if the patient becomes pregnant
while taking the drug, the patient should be advised of the potential
hazard to the fetus and the treatment continued only if the benefits
outweigh the risks.
Precautions
1. General: Cytadren (aminoglutethimide) should be administered only by
physicians who are familiar with its use; therapy should be initiated in a
hospital setting until a stable dosage regimen is achieved. (See Dosage
and administration)
2. Information for patients: Patients should be warned that drowsiness may
occur and that when present they should not drive, operate potentially
dangerous machinery, or engage in other activities which require mental
alertness.
Patients should also be warned of the possibility of hypotension and its
symptoms. (See Warnings)
3. Laboratory tests: Hypothyroidism may occur in association with aminoglu
tethimide; hence, appropriate clinical observations should be undertaken
and laboratory studies of thyroid function performed where indicated.
Supplementary thyroid hormone may be required.
Hematologic abnormalities in patients receiving Cytadren have been
reported (see Adverse reactions). Therefore, baseline hematologic
studies should be carried out and repeated at regular intervals.
Since elevations in SGOT, alkaline phosphatase and bilirubin have been
reported, appropriate clinical observations and regular laboratory studies
should be performed before and during therapy.
Serum electrolytes should be determined periodically and mineralocorticoids should be administered depending upon the clinical and/or
the electrolyte status.
4. Drug interactions: Cytadren accelerates the metabolism of dexa
methasone; therefore, when glucocorticoid replacement is needed,
hydrocortisone or cortisone acetate should be prescribed.
Cytadren also decreases the clinical effect of oral hypoglycemic and
anticoagulant drugs. Therefore, appropriate laboratory tests must be
performed and the doses of oral hypoglycemic and/or anticoagulant drugs
increased to maintain an optimal therapeutic effect.
5. Carcinogenesis, mutagenesis, impairment of fertility: Neither mutage
nesis studies nor animal carcinogenicity studies have been performed.
Cytadren affects fertility in female rats. (See Warnings) Whether it does so
in humans has not been determined.
6. Pregnancy-. See Warnings section.
7. Pediatric use: Safety and effectiveness have not been established by
adequate and well-controlled studies in children.
Adverse reactions
Adverse reactions reported in patients treated for Cushing’s syndrome and
metastatic breast cancer include observations in 374 and 1043 patients,
respectively, who received Cytadren (aminoglutethimide) for periods ranging
from a few days to several years. Patients concurrently received glucocorti
coid and occasionally mineralocorticoid replacement therapy. Approximately
60% of patients reported one or more unwanted effects, most of which
disappeared spontaneously with continued administration of Cytadren.
A. Adverse effects most frequently encountered
The most frequent and reversible side effects were essentially from one of
the following sources:
i) Central nervous system: These side effects are related to one or
more manifestations of the known central depressant action of
Cytadren.
Lethargy/somnolence
34%
Ataxia
5%
Dizziness
5%
ii) Dermatological
Skin rash (morbilliform and/or maculopapular)
26%
iii) Gastrointestinal
Nausea/vomiting
10%
iv) Systemic
Fever
2%
B. Other minor adverse effects which occurred a t a frequency o f 1% or less
are: Hypoadrenalism, depression, nystagmus, dermatitis, hypothyroidism,
constipation, indigestion, diarrhea, headache, insomnia, unstable gait,
anxiety, hallucinations, poor memory, seizures, jaundice, electrolyte
changes, arthralgia, hyponatremia, hypotension, sweating, chills, and
urinary retention.
Although some of these symptoms may not be necessarily ascribed to
Cytadren therapy, they are listed as alerting information.
The following minor adverse effects which occurred at a frequency of 1% or
less are believed to be associated with the glucocorticoid replacement
therapy; Cushingoid facies, weight gain, hyperadrenalism, edema, and
hypercalcemia. Occasionally, mineralocorticoid replacement therapy pro
duces hypertension and congestive heart failure due to its marked effect
on sodium retention.
C Hematologic abnormalities
Blood dyscrasias related to Cytadren have been reported. Most patients
studied had neoplastic involvement of the bone marrow and were receiving
other drugs when blood dyscrasias were observed. Hence, the exact
relationship of Cytadren administration to these complications could not
always be established. Nonetheless, 4 cases of pancytopenia have been
reported. In addition, rare cases of agranulocytosis and thrombocytopenia
have also been recorded.
A reduction in hemoglobin and usually a transient decrease in white blood
cell counts have been reported with chronic administration of Cytadren.
D Clinical laboratory abnormalities
Increased bilirubin and elevation of alkaline phosphatase and SGOT have
been reported. Although the casual relationship of these abnormalities to
aminoglutethimide is uncertain, periodic liver function tests are recom
mended.
E. Other
Some patients occasionally show clinical symptoms of hypoaldosterone
mia (i.e. dizziness, hypotension, and occasionally hyponatremia). Admini
stration of small doses of fludrocortisone (0.1 mg/day or on alternate days)
usually alleviates these symptoms.
Rarely, adrenal hematomas have been seen at surgery in patients
receiving aminoglutethimide. Cellular hypertrophy, cytoplasmic vacuoliza
tion and excessive accumulation of lipids have been observed in adrenal
tissue.
Symptoms and treatm ent of overdosage
Symptoms
The most common signs to be expected with overdosage of Cytadren
(aminoglutethimide) are ataxia, sedation, and deep coma with hyperventila
tion and hypotension. Deaths have not been reported following administra
tion of Cytadren at doses up to 7 grams.

Treatment
Gastric lavage and supportive treatment have been employed. Full
consciousness following deep coma was regained forty hours or less after
ingestion of three or four grams of Cytadren without lavage. No evidence of
hematologic, renal or hepatic effects were subsequently found. Dialysis may
be considered in severe intoxication.
Extreme weakness has been reported when patients received 3 grams/day in
divided doses.
A parenteral glucocorticoid, preferably hydrocortisone or cortisone acetate,
and/or a mineralocorticoid, such as fludrocortisone, may be indicated in the
event of extreme prostration as this may be the result of adrenocortical
insufficiency.
Dosage and administration
Cushing's syndrome
Adults: Treatment should be instituted in a hospital setting until a stable
dosage regimen is achieved. Therapy should be initiated with a daily dose of
1000 mg in 4 equally-divided doses, preferably at 6-hourly intervals.
The response of cortisol secreting tissue to Cytadren (aminoglutethimide)
should be followed by carefully monitoring plasma cortisol levels until the
desired level of suppression is achieved. (When glucocorticoid replacement
therapy is instituted, monitoring of DHEA-S (dehydro-epi-androsterone
sulfate) levels will provide a measure of suppression of cortisol secretion.)
If adrenal suppression is inadequate, the daily dose may be increased in
increments of 250 mg each week to a maximum daily dose of 2000
milligrams (2 grams) in equally-divided doses.
Dose reduction or temporary discontinuation may be required in the event of
adverse responses, including extreme drowsiness or severe skin rash.
Incremental increases to maintenance level can then be achieved as the
patient's condition allows. If a skin rash persists for longer than five to eight
days, or becomes severe, the drug should be discontinued. It may be possible
to reinstate therapy at a lower dosage following the disappearance of a
mild-to-moderate rash.
Hydrocortisone: Forty (40) mg per day or cortisone acetate fifty (50) mg per
day in equally-divided doses orally is suggested as replacement therapy for
frank adrenal insufficiency or when cortisol levels drop to a level where
increased pituitary ACTH secretion is likely.
Fludrocortisone: If patients show the signs and symptoms of hy
poaldosteronemia (e.g. hypotension, dizziness, and/or hyponatremia), fludro
cortisoneat a daily dose of 0.1 mg p.o. should be administered daily or on
alternate days depending on the severity of symptoms. As fludrocortisone
may have a marked effect on sodium retention, physicians should monitor
patients closely for signs and symptoms of fluid retention, hypertension,
congestive heart failure and related conditions.
Metastatic breast cancer
In order to achieve optimal therapeutic effects and to encounter the least
side effects, aminoglutethimide should be administered orally in escalating
doses together with hydrocortisone or cortisone acetate.
Aminoglutethimide: Aminoglutethimide should be administered orally in
gradually increasing doses as follows: 250 mg b.i.d. during the first week;
250 mg t.i.d. during the second week; thereafter 250 mg q.i.d. The graduated
dose approach allows time for Cytadren to induce its own metabolism and for
patients to accommodate to the soporific side effects. In exceptional cases,
the daily dose may be increased to a maximum of 2000 mg in equally-divided
doses.
Hydrocortisone: 100 mg perday orally (20 mg a.m.; 20 mg p.m.; and 60 mg h.s.)
during the first 2 weeks; thereafter 40 mg daily (20 mg a.m., and 20 mg p.m.).
Cortisone acetate: 125 mg per day orally (25 mg a.m.: 25 mg p.m.; and 75 mg
h.s.) during the first 2 weeks; thereafter 37.5-50 mg daily (25 mg a.m. and
12.5 or 25 mg p.m.). The initial high dose of hydrocortisone or cortisone
acetate reduces the severity of the skin rash which is highly steroid sensitive
and which usually occurs 10-15 days after initiation of therapy.
Fludrocortisone: If patients show the signs and symptoms of hypoaldostero
nemia (e.g. hypotension, dizziness, and/or hyponatremia), fludrocortisone at
a daily dose of 0.1 mg p.o. should be administered daily or on alternate days
depending on the severity of symptoms. As fludrocortisone may have a
marked effect on sodium retention, physicians should monitor patients
closely for signs and symptoms of fluid retention, hypertension, congestive
heart failure and related conditions.
Infrequently, patients receiving Cytadren continue to complain of persistent
lethargy, somnolence or mild lack of alertness during chronic therapy. If
facilities are available to measure plasma levels of aminoglutethimide,
allow reduction in dosage to maintain drug concentrations in the therapeutic
range of 10-15 jzg/ml. If unavailable, reduction in dosage to 750 mg Cytadren
daily with 500 mg just before sleep and 250 mg in the morning will often
alleviate this problem. It should be remembered that Cytadren is excreted
largely unchanged in the urine and patients with compromised renal
function may have high blood levels. 5% of patients cannot tolerate
Cytadren in any dosage. The skin eruption occurring with aminoglutethimide
is a maculopapular, generalized or urticarial rash often associated with fever
which commonly begins on day 10 and subsides by day 15 or 16 of treatment.
Forewarning patients of this problem alleviates anxiety should the rash
appear. The rash is responsive to a daily dose of hydrocortisone or cortisone
acetate and improves with concurrent administration of antihistamine, e.g.
diphenhydramine, 25 mg b.i.d. to q.i.d. daily. If the rash persists beyond day
16, the drug should be discontinued until the rash subsides, then restarted at
125-150 mg daily with gradual increments to full dosage.
Supplied
250 mg tablets: off-white, round, bisected, biconvex tablet with CIBA
engraved on one side and GG engraved on the other. Bottles of 100.
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Extra-anatomic Bypass Grafting in the Lower Extremity
Between January 1975 and December
1980, 104 extra-anatomic bypasses
were performed on 102 patients. Of
these, there were 81 femorofemoral
bypasses on 80 patients and 23
axillofemoral bypasses on 22 patients.
Those who underwent femorofemoral
grafting were divided into three groups:
group 1 - 1 8 patients who had
undergone previous aortofemoral bypass
grafting with occlusion of one limb of
the graft, group 2 - 1 7 patients who
were considered to be at high risk and
group 3 - 4 5 patients who could have
tolerated a conventional reconstructive
procedure.
Our results indicate that the
cumulative patency rate of the
femorofemoral bypass at the end of 1
year and 5 years is good and that this
operation is an excellent first choice
procedure in cases of unilateral iliac
disease, to relieve severe ischemia or
disabling claudication, whether the
patient is a poor or good operative risk.
On the other hand, axillofemoral grafting
has a lower patency rate and should be
reserved for high-risk patients and for
the relief of severe ischemia only.

groups reflect the medical status of the
patients, the results of previous vascular
procedures and the possibility of a simpler
operation. Of the 102 patients operated
on, all but 8 (92.1%) were seen or
contacted at the time of preparation of
the manuscript.

trois groupes: le groupe 1 - 1 8 patients
qui avaient auparavant subi un pontage
aorto-femoral avec une thrombose d'une
branche du greffon, le groupe 2 - 1 7
patients evalues a "risque eleve" pour
un pontage conventionnel et le groupe 3
- 45 patients qui auraient pu subir un
pontage conventionnel.
Nos resultats indiquent que le taux de
permeabilite du greffon femoro-femoral
au bout de 1 an et 5 ans est tres bon et
que cette intervention est excellente
dans les cas d'obstruction iliaque
unilateral, pour traiter les patients
souffrants d'ischemie severe ou de
claudication importante, que le patient
soit considere un bon risque ou non.
D'un autre cote, le taux de permeabilite
du pontage axillo-femoral est plus bas et
cette intervention devrait etre reservee
aux patients a haut risque et pour le
traitement d'ischemie severe
uniquement.

Femorofemoral Bypass Grafting
Of the 104 extra-anatomic bypasses
performed, 81 were femorofemoral. They
were performed on 80 patients in whom
physical and arteriographic examination
had shown unilateral iliac disease. To gain
a better understanding of the results,
these patients were divided into three
groups: group 1, those who had
undergone aortofemoral or aortoiliac
bypass grafting previously with occlusion
of one limb of the graft; group 2, those
who were considered to be at high risk
due to associated diseases; and group 3,
those who were considered good risks and
It is almost universally accepted that able to withstand a conventional aorto
atherosclerotic occlusion of the aortoiliac femoral reconstruction.
system is best managed by aortofemoral
reconstruction. However, the mortality Croup 1
(3% to 5% in most series') and the
morbidity have limited this operation to
This group included 18 patients (13
Entre janvier 1975 et decembre 1980,
patients who are relatively good operative men, 5 women) in whom 19 femoro
104 pontages extra-anatomiques ont ete
risks. For this reason, some have pro femoral bypass grafts were inserted. Age
pratiques sur 102 patients. De ce
posed reconstruction using the axillary or distribution is shown in Table I and
nombre, il y avait 81 pontages
the contralateral femoral artery.
associated conditions in Table II. Opera
femoro-femoraux chez 80 patients et 23
Most series on this subject have not tive indications were intermittent
pontages axillo-femoraux chez 22
made any differentiation with regard to claudication in 14 and severe ischemia in
patients. Les patients ayant subi un
patient selection. The purpose of this 4 patients. The material used was either
pontage femoro-femoral furent divises en
review of femorofemoral and axillo knitted Dacron or polytetrafluoroFrom the department o f surgery, Universite femoral bypasses performed between Jan. ethylene, 8 to 10 mm diameter, and, in
de Montreal, Montreal, PQ
1, 1975 and Dec. 31, 1980 is to identify one instance, saphenous vein. In two
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Table I—Age Distribution of Patients Who Underwent
Axillofemoral or Femorofemoral Bypass Grafting
Femorofemoral bypass groups, no. (%)
Age, yr

bypass, no. |%)

20-39
40-49
50-59
60-69
70-79
80-89

0
0
4 (18)
13 (59)
5 123)
0

1
0
1
12
3
1
1

(5.5)
(66.6)
(16.6)
(5.5)
(5.5)
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2
1
1
1
3
9
2

(5.9)
(5.9)
(5.9)
(17.6)
(52.9)
(11.7)

3
0
7
21
14
3
0

(15.5)
(46.6)
(31.1)
(6.6)

335

Results.—There was only one death
postoperatively (5.5%), due to pulmonary
embolism. Morbidity was minimal, with
only one superficial groin infection.
There were six cases of late thrombosis
(Table III). In one of these, a
thrombectomy successfully restored
patency, giving a thrombosis rate of
26.3% (5 of 19). In one other case, a new
femoral-deep femoral bypass graft was
inserted and, in a second case,
aortofem oral bypass grafting was
performed successfully. The other three
were treated conservatively and
amputation was not required.
The cumulative patency rate for this
group of patients, based on life-table
analysis, was 82.4% at the end of 1 year
and 65.9% at the end of 5 years (Fig. 1).

men and 5 women. Their ages ranged
from 41 to 72 years (mean 56.5 years).
Disabling claudication was the indication
for operation in 42 patients and severe
ischemia in 3. Associated conditions are
listed in Table II.
Results.—Complications were rare:
four superficial groin infections and two
graft infections. In both cases of graft
infection, excision of the graft was
required. Thrombosis occurred in three
patients (6.6%) (Table V), but only one
major amputation was necessary — in
one of the cases of graft excision.
Life-table analysis showed a cumulative
patency rate of 93.2% at the end of 1 year
and 88.6% at the end of 5 years (Fig. 1).
There were no postoperative or late
deaths.

Group 2

Axillofemoral Bypass Grafting

In this group were 17 patients (16 men,
1 woman). Age distribution is shown in
Table I and associated conditions in Table
II. Operative indications were severe
ischemia of the leg in 13 cases and
disabling claudication in 3.
Results.—There were no operative
deaths, but three complications occurred
(Table IV). Thrombosis developed
postoperatively in two cases and
precipitated major amputation in both.
In these two, the run-off was poor and
the operation was for limb salvage. There
was one case of nonfatal pulmonary
embolism. The cumulative patency rate
was 88.2% at the end of 1 year and 79.8%
at the end of 5 years (Fig. 1). The late
mortality was 23.5% (4 of 17).

Twenty-three axillofemoral bypass
grafts were inserted in 22 patients (18
men, 4 women). The ages of the patients
ranged from 52 to 76 years (mean 64
years) (Table I). The only indication for
operation was severe ischemia. All
patients were heavy smokers and had one
or more of the associated conditions listed
in Table II, that made them poor-risk
candidates for conventional revascular
ization. Fourteen of these grafts were
unilateral and 9 were bilateral with one
limb of the graft crossing over the pubis.
The material used was either knitted
Dacron or polytetrafluoroethylene of 8 to
10 mm diameter.

Group 3
Of the 45 patients in this group, 40 were

Results
Complications were rare. There was
one axillary hematoma, which had to be
evacuated, and one false aneurysm, which

led to excision of the graft and sub
sequently major amputation. There was
one death postoperatively (4.3%) and it
occurred in a patient operated on for an
aortoduodenal fistula. Six late deaths oc
curred (27.2%) (Table VI) of which only
one was related to the operation — the
patient with the false aneurysm.
In the follow-up period, 10 grafts
occluded (Table VII). However,
thrombectomy was successful in three,
which gives a total graft failure rate of
31.8% (7 of 22). Graft occlusion

FIG. 1—Cumulative patency rates of
femorofemoral ( — = group 1 , ------- =
group 2, — = group 3) and axillofemoral
(. . .) grafts by life-table method.

T a b le IV — G r a f t O c c lu s io n s a f t e r
F e m o r o f e m o r a l B y p a s s in H ig h -R is k P a tie n ts
No.
T im e , y r

o f g ra fts

R e s u lts

Im m e d ia te ly
p o s to p

2

2 a m p u ta tio n s

2

1

N o a m p u ta tio n

5

1

T h r o m b e c to m y a n d
p r o f u n d a p la s ty :
d e a th f r o m
s e p tic s h o c k

T a b le I I — A s s o c ia t e d C o n d itio n s
F e m o r o f e m o r a l b y p a s s g ro u p , n o .
A x illo f e m o r a l
C o n d itio n

T a b le V — G r a f t O c c lu s io n s a f t e r

b y p a s s , n o . (% )

1

C h ro n ic p u lm o n a ry d is e a s e

1 0 (4 5 )

3

5

2

A th e ro s c le ro tic c a r d ia c d is e a s e

1 7 (7 7 )

8

13

8

C e r e b r o v a s c u la r a c c id e n t

4 (1 8 )

D ia b e te s

7 (3 2 )

M e ta s ta tic b re a s t c a n c e r

—

2

3

_

3

_

1

1 (4 .5 )

—

_

M y e lo p a t h y

1 (4 .5 )

—

—

—

Lung can cer

1 (4 .5 )

—

—

lo o d - R is k P a tie n ts
R e s u lts

N o . o f g ra fts

2

1

A m p u ta t io n

12

2

1 c o n v e r te d to
a o rto b ife m o ra l

—

1

—

T im e , m o

9

—

C o lo s to m y

F e m o r o fe m o r a l B y p a s s in

~
T a b le V I— T im e a n d C a u s e o f D e a t h in
S e v e n P a t ie n t s f o llo w in g A x illo f e m o r a l
B ypass

T a b le I I I — C a s e s o f L a t e T h r o m b o s is in T h o s e W h o U n d e r w e n t

T im e , m o

C a u s e o f d e a th

F e m o r o f e m o r a l B y p a s s G r a f t in g a f t e r a P re v io u s V a s c u la r O p e r a t io n
T im e ,

mo

N o . o f g ra fts

R e s u lt s

1

1

S u c c e s s fu l

3

1

N o a m p u t a t io n

8

1

N e w f e m o r a l- d e e p f e m o r a l

th ro m b e c to m y

b y p a s s s u c c e s s fu l
18

336

3

P o s t o p e r a t iv e

A o r t o d u o d e n a l f is t u la

2

Lung c a n c e r

2

F a ls e a n e u r y s m -

a m p u ta tio n

(b re a s t c a n c e r)
12

P u lm o n a r y e m b o lis m

15

A m p u t a t io n -

N o a m p u t a t io n

a c u t e re n a l

in s u f f ic ie n c y

N o a m p u t a t io n

24

M y o c a r d ia l in f a r c t io n

A o rto fe m o ra l b y p a ss

36

Lung c a n c e r
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precipitated major amputations in five
patients. Poor run-off appeared to be the
major problem in all these patients. One
of the grafts thrombosed after 5 months
and an aortobifemoral bypass was then
performed. In this case, the risk of the
first operation was not well evaluated.
The cumulative patency rate at the end
of 1 year was 71.9°7o and dropped to
52.1% at the end of 4 years (Fig. 1).
Discussion

Femorofemoral bypass grafting was
described by Vetto in 1962.2 It was first
devised for the treatment of poor-risk
patients with unilateral iliac disease. Since
then, indications have been extended to
include other groups of patients.3'5
Three groups of patients submitted to
femorofemoral bypass grafting are de
fined in this study. Group 1 represents
patients who had a previous aortofemoral
or aortoiliac bypass with occlusion of one
limb of the graft, group 2 includes
patients who were considered at high risk
due to associated diseases and group 3
patients were considered good risks and
could have tolerated a conventional
aortofemoral reconstruction. Recognition
of these different groups is an important
step in the analysis of the results.
In group 1 patients, thrombosis of one
side of a previously implanted graft
occurs. It usually means progression of
the atherosclerotic process in the outflow
tract and may reflect the severity of the
underlying disease. This is indicated in
our series by a higher rate of late
thrombosis (26.3%).
In a group 2, the late mortality (23.5%)
reflects the short life expectancy of this
group. These patients are usually affected
by severe medical problems precluding
any major vascular reconstruction. The
natural evolution of their diseases
imposes a high mortality. The absence of
operative mortality is a strong point in
favour of femorofemoral bypass grafting.
In group 3, the low morbidity and the
absence of operative and late mortality
combined with the excellent long-term
patency rate (88.6% at 5 years) provide
the proof of the value of this operation.
In fact, these results indicate that

Time, mo

femorofemoral bypass grafting is
probably the operation of choice in this
group.6 The classic aortofemoral bypass
has a comparable patency rate but a
higher morbidity and a 3% to 5%
operative mortality.
The traditional controversies concern
ing femorofemoral bypass focus on two
major issues: the “ steal” phenomenon
and the late appearance of proximal
disease on the donor side. The combina
tion of important peripheral resistance on
the donor side and restricted inflow due
to a clinically overlooked iliac stenosis
could theoretically lead to a “ steal”
phenomenon.7 A preoperative angio
gram of excellent quality combined with
a systemic femoral gradient of less than
10 mm Hg should help avoid this poten
tial complication. Furthermore, Sumner
and Strandness8 have demonstrated that,
even if a steal could be detected by
physiologic testing, the blood flow to the
donor limb was not compromised appre
ciably under resting conditions. In our
studies, this complication did not occur.
One important concern would be the
late appearance of stenosis or occlusion
of the common or external iliac artery on
the donor side that would compromise the
patency of the graft. In fact, experience
shows that atherosclerotic lesions are
frequently dominant on one side and that
the progression of these lesions can be
very slow.4’9 Vetto3 has stated that
femorofemoral bypass grafting protects
against atherosclerosis in the donor iliac
artery due to a high rate of flow. This
increased linear blood flow could theoret
ically lead to decreased tension in the
lateral vessel wall and, as a result, less
subsequent atherosclerosis.
It is emphasized that the graft should
be at least 8 to 10 mm in diameter.10
Smaller grafts have a substantially
increased failure rate. The saphenous vein
is not acceptable because of its calibre.
When the atherosclerotic lesion
involves the distal abdominal aorta or the
iliac arteries, or both, a conventional
aortofemoral bypass may be too danger
ous for poor-risk patients, a category that
includes those with severe associated
diseases, especially of the pulmonary,
cardiac or cerebrovascular systems.11,12

Table VII—Graft Occlusion following
Axillofemoral Bypass Grafting
No. of grafts

0.5

2

4
5

1
1

8
12
15
24

2
1
1
2

Results
1 amputation
1 successful thrombectomy
Amputation
Successful aortobifemoral
graft
2 successful thrombectomies
No amputation
Amputation
2 amputations

Surgery of the abdominal aorta might
also be contraindicated in patients such
as those with intra-abdominal sepsis,
those who have a colostomy or numerous
adhesions.
In 1963, Blaisdell and Hall13 and
Louw14 described the axillofemoral by
pass almost simultaneously. Three years
later, Sauvage and Wood15 added a
crossover femorofemoral graft to the side
of the axillofemoral graft. LoGerfo and
associates16 later suggested that a
bilateral graft would have a better chance
of success, by increasing the flow and
lowering the resistance in the limbs of the
graft.
The reported patency rates of these
grafts vary considerably, from 24% to
89%.17 These discrepancies underline the
fact that, in the majority of the reported
series, all patients who have undergone
axillofemoral bypass are viewed as a
homogeneous group. This assumption
has caused conflicting reports on patency
rates and long-term survival of these
grafts. Theoretically, axillofemoral
bypass grafting may be applied to three
categories of patients: the poor-risk
patient, those with unsuitable anatomy
and the good-risk patient. In this study,
strict selection has been observed and we
used axillofemoral bypass only for
poor-risk patients and those with
anatomy unsuitable for other procedures.
The operative technique is standard
ized,18 and the position of the graft, the
tension on the graft and the compression
at night are possible causes of
thrombosis.19 Experience indicates that
the results depend primarily on the
adequacy of run-off.
Operative morbidity and mortality
have been low in our experience with
axillofemoral bypass (4.3% for each)
despite the poor medical status of the
patients. However, the patency rate is not
as good as that observed for the
conventional operation (52.1% at 4
years).20 This figure precludes the
application of this technique to the
good-risk patients.21 This operation is
designed for poor-risk patients with a
short life expectancy so the long-term
survival rates should not be very high
(22.7% late mortality in our series).22
Although our series is small and
inconclusive in this regard, we agree with
LoGerfo and associates16 that bilateral
grafts should be used in preference to
unilateral grafts. The choice of material
can vary, but the graft should be at least
8 to 10 mm in diameter.23
Thrombectomy should be attempted if
the graft becomes occluded in the
immediate postoperative period or during
the first year. Occlusion occurring later
usually implies a modification of the
outflow tract, which requires further
surgery in the form of extended
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profundaplasty or fem oropopliteal
bypass.
The selection of patients for this
procedure is important; it should be
reserved for those with limb-threaten
ing ischemia. It should not be used for the
relief o f claudication alone.

Summary
Femorofemoral bypass is an excellent
first choice operation in cases o f unilateral
iliac disease, regardless of whether the pa
tient is a poor or good risk. It is the opera
tion o f choice when one o f the limbs of
a previous aortobifem oral bypass
becomes obstructed. This technique may
be used to relieve severe ischemia or
disabling claudication. On the other
hand, axillofemoral bypass grafting is
necessary when there is bilateral involve
ment of the choice arteries in high-risk pa
tients and in such patients femorofemoral
bypass should be reserved for the relief
o f severe ischemia only.
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A Prospective Study of Lower Limb Amputations
Most leg amputations are performed for
vascular disease. A mortality of 30%
was associated with above-knee
amputations in this study. Healing by
primary intention took place in 59% of
patients, 31% had delayed healing and
10% required a revision. Only 10% of
above-knee amputees used a prosthesis
and 48% required total bed care.
Below-knee amputations in which a
rigid dressing was used had slightly
better healing than when soft dressings
were used but the difference was not
significant. The overall reamputation rate
was 15% , the mortality was 7.2% and
57% were fully ambulatory with a
prosthesis. Amputation at either the
transmetatarsal or digital level was
carried out in 25% and 80% healed. The
mortality was 11%.
Clinical observation is still the best
determinant of the level of amputation;
below-knee amputation should be strived
for in every patient who is a candidate
for rehabilitation. Use of a rigid dressing
is recommended.
La plupart des amputations d'un membre
inferieur sont le resultat d'une maladie
vasculaire. Dans la presente etude, une
mortality de 30% a ete reliee aux
amputations au-dessus du genou. Une
cicatrisation par premiere intention fut
obtenue chez 59% des patients alors
que la cicatrisation etait retardee chez
31% et que 10% necessitaient une
revision. Seulement 10% des amputes
au-dessus du genou ont utilise une
prothese et 48% ont necessite des soins
pour malades grabataires.
Dans les cas d'amputations au-dessus
du genou, ('utilisation d'un pansement
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rigide a ameliore legerement la
cicatrisation mais la difference par
rapport aux pansements mous n'etaient
pas significative. Le taux global de
reamputations a ete de 15%, la mortalite
de 7.2% et 57% etaient parfaitement
ambulatoires avec une prothese. Une
amputation au niveau trans-metatarsien
ou digital fut pratiquee dans 25% des
cas et 80% ont cicatrise. La mortalite fut
de 11%.
L'examen clinique demeure le meilleur
determinant pour choisir le niveau
d'amputation; on devrait tenter
I'amputation sous le genou pour tout
patient candidat a la readaptation.
L'usage d'un pansement rigide est
recommande.

Amputations because of vascular disease
have often been considered the result of
failure or lack of treatment. In certain
respects that is true and because of it
amputees have not always received the
type of care they require. Amputation
should not be considered destructive but
rather a reconstructive procedure that will
produce a comfortable, well-healed,
mobile stump, which will enable the
patient to walk with or without a
prosthesis.
Most patients require angiography
before amputation to be certain that
reconstruction is not possible. Even if this
is possible, amputation may be more
judicious for severe pain and tissue
necrosis than several lengthy reconstruc
tive procedures that would, at best, leave
the arteries with tenuous patency. We
studied prospectively all amputations of
the lower limb carried out on the vascular
surgery service of the Ottawa Civic
Hospital from July 1, 1979 to Dec. 31,
1981.
The main purpose of our study was to
compare rigid to soft dressings in belowknee amputations. Some authors have ad
vocated fitting a prosthesis immediately
after operation because edema is con
trolled, the stump is immobilized, joint
contracture is prevented and protection
from physical trauma is provided.u5
Psychological trauma may also be re

duced if the artificial leg is in place when
the patient awakens after the operation.
This usage also encourages a multidisci
plinary approach. However, others dis
agree and do not believe that this
approach is cost-effective and in fact have
stated that it can be deleterious.6'7
We also wished to determine the pro
portions of amputations at the different
levels of ischemic limbs and to determine
our mortality and morbidity to help us to
improve our management. Selection of
the appropriate level of amputation is
critical and we wished to ascertain which
parameters are useful in this selection. If
the level chosen is too distal for healing
then the patient is submitted to undue
psychological stress, additional pain and
at least a second operative procedure,
often after having undergone several
other procedures. If the level selected is
too proximal, the patient may be deprived
of the chance to walk.
The objective, therefore, is to amputate
at the most distal site that will produce
a healed, painless stump that can be fitted
with a prosthesis. Our study was carried
out to help us and others to achieve this
goal more frequently.
Patients and Methods

All patients requiring amputation be
tween July 1, 1979 and Dec. 31, 1981
because of vascular disorders were
included in the study. There were 187
am putations, or 97% of all the
amputations carried out during this time,
excluding digital traumatic amputations.
There were 70 amputations below the
knee, 71 above the knee, 21 metatarsal
and 25 digital amputations. The general
history and physical examination made
specific note of associated diseases that
might limit rehabilitation with a
prosthesis. The presence or absence of
diabetes and procedures carried out to
preserve the limb were recorded. The
extent and degree of ischemic changes
were carefully noted and the results of
angiography and Doppler pressure studies
were evaluated to assess their influence on
the level of amputation. All patients were
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followed up until the presenting problem
was resolved and the final level of activity
achieved. We are attempting to follow up
these patients indefinitely. There was a
special subgroup of amputees who were
thought by the attending surgeons, after
appropriate consultation amongst the
group, to require above-knee amputation
because rehabilitation with a prosthesis
would not be possible even at a belowknee level on the basis of their mental or
physical status, or both, not solely
because of the degree of vascular
impairment.
Our approach was multidisciplinary.
All patients were seen by an orthopedic
surgeon as well as the vascular surgeon
who performed the amputation. The level
of amputation was selected jointly, using
mainly clinical assessment but aided by
Doppler pressure measurements and
angiography when these studies were
carried out. The degree of ischemic
change was the primary determinant and
the amputation was carried out at the
lowest acceptable level above the area of
marked dependent rubor and frank skin
necrosis.8-9 Each patient was seen by a
physiotherapist, given m aintenance
exercises and carefully inform ed
concerning rehabilitation plans. Special
group classes were arranged with the
physiotherapist and these continued until
the maximum level of walking was
achieved. Patients were then followed up
regularly in the amputee clinic, attended
by the orthopedic surgeon, the vascular
surgeon, physiotherapist, social worker
and prosthetist.
Below-knee Amputations
The 70 below-knee amputations were
randomly divided into two subgroups of
equal number by alternating a rigid10
with a soft dressing. A standard long
posterior flap was used, large Hemovac
drains were placed subcutaneously and
subfascially and one of the two standard
dressings was applied.
The two subgroups were similar. The
mean age was 68.7 years. The incidence
of diabetes was 28% in both groups, 33%
had had a sympathectomy. The most
distal palpable pulse was the same in both
groups with the popliteal pulse being
absent in 83% of the cases. At one time
the presence of a popliteal pulse was
considered to be a prerequisite for
below-knee am putation. Im portant
associated disease that was at least
potentially limiting was extremely
com m on in both groups. Those
specifically noted, in addition to diabetes,
were coronary artery disease, chronic
obstructive lung disease, musculoskeletal
problems or a previous stroke. Only 24%
of the patients had no associated disease,
56% had one problem, 14% had two
problems and 6% had three problems.
340

Senility was present in 6% but did not
preclude reh ab ilitatio n . A rterial
reconstruction had been carried out in 28
p atients; 18 patients had had a
femoropopliteal graft, 3 an embolectomy,
6 an inflow procedure and 1 patient had
had an inflow procedure and a femoral
artery graft inserted.
The postoperative management was
similar in both subgroups. Positioning of
the stump to prevent contractures,
exercises to maintain and improve
strength and walking at 3 to 5 days were
emphasized. The drains were removed 3
days after operation and the dressing was
changed after 2 weeks. A temporary
prosthesis was then applied in both
groups if healing was satisfactory. The
patients with a rigid dressing started
feather weight bearing, care being taken
not to allow the rigid dressing to act as
a lever on the end of the stump. The foot
component was removed when not walking.

amputations, but there was far too great
a variation to allow them to be used as
a predictor of successful amputation.
Others have found ankle and thigh
pressures to be useful predictors.18'21

Results

The in-hospital mortality was 8.6% in
those who underwent a below-knee am
putation with a rigid dressing and 5.7%
in those with a soft dressing. Two died
of cardiac disease, two of renal disease
and one of generalized disease. The mor
tality for above-knee amputees was 31%;
14% died less than 1 month after opera
tion; 17% died after the amputation was
stabilized and the patient was awaiting
transfer to a chronic care facility. Of the
early deaths four died of cardiac disease,
one of pulmonary disease, one of renal
failure and one of pulmonary embolism.
The late deaths were due to generalized
disease with gradual deterioration. The
Above-knee Amputations
mortality associated with transmetatarsal
The above-knee amputees differed procedures was 19%, three due to cardiac
from those who had below-knee disease and one to general deterioration.
amputation. Their average age was 74.6
Three below-knee amputations with a
years and only 14 were diabetic. rigid dressing failed. Healing was delayed
Associated conditions were also common; in 8 and 23 healed by primary intention.
only 22% had no problems, 52% had One patient died before the healing status
one, 20% had two and 6% had three could be determined. Of the amputations
problems. Seventeen percent of patients with a soft dressing 7 failed, healing was
had severe limitations. They were delayed in 8 and 19 healed by primary in
bed-ridden before the onset of their tention. One patient died before healing
gangrene. Above-knee amputation was could be determined. The difference in
carried out because rehabilitation would these two groups is not statistically signifi
have been impossible even at a lower cant. The history, findings on physical
level. The incidence of associated disease examination, Doppler measurements and
was similar in both the survivors and angiographic findings were similar in the
those who died. In this group, 7 had patients whose stump healed and those
undergone a femoropopliteal reconstruc whose stump did not except that in no
tion, 9 an embolectomy, 5 a combined diabetic was a below-knee converted to
procedure and 10 had had inflow pro an above-knee amputation.
cedures. Twelve patients had undergone
Only 42 of the above-knee amputations
a sympathectomy. We could not deter healed by primary intention or were
mine from this study whether the failure healing at the time of death, in 22 healing
of previous reconstruction had changed was delayed and 7 required a revision at
the level of amputation. This is a con a higher level that was followed by
troversial subject.11' 17
healing. Five of the transmetatarsal
amputations required conversion to a
Transmetatarsal and Digital Amputation below-knee level, in 4 healing was delayed
and 12 healed by primary intention. Of
The patients who had a transmetatar the failed forefoot amputations four were
sal amputation were approximately the in nondiabetic patients who did not
same age as the below-knee amputees undergo an arterial reconstructive
(mean 65.7 years). Fourteen patients were procedure and one was in a diabetic who
diabetic and 9 had no pulse distal to the did not have a reconstructive procedure
common femoral artery. One patient had (i.e., all successful transm etatarsal
had a femorofemoral graft, four a femo amputations were done in either diabetics
ropopliteal graft and one patient had or patients who had a functioning
undergone a combined procedure. Digital reconstruction). Digital amputations
amputation was carried out in 25. Their healed in 8 patients by primary intention,
mean age was 60 years, 21 were diabetic, in 13 by delayed healing and in 4 patients
5 had undergone a reconstructive pro a below-knee amputation was required.
cedure and 6 had had a sympathectomy. AH the patients whose digital amputation
Doppler studies were carried out on healed had primarily either small vessel
most of the patients and the average disease only or had undergone a
readings were highest in the more distal functioning reconstructive procedure.
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The four patients whose amputation
failed were nondiabetic, three had not
undergone reconstruction and one had a
failed femoropopliteal graft.
All the patients with a successful digital
or transmetatarsal amputation were fully
ambulatory.
The level of ambulation achieved was
similar in the two subgroups of
below-knee amputees. Sixteen patients
with a rigid dressing and 14 with a soft
dressing became fully independent, 4 with
the rigid and 3 with the soft dressing were
partially independent with a prosthesis,
4 with a rigid and 3 with a soft dressing
became wheelchair independent and 2 in
each group required total bed care. Four
patients in the group with a rigid dressing
and two in the group with a soft dressing
tried a prosthesis without success. One
bilateral below-knee amputee in each
group became partially ambulatory and
one in each group required total bed care.
One below-knee amputee with a rigid
dressing whose other limb had previously
been amputated above the knee became
partially ambulatory.
The patients w ith above-knee
amputations did not do nearly as well.
Only 6 were fully ambulatory with a
prosthesis, 1 was partially ambulatory
with a prosthesis, 5 were partially
ambulatory without a prosthesis, 17 were
wheelchair independent and 9 patients
required total bed care. Ten patients
became bilateral amputees during the
period of study. Six then required total
bed care and four were wheelchair
independent. There were 23 deaths.
Discussion
If we exclude the patients who had an
above-knee amputation because of their
general physical or mental status before
amputation, the corrected incidence of
amputation at the different levels is 34%
above the knee, 40% below the knee,
12% transmetatarsal and 14% digital.
This is consistent with other reports in the
literature.22'24 Blaisdell in his discussion
of the paper by Moore and associates2
stated that if enlightened surgery is
performed the incidence of below-knee
amputations should always exceed that of
above-knee amputations.
Mortality associated with above-knee
amputations is much higher than that for
below-knee amputations but this is
probaby related to the patients’ general
status and to advanced arteriosclerosis
rather than to any difference in the
operative procedures. Our mortality of
31% for above-knee amputations and 7%
for below-knee amputations is quite
comparable to other reports in the
literature.5'23,25 Of greater importance is
the fact that the below-knee amputees
with soft dressings had a mortality

similar to that of the rigid group. The
rigid dressings appeared to favour healing
but the difference was not statistically
significant. Reports on this have been
quite variable.3'5'8'22,23 The final level of
activity was indentical in the two groups
of below-knee amputations but we believe
that the rigid dressings facilitated this end.
The patients who underwent below-knee
or more distal amputations were far more
independent and had less change in their
life-style than did patients who required
an above-knee amputation. Clinical
assessment of the blood supply appeared
to be quite accurate in deciding upon the
correct level of amputation. Doppler
assessment may be complementary but by
itself is not useful in selection.
Angiography was helpful only in ruling
out the possibility of reconstruction.
Conclusions
Since the rate of healing and the final
level of activity obtained are at least as
good with a rigid dressing as with a soft
dressing we believe that immediate pros
thetic fitting is advantageous. There is less
pain, an improved feeling of well-being
and facility in reaching the end result. We
therefore recommend the use of a rigid
dressing where expertise is available.
We feel there is no place for a digital
amputation in the patient with notable
conduit artery disease unless a reconstruc
tion is possible. If there is localized
gangrene and the plantar skin has good
nutrition and no significant rubor then a
transmetatarsal amputation is the pre
ferred procedure because a failed digital
amputation invariably leads to a belowknee am putation.26-28
A m ultidisciplinary approach is
imperative for the patient who requires
an amputation. Such an approach should
start before operation and continue
indefinitely. This is the only way we can
return the critically ill, pain-ridden,
bed-confined p atient to a happy
independent place in society. Every effort
should be made to increase the percentage
of below-knee or more distal amputations
to help to achieve this goal. A program
that is complete and well thought out will
decrease morbidity and mortality and ef
fect great financial savings.
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Dalacin C Phosphate
is part of the “Gold Standard
in the treatment of
polymicrobial abscesses
1. Staphylococci; 2. Bacteroides fragilis; 3. Polymorphonuclear Leukocyte

Polymicrobial Abscess
A Potential Post-Surgical Complication

Dalacin C Phosphate Sterile Solution

(clindamycin phosphate)
*

...the standard to which
others are compared.
• Provides excellent penetration into infected
abscesses.2

t
•

• Highly effective against gram -positive aerobes
including penicillinase - producing Staphylococci.

‘

• Highly effective against gram -positive and gram 
negative anaerobes, in particular Bacteroides fragilis.

•

• Has never been associated with any carcinogenic or
mutagenic activity.

'.

• May enhance the natural host defense system ; has
been shown to concentrate within polym orphonuclear
leukocytes in vitro. These neutrophils in turn may act
as an im portant antibiotic delivery system to the site of
infection.4

»

(r

After 10 years of clinical use, resistance developm ent
to Bacteroides fragilis is as low as 2% .3

<-

1. R. Fekety, M.D., Drug Therapy Hospital, October 1982
*ln combination with an aminoglycoside.
2. Mouzas G.L., et al (1980) Brit J Clin Pract 34:234
3. M.H. Yee, M.D. et al, JAMA, October 15, 1982, Vol. 248, No 15
4. M.S. Klempner et al, J. Inf. Dis., Vol. 144, No. 5, November 1981
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Dalacin C Phosphate Phosphate S.S.
Recommended Applications
Action: Clindamycin exerts its antibacterial effect by causing cessation of protein synthesis a nd also
by causing a reduction in the rate of synthesis of nucleic acids.

Indications: Dalacin C P hosphate (clindam ycin phosphate) is indicated for the treatment o f infec
tions where the oral route is not indicated or feasible.
Dalacin C P hosphate is indicated in the treatment of serious infections due to sensitive anaerobic
bacteria, such as Bacteroides species, peptostreptococcus, anaerobic streptococci, Clostridium
species a nd m icroaerophilic streptococci.
Dalacin C Phosphate is also indicated in serious infections due to sensitive Gram-positive organisms
(staphylococci, including penicillinase-producing staphylococci, streptococci and pneumococci) when
th e patient is intolerant of, o r the organism resistant to other appropriate antibiotics.

Contraindications: The use of Dalacin C Phosphate (clindamycin phosphate) is contraindicated
in patients previously found to be hypersensitive to this com pound, the parent com pound, clinda
mycin, or clindamycin palmitate. Although cross-sensitization with Lincocin® (lincomycin hydrochloride)
has not been dem onstrated, it is reco m m e nd e d that Dalacin C Phosphate not be used in patients
w h o have dem onstrated lincom ycin sensitivity.
Until further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn
(infants below 3 0 days of age), or in pregnant women.

Warnings: Som e cases of severe a nd persistent diarrhea have been reported during o r after ther
apy with Dalacin C P hosphate (clindam ycin phosphate). This diarrhea has been occasionally asso
ciated with blood a n d m ucus in the stools and has at times resulted in acute colitis. W hen e ndos
c o p y has been perform ed, som e of these cases have shown pseudom em brane formation.
If significant diarrhea occurs during therapy, this d ru g should be discontinued or, if necessary, con
tinued only with close observation. Significant diarrhea o ccurring u p to several weeks post-therapy
should be m a n ag ed as if antibiotic-associated.
If colitis is suspected, endoscopy is recom m ended. Mild cases showing minim al mucosal changes
m ay respond to sim ple d rug discontinuance. Moderate to severe cases, including those showing
ulceration or pseudom em brane formation, should be m anaged with fluid, electrolyte, a nd protein
supplementation as indicated. C orticoid retention enemas a nd systemic corticoids may be of help
in persistent cases. Anticholinergics and antiperistaltic agents may worsen the condition. Other causes
of colitis should be considered.
Studies indicate a toxin(s) pro du ced by Clostridia (especially Clostridium difficile) may be a princi
pal cause of clindam ycin and other antibiotic-associated colitis. These studies also indicate that this
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. When 125 m g to 500 m g of vanco
m ycin were adm inistered orally four tim es a day for 5 - 1 0 or m ore days, there was a rapid observed
disappearance of the toxin from faecal sam ples and a coincidental recovery from the diarrhea.

Clinical and Laboratory Findings: Patients treated d uring clinical trials of Dalacin C Phosphate
(clindamycin phosphate) were followed with clinical laboratory tests, including complete hematology,
urinalysis and liver and kidney function tests. S om e of these tests were abnorm al initially and return
ed to normal during therapy with Dalacin C Phosphate, while others were normal initially and became
abnorm al during therapy. Overall evaluation of clinical laboratory values in these patients does not
indicate that Dalacin C Phosphate therapy has a toxic effect on the hematopoietic, hepatic or renal
systems. Transient elevations of serum transaminases have o ccurred in some patients, but other liver
function tests (alkaline phosphatase, serum bilirubin) have not shown any tendency to increase and
there have not been clinical signs of drug-induced hepatic toxicity.
Symptoms and Treatment of Overdosage: N o cases of overdosage have been reported. No
specific antidote is known. Doses as high as 1200 m g every six hours (4800 mg/day) by infusion for
five days have been given without adverse effects.
DOSAGE A N D ADMINISTRATION

Adults
Intram uscular Injection: 600 mg/day in 2 equal doses.
M oderately severe infections: 600 to 1200 m g/day in 2 or 3 equal doses.
Severe infections: 1200 to 2400 m g/day in 2 ,3 o r 4 equal doses. Intramuscular injections of more
than 600 m g into a single site are not recom m ended.

Intravenous Administration: Dalacin C Phosphate (clindamycin phosphate) must be diluted prior
to I.V. administration to a dilution of 300 m g in 5 0 m l of diluent (6 m g/m l) or more, and infused in not
less than 10 minutes. Administration of m ore than 1200 m g in a single 1 hour infusion is not recom 
m ended. Dalacin C Phosphate should not be injected intravenously undilutea as a bolus.
M oderately severe infections: 9 00 to 1800 m g/day by continuous d rip or in 2 o r 3 equal doses, each
infused over 20 minutes or longer.
Severe infections: 1800 to 2700 mg/day by continuous d rip o r in 3 o r 4 equal doses, each infused
over 20 minutes or longer. In life-threatening infections, doses of 2700 to 4800 m g/day by continuous
d rip o r in 3 or 4 equal doses each infused over 20 minutes o r longer may be given.

Dilution and infusion rates:

It should be noted that serious relapses have occurred up to one month after apparently successful
treatment. A relatively prolonged period of continuing observation is therefore recom m ended.

Precautions: Dalacin C Phosphate (clindam ycin phosphate), like any drug, should be prescribed
with caution in a topic individuals.
Dalacin C Phosphate must be diluted for intravenous administration. (See Dosage and Administration)
The use of antibiotics occasionally results in overgrowth of nonsusceptible organisms - particularly
yeasts. Should superinfections occur, appropriate m easures should b e taken as dictated b y the clin
ical situation.
As with all antibiotics, perform culture a nd sensitivity studies in conjunction with drug therapy.
Since abnormalities of liver function tests have been noted occasionally in animals and m an, peri
o d ic liver function tests should be perform ed d uring prolonged therapy. Blood counts s h ould also
b e monitored d uring extended therapy.
Dalacin C Phosphate may be used in anuretic patients. Since the serum half-life of clindam ycin in
patients with im paired hepatic function is greater than that found in norm al patients, the dose of
Dalacin C Phosphate should be appropriately decreased. Hemodialysis and peritoneal dialysis are
not effective means of removing the com pound from the blood. Periodic serum levels should be deter
m ined in patients with severe hepatic and renal insufficiency.

A dverse

Reactions: L o ca l.

(a) Intramuscular Injections: Of 404 patients treated with Dalacin C Phosphate (clindamycin phosphate)
intram uscularly (with a solution containing 150 mg/mL), six (1.5%) dem onstrated local reactions as
follows: Two com plained of pain at the injection site, two dem onstrated induration at the injection site
a nd two developed sterile abscesses.
(b) Intravenous Infusions: O f 192 patients treated with Dalacin C Phosphate by intravenous infusion,
14 (7.3%) demonstrated local reactions. Eleven patients developed superficial throm bophlebitis and
one patient developed both superficial and d ee p throm bophlebitis. The majority of these cases
developed in conjunction with the use of in dw elling I.V. catheters and it is difficult to know h ow much
the d rug contributed to the irritation. Two patients developed localized erythema, swelling a nd pain
at the site of the infusion.

Systemic Side Effects: Twenty-eight patients of 596 treated with Dalacin C Phosphate (clindamycin
phosphate) by either the intramuscular or intravenous routes developed systemic side effects as follows:
Num ber o f Patients
R a s h ...................................................................................................................................................................7
U rtic a ria .............................................................................................................................................................. 1
P r u r it u s ........................................................................................................................................................... ...
Fever, Leucocytosis.......................................................................................................................................... 1
Nausea, with or without v o m itin g ..................................................................................................................1
Dia rrhea (See also under ‘W arnings’) .........................................................................................................4
H yp o te n sio n .................................................................................................................................................. 1
H y p e rte n s io n ...........................................................................................................................................
1
Shortness of Breath ................................................................................................................................
1
S upe rin fe ctio n*..................................................................................................................................................4
C ard ia c arrest* * ............................................................................................................................................... 1
B ad or bitter taste in m o u th ........................................................................................................................... 5
‘ Superinfection is a com plication of antibiotic therapy in general a nd is not necessarily a true
side effect of clindam ycin phosphate.
‘ D ue to underlying myocarditis in this patient.
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Dose

Diluent

Time

300 mg
600 m g
900 m g
1200 m g

50 ml
100 ml
150 ml
200 ml

10 min.
20 min.
30 min.
45 min.

Alternatively, d rug may be administered in the form of a single rapid infusion of the first dose followed
by continuous I.V. infusion as follows:
To maintain serum
clindam ycin levels

R apid
infusion rate

Maintenance
infusion rate

A bove 4 mcg/ml
A bove 5 mcg/ml
A bove 6 mcg/ml

10m g/m in. for 3 0 min.
15m g/m in. for 3 0 min.
2 0m g/m in . for 30 min.

0.75 mg/min.
1.00 mg/min.
1.25 mg/min.

Children: (Over one month of age)
Intram uscular injection: 10 to 15m g/kg/day in 2 ,3 o r 4 equal doses.
M oderately severe infections: 15 to 20 m g/kg/day in 3 or 4 equal doses.
Severe infections: 20 to 3 0 mg/kg/day in 3 or 4 equal doses.

Intravenous Administration:
M oderately severe infections: 15 to 25 m g/kg/day by continuous d rip or in 3 o r 4 equal doses, each
infused over 20 minutes or longer. In severe infections, it is reco m m e nd e d that children be given no
less than 300 m g/day regardless of bod y weight. (Dilute Dalacin C Phosphate Sterile Solution in the
sam e m anner as for adults.)

Dilution and Compatibility:
4 ml (600 m g) Dalacin C Phosphate w hen diluted with 1000 ml of the following com m only used in
fusion solutions was found to be physically com patible a nd dem onstrated no significant ch an ge in
pH o r antim icrobial potency over a period of 24 hours:
S odium chloride injection
Dextrose 5 % in water
Dextrose 5 % in saline
Dextrose 5 % in Ringer's Solution
Dextrose 5 % in half-strength saline plus 40 m Eq potassium chloride
Dextrose 2 1/2 % in Lactated Ringer's Solution (H artm ann’s Solution).
Dalacin C Phosphate was not stable w hen a dd ed to Dextrose 5 % in water plus vitamins. Therefore
it is not recom m ended that Dalacin C Phosphate be m ixed with any infusion solution containing B
vitamins.

Supplied:
Dalacin C Phosphate contains the following per ml of sterile solution:
Clindam ycin phosphate equivalent to clindam ycin base 150 m g
Benzyl alcohol 5 mg
Disodium edetate 0.5 mg
Water for injection q.s.
W hen necessary the pH is adjusted with sodium hydroxide a n d /o r hydrochloric acid to maintain a
pH range of 5.5 to 7.0.
Dalacin C Phosphate is available in 2 ml a nd 4 ml ampoules.

NOTE: Do not store below 15°C.
Product Monograph available upon request,
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Revision of Total Hip Arthroplasty
Between September 1978 and December
1980, 28 revision procedures were car
ried out at the Wellesley Hospital, Toron
to, for biomechanical failure of total hip
arthroplasties. Twenty-six patients were
personally reviewed and assigned a Har
ris hip rating. Seven patients had major
complications intraoperatively or
postoperatively; three of them required
further surgery. Twenty-four patients
had satisfactory results and none were
worse. The mean Harris score
preoperatively was 36.3. At a minimum
follow-up of 1 year after revision, the
mean Harris score rose to 79.9
(p < 0.01). Revision of total hip ar
throplasty is a difficult and demanding
procedure but can produce satisfactory
results.
Entre septembre 1978 et decembre
1980, 28 revisions d'arthroplasties totales de la hanche ont ete pratiquees au
Wellesley Hospital de Toronto, suite a
une defaillance bio-mecanique. Vingt-six
patients ont pu etre etudies et on leur
attribua une cote sur I'echelle de la han
che de Harris. Sept patients eurent des
complications majeures durant la periode
per ou postoperatoires, et trois necessiterent de nouvelies interventions chirurgicales. Vingt-quatre patients beneficierent
de resultats satisfaisants et aucun n'empira. Avant I'operation, la cote moyenne
sur I'echelle de Harris etait de 36.3. Aux
examens de controle au moins 1 an
aprfes la revision, la cote moyenne sur
I'echelle de Harris avait augmente a 79.9
Ip < 0.01). La revision d'une arthroplas-
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tie totale de la hanche est une operation
difficile et exigeante, mais elle peut donner des resultats satisfaisants.

According to Statistics Canada1 more
than 9000 total hip replacements are car
ried out in this country annually.
Although most patients have a good ob
jective and subjective result, the pro
cedure fails in a small percentage. Total
hip arthroplasty can fail for two reasons:
infection or biomechanical instability.
Many authors2'7 have reported the
results of revision of total hip replacement
resulting from sepsis, the success rate
ranging from 35%3 to 90%7 with vary
ing techniques. There is little information
on the results of revision after
biomechanical failure. In 1975, Dandy
and Theodorou8 reviewed their ex
perience in revising McKee-Farrar ar
throplasties. Of revisions for loosening,
40% needed no further operation but
23% required excision. The report by
Hunter and associates9 of 140 total hip
arthroplasty revisions is particularly
distressing. Only 24% of patients had ex
cellent or good results and 51% fair or
poor results. Thirty-one patients (22%)
subsequently required excision ar
throplasty. The patients reported in that
series were operated on by many different
surgeons at a number of hospitals. It was
our impression that the results of revision
of total hip arthroplasty were significantly
different from those reported in the
literature. With this in mind, we thought
it important to review and report our
findings. We describe two cases to il
lustrate our methods and results.
Patients

Between Sept. 1, 1978 and Dec. 31,
1980, 28 patients, who ranged in age from
30 to 78 years (mean 62.7 years), under
went a revision procedure at the Wellesley
Hospital, Toronto. The indication for the
first total hip replacement was osteo
arthritis in 16 patients. Other indications
included rheumatoid arthritis, avascular
necrosis, displaced subcapital fracture
and ankylosing spondylitis. The surgical

history of these patients is shown in Table
I. Twenty-three patients had clinical and
roentgenographic evidence of loosening.
Two patients had a fracture of the
femoral component and one patient had
a fracture of the acetabular component.
All operations were performed or
supervised by two senior orthopedic
surgeons. Two patients were lost to
follow-up, leaving 26 patients who were
personally examined. The minimum
follow-up was 1 year and in over half it
was 2 years.
Operative Technique

In half of the procedures the posterior
modified Gibson exposure was used. This
allows a clear view down the in
tramedullary canal of the femur once the
femoral prosthesis has been removed.
This is particularly important for com
plete removal of the old cement. Also,
this approach makes osteotomy of the
greater trochanter unnecessary. In the
other half of the revision procedures the
anterolateral exposure was used. Osteo
tomy of the greater trochanter must be
performed with this approach unless on
ly the acetabular component is being
replaced. This exposure makes orienta
tion of the arthroplasty components
easier.
Frequently, it is difficult to remove the
Table 1—Operations In = 26)
Operation
Previous
Total hip replacement only
Osteotomy
Hemiarthroplasty
One revision of total
hip replacement
Two revisions of total
hip replacement
Revision
Acetabular component only
Femoral component only
Both components
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No. of
patients
20
2
1
2
1
3
7
16
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cement from the intramedullary canal of
the femur. Stiihmer and associates10
have developed special instruments for
this purpose and we recommend their use.
Occasionally, a cortical window must be
created to remove all the methylmetha
crylate. To do this, the cortex should be
breached anteriorly rather than laterally,
to avoid making a defect on the tension
side o f the bone and thus creating a
greater stress riser (a point o f weakness
from which a fracture line may propagate
as a result o f repeated stress). Similarly,
when the femoral component is fractured,
the distal fragment must sometimes be
punched out retrogradely through a cor
tical window.
The acetabular component is often
hard to remove when it is still bonded to
the cement and pelvis. In this case, we
recommend cutting the polyethylene
plastic into quarters along the diameter
o f the cup, like cutting a pie into pieces.

Case Reports

both components of the arthroplasty and cor
tical erosion around the tip of the femoral pros
thesis (Fig. 1). The arthroplasty was revised us
ing a posterior approach. At operation, both
components were loose and easily removed. A
54-mm cup and 180-mm long neck femoral
component were inserted (Fig. 2). Preoperatively, the patient’s Harris score11 was 33.4.
At 18 months after revision her Harris score
was 95.

Case 2
Nine years after a left total hip replacement,
a 73-year-old man experienced sudden onset
of pain in his left buttock, groin and thigh
when he fell. He was unable to bear weight on
that extremity. Roentgenograms showed a
loose femoral component with fracture of the
stem 6 cm proximal to the tip (Fig. 3). The ar
throplasty was revised, using a posterior ap
proach. The proximal part of the femoral com
ponent was easily removed. A window was
made in the anterior femoral cortex at the level
of the distal prosthetic fragment. The re
mainder of the stem was then removed through
this window. The acetabular component was
stable and was not removed. A 180-mm regular

neck femoral prosthesis was then inserted (Fig.
4). Two years after revision this patient had
a Harris score of 78.4.

Complications
There were few intraoperative com
plications. In four instances, the cement
drill perforated the femur creating a small
cortical defect. This emphasizes the need
for adequate visualization during this
step. When the cortex is breached, the
defect should be exposed, and digitally
occluded when the new methylmetha
crylate is introduced. In two instances the
femoral cortex was split longitudinally,
while inserting the new prosthesis. These
patients required circlage wiring. In one

Case 1
A 65-year-old woman underwent total hip
replacement in 1975 for osteoarthritis. She was
free of pain and her prosthesis functioned well
until 1978 when she experienced spontaneous
onset of pain in her right groin. The pain in
creased and gradually became incapacitating.
Roentgenograms showed radiolucency around

Fig. lb
FIG. 1—Case 1. (a) Anteroposterior and (b)
lateral views. There is radiolucency around
both components and cortical erosion at tip of
femoral prosthesis.
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Fig. 2b
FIG. 2—Case 1. (a) Anteroposterior and (b)
lateral views after revision.

Fig. 3b
FIG. 3—Case 2. Stem of femoral component
has fractured (arrow).
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instance the hip was considered unstable
after the new prosthesis had been inserted
and the patient was placed in boots and
bars. Blood loss intraoperatively averaged
730 ml. There was no statistically signifi
cant difference in intraoperative blood
loss between the anterolateral and the
posterior exposures.
Eight patients had complications
postoperatively. Two had cardiac
arrhythmias in the recovery room. These
were successfully managed. One patient
had a thigh ulcer requiring split-thickness
skin grafting. There was a single case of
pulmonary embolism, successfully treated
with anticoagulants. Two patients had
hematoma. Two patients had anterior
dislocation of the femoral prosthesis. One
occurred 10 days postoperatively and was
reduced after a d m in istra tio n o f
intravenous neuroleptic agents. The
patient was placed in boots and bars for
6 weeks. He has since done well. The
second dislocation occurred 3 weeks post
operatively and required surgical replace
ment of the femoral component. Thus,
three patients required additional surgery
on the hip: two for evacuation of hema
tomas and one because of dislocation.
There were no deaths perioperatively.

Results

Twenty-six patients were personally
examined and given a Harris rating."
These results are shown in Table II. There
were statistically significant improve
ments in pain, activities of daily living
and gait (p < 0.01, paired t-test). There
was no significant improvement in range
of motion. The mean overall Harris
score postoperatively was 79.9 (of a
possible 100 points) compared with a
mean of 36.3 preoperatively (p < 0.01).
There were only two patients in whom
there was not a significant improvement
in the Harris rating. No patient was made
worse by the surgery. Analysis of these
results showed that patients having both
components replaced did as well as those
who had only one replaced. Furthermore,
there was no statistical difference between
patients followed up for 1 year and those
followed up for 2 years.
Sixteen patients had aspiration of the
hip joint preoperatively. No organisms
were cultured. Three of these patients,
however, had positive cultures at time of
operation. Material was taken from all 26
hips intraoperatively. The three patients
with positive cultures at the time of opera
tion have all had significant (p < 0.01)
improvement in their Harris rating.
Discussion

FIG. 4—Case 2 after revision.

Criterion
Pain
Activities of
daily living
Gait
Range of motion
Total Harris score

As the number of total hip ar
throplasties being performed increases,
more attention must be focused on pa
tients in whom the procedure is unsuc
cessful. The reported results of revision
for biomechanical failure of total hip ar
throplasty are variable. In this series of
26 cases, all operations were performed
or supervised by one of two senior or
thopedic surgeons who had a particular
interest in hip surgery. Only two patients
did not benefit from revision. Twentyfour (92%) demonstrated significantly
higher Harris scores following their
operation. A longer follow -up is
necessary to see if this improvement will
last. It is promising, however, that there
was no deterioration at the 2-year follow
up compared with the 1-year follow-up.
Revision surgery is difficult and
demanding. It requires special in
struments and techniques. Acceptable

Table II—Harris Ratings
Preop value,
Maximum possible
mean
Harris value
44
10.8
14
33
100.5
100

5.3
12.7
84.6
36.3

Postop value,
mean
36.2

p value
< 0 .0 1

10.8
25.8
86.1
79.9

< 0 .0 1
< 0 .0 1
NS
< 0 .0 1

results can be achieved in the majority of
cases. Revision of total hip arthroplasty
is a reasonable operation for those pa
tients in whom there has been bio
mechanical failure.
We thank Mrs. Suzanne White for typing the
manuscript.
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Valeur predictive des tests d'acidite preoperatoires dans
la recidive ulcereuse apres vagotomie supra-selective
Les a u teu rs a nalysent la valeur p redictive
du ch im is m e gastrique preoperatoire
dans une serie de 2 7 vag o to m ie s suprase le ctive s. Ms reco m m an d e n t la prudence
dans le c h o ix de c e tte in te rve n tio n pour
les hypersecrG teurs e t p ro p o se n t des crite re s de selection p reoperatoires bases
sur I'a c id ite ga striq u e basale et un te st
de suppression a la c im e tid in e pour iden
tifie r les p a tie nts a ha u t risque.

tats de la vagatomie supra-selective pratiquee dans notre etablissement. Elle tente
de determiner si l’analyse des taux d’aci
dite gastrique preoperatoires, avec ou
sans suppression a la cimetidine, permet
d ’evaluer les risques de recidive ulcereuse.

The a u th o rs have analysed the predictive
value o f th e basal and peak gastric acidi
ty levels, m easured p re o p e rative ly, in a
series o f 2 7 supraselective vagotom ies.
T hey recom m end care in th e choice o f
th is o p e ra tio n fo r h yp e rse cre to rs and
th e y pro p o se criteria fo r th e preoperative
se le ctio n o f the can d id ate s. They sug
g e s t d e te rm in a tio n o f th e preoperative
basal g a s tric a c id ity level and a
c im e tid in e suppression te s t to id e n tify
p a tie n ts a t high risk fo r recurrence o f the
ulcer.

D ’octobre 1976 a octobre 1981, 29
malades consecutifs ont subi une vagoto
mie supra-selective. Deux ont ete exclus
de l’etude pour les raisons suivantes: un
etait porteur d ’un ulcere pre-pylorique et
fut opere d’urgence pour hemorragie sans
test d ’acidite gastrique prealable; l’autre,
bien qu’opere electivement pour un ulcere
duodenal, presentait une affection ulcerogene associee, soit une pince mesenterique, qui ne fut pas corrigee.

Le concept de la vagotomie supra
selective a ete introduit dans la litterature
medicale de ces 15 dernieres annees dans
le but de traiter la maladie ulcereuse duodenale par une approche chirurgicale
ultra-selective et partant plus physiologique.
Par rapport aux interventions classiques, la vagotomie supra-selective offre
des avantages incontestables qui se traduisent par une reduction de la mortalite et
de la morbidite chirurgicale, fonctionnelle
et metabolique. Cependant les resultats de
l’operation sont entaches par des taux de
recidive variant de 2% a 22% .1-3
La presente etude porte sur les resulDes departements de “chirurgie, t gastroenterologie et fadiologie, Hopital NotreDame, Universite de Montreal, Montreal,
PQ
Accepte pour publication le 14 janvier,
1983
Les demandes de tires a part doivent etre
adressees au Dr J. Corman, Departement
de chirurgie, Hopital Notre-Dame, CP
1560, Station C, Montreal, PQ H2L 4K8
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Materiel clinique

Selection

Indication operatoire
Chez les 27 autres patients, l’indication
operatoire fut posee de fa?on elective en
raison de la presence d ’une maladie ulce
reuse duodenale isolee, non compliquee
et en l’absence de pathologie associee
ulcerogene, quelle qu’ait ete la valeur des
taux d’acidite gastrique preoperatoires.
Investigation preoperatoire
Endoscopie et radiologie.—Chez tous
les patients, la maladie ulcereuse fut prouvee soit par une ou plusieurs endoscopies,
soit par un transit radiologique gastro
duodenal ou les deux examens a la fois.
Epreuves d ’acidite gastrique.—L’acidite gastrique basale (BAO en mmol/h)
et le pic maximum de debit acide (PAO
en mmol/h) apres stimulation a la pentagastrine (6 /tg/kg) furent mesures chez
tous les candidats a I’intervention. De
plus, 17 malades subirent 1’examen sous
traitement d ’epreuve a la cimetidine (300
mg per os qid pendant 24 heures), le test
d ’acidite debutant 1 heure apres la prise
de la derniere dose du medicament.
Enfin, la gastrinemie fut evaluee chez tous
les patients sauf quatre.

Technique operatoire
Les 27 interventions furent pratiquees
exclusivement par les deux auteurs chirurgiens, en collaboration au debut de [’ex
perience, puis seuls par la suite. La tech
nique utilisee fut celle decrite par Hollender et Otteni.4
Au debut de l’etude, le controle de
I’acidite gastrique peroperatoire fut assure
chez quatre malades soit par une electrode
a pH per-oesophagienne, soit par la tech
nique au Rouge Congo via une gastrotomie. Ces epreuves furent delaissees par la
suite et [’intervention fut conduite essentiellement sur la base des reperes
anatomiques.
Investigation postoperatoire
Tous les malades furent revus et exa
mines regulierement par les auteurs et leur
symptomatologie postoperatoire fut
etudiee.
La duree minimale de relance fut d’un
an.
La presque totalite des malades subi
rent des epreuves de chimisme gastrique
(BAO et PAO) au minimum 1 mois
(24/27), 6 mois (23/27), 1 an (23/27) et
2 ans (12/27) apres l’operation.
La plupart (23/27) eurent repas baryte
de controle. L’endoscopie fut specifiquement reservee aux malades symptomatiques.
Repartition des groupes
Les patients furent divises en deux
groupes principaux en fonction du succes de l’intervention ou de son echec, soit
le groupe des non-recidivants et celui des
recidivants. Deux sous-groupes furent
egalement etudies parmi les malades qui
avaient subi un test de suppression a la
cimetidine en preoperatoire, soit le sousgroupe des non-recidivants et celui des
recidivants.
Les recidives ulcereuses furent toutes
basees sur la reapparition d’une sympto
matologie ulcereuse et la preuve radiolo
gique ou endoscopique d’un nouvel ulcere
duodenal.
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Une analyse de variance (test de Fisher)
fut utilise pour les calculs statistiques.
Resultats

L’age moyen des operes fut de 45 ans,
avec des extremes de 24 a 70 ans. On
comptait 22 hommes et 5 femmes. Dix

etaient obeses au m om ent de
l’intervention.
L’operation fut realisee en moyenne en
2 heures 22 minutes.
Les malades furent suivis pour une
duree de 1 a 6 ans.
Sur les 27 patients etudies, il y eut 3
(11%) recidives de la maladie ulcereuse,

respectivement 6, 14 et 64 mois apres l’intervention. Ces recidives sont survenues
essentiellement chez des femmes et une
seule d ’entre elles etait obese au moment
de l’operation. II est important de noter
que bien que la vagotomie supra-selective
fut un echec chez ces trois patientes,
[’operation a permis un controle medical
plus facile et plus adequat de la maladie
ulcereuse lors de sa reapparition.

Tableau 1—Evolution de I'acidite gastrique basale (BAO)
dans les groupes non-rbcidivants et recidivants*

Etude du chimisme gastrique

Recidivants

Non-recidivants
Temps

No.

BAO, mmol/h

Preop

24

6.59 ± 4 . 0 l

1
6
1
2

22
21
20
11

0.98
1.72
1.90
2.09

No.

BAO, mmol/h

3

11.00 ± 7.2

2
2
3
1

5.10 ± 3.1
6.65 ± 1.9
7.30 ± 6.5
14.10

p < 0.001
mois
mois
an
ans

±
+
±
±

1.6
1.9
2.1
1 .9 _I

*Les chiffres representent la moyenne ± I'erreur type.

Tableau II—Facteurs de risques de recidive
Malade
no.

BAO preop,
mmol/h

Valeur
du test

i
2
3
4
5

11.7
8.0
21.2
12.5
17.5

+

BAO preop sous
cimetidine,
mmol/h

Valeur
du test

2.6
3.0

+
+

-

+
+
+

0.0

-

3.0
2.0

+
+

Recidive

0
0
0
+
+

La presence de deux criteres positifs soit BAO > 10 mmol/h et suppression incomplete de I'acidite
sous cimetidine correspond a une recidive ulcereuse chez deux malades sur trois (66%).

Tableau Ill-Evolution du pic maximum de debit acide (PAO)
dans les groupes non-recidivants et recidivants
Non-recidivants

Recidivants

Temps

No.

Preop

24

43.88 ± 1 6 .2 Z D —

1
6
1
2

22

21.09
24.40
25.23
22.93

PAO, mmol/h

No.

PAO, mmol/h

3

38.83 ± 13.8

2
2
3
1

30.80 ± 1.3
36.25 + 13.2
31.20 ± 13.3
23.5

p < 0.001
mois
mois
an
ans

21

20
11

± 8.1
± 12.2
±11.4
±
5.9

Les chiffres representent la moyenne ± I'ecart type.

Tableau IV—Evolution du BAO dans les groupes non-recidivants
et recidivants. Test de suppression a la cimetidine
Non-recidivants
Temps

No.

Preop

15

Recidivants

BAO, mmol/h

No.

7.05 ± 4 . 8 = J — |

BAO, mmol/h

2

15.0 ± 3.5=1]—

2

2.5 ± 0 . 7 L ] —

p < 0.001
Cimetidine

15

0.37 ± 0 . 9 8 E H

a-a, b-b - p < 0.05.

p < 0.05

Valeurs preoperatoires. —La moyenne
de la gastrinemie preoperatoire fut de 110
ng/ml chez les 23 des 27 malades etudies
sans jamais depasser la normale chez
aucun d ’entre eux.
Bien que statistiquement non significatives, les valeurs moyennes des BAO preo
peratoires etaient nettement plus basses
dans le groupe des non-recidivants que
dans le groupe des recidivants, soit res
pectivement 6.59 m m ol/h et 11 mmol/h
(tableau I).
De plus, seuls 2 des 24 malades du
groupe des non-recidivants avaient des
BAO preoperatoires superieurs a 10
mmol/h contre 2 des 3 patients du groupe
des recidivants (tableau II).
Les valeurs de depart du PAO etaient
par ailleurs sensiblement les memes dans
les deux groupes (43.9 m m ol/h et 38.8
mmol/h) (tableau III).
Evolution postoperatoire.—Dans le
groupe des non-recidivants, revolution
des taux des BAO et PAO mesures a 1
mois, 6 mois, 1 an et 2 ans apres la
vagotomie supra-selective a montre une
reduction statistiquement significative des
valeurs postoperatoires par rapport aux
chiffres pre-vagotomie supra-selective
pour l’ensemble des patients (p < 0.001).
De plus, cette reduction du taux d ’acidite,
aussi bien basale que maximale, est restee
relativement stable durant le temps de
l’etude (tableaux I et III ).
L’evolution des valeurs de I'acidite
gastrique dans le temps fut completement
differente chez les malades qui ont
recidive. Compte tenu du petit nombre de
cas etudies, et bien que les valeurs
postoperatoires du BAO aient sensible
ment baisse, il n’y a pas eu de difference
statistiquement significative entre les taux
d ’acidite pre- et postoperatoires (BAO et
PAO) et ces taux ont eu tendance a
revenir au niveau preoperatoire apres 6
mois devolution contrairement au groupe
des non-recidivants (tableaux I et III).
Chez les 15 malades etudies et exempts
de recidive, l’administration de cimetidine
a provoque une suppression complete du
BAO en preoperatoire chez tous sauf 2.
La cimetidine a egalement abaisse mais
de fagon incom plete les BAO
preoperatoires des deux malades du
groupe des recidivants testes (tableaux II
et IV ).
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La drogue a egalement provoque une
reduction beaucoup moins importante des
PAO preoperatoires dans les deux sousgroupes (tableau V).
Discussion
Theoriquement, la meilleure interven
tion chirurgicale correctrice de la maladie
ulcereuse duodenale serait celle qui
perm ettrait d ’eliminer les facteurs
ulcerogenes sans compromettre ni influencer les autres fonctions du tube
digestif.
En se limitant uniquement a la dener
vation selective des deux tiers proximaux
de l’estomac, la vagotomie supra-selective
permet une reduction marquee de l’acidite
gastrique en preservant la secretion hormonale et digestive extra-gastriques, les
m ecanism es de pro p u lsio n antropylorique et la valve anti-reflux que constitue le pylore. De plus, contrairement aux
autres interventions preconisees, elle
permet une approche digestive extraluminale puisqu’a aucun moment, le
viscere n ’est ouvert et partant, sur le plan
chirurgical, elle presente beaucoup moins
de risques.
Cependant, il est devenu a l’heure actuelle evident que le taux de recidive
ulcereuse apres vagotomie supra-selective
est au moins aussi eleve q u ’apres
vagotomie-pyloroplastie classique et est
nettement plus eleve qu’apres gastrectomie sub-totale ou vagotomie et antrectomie. Ces taux varient de 2% a 22%
dans la litterature recente.1'3,5
N o tre etude, bien que lim itee,
n’echappe pas a la regie puisque nous accusons 11 % de recidive ulcereuse et ce,
dans une population qui presentait une
maladie ulcereuse duodenale isolee et non
compliquee, sans facteurs de risques supplementaires attribuables a des maladies
ulcerogenes associees. Dans notre serie,
l’obesite n’a pas joue de role nefaste puis
que la vagotomie supra-selective a gueri
9 des 10 malades obeses.
Nous avons done tente de discerner
dans l’analyse des tests d ’acidite
preoperatoires, des elements de valeur
pronostique quant au choix des candidats
a une vagotomie supra-selective.
Dans la litterature, il existe peu de
renseignements a ce sujet. De plus, ces
renseignements ne s’appuient pas tous sur

le meme test, sont souvent contradictoires
et n ’analysent pas necessairement leurs
resultats en fonction d ’un seul type
d ’intervention. Pour Baron,6 ces tests
preoperatoires ne sont pas necessaires
pour dieter le choix de l’intervention. Etudiant specifiquement une serie de 100
vagotomies supra-selectives, Johnston et
collaborateurs7 et Marceau et collaborateurs8 ne voient aucune relation entre le taux d ’acidite preoperatoire et le
taux de recidive.
Ce n’est pas l’avis de Kronborg9 qui
analyse une serie de 500 cas ayant subi des
vagotomies tronculaires at diverses inter
ventions de drainage. Kronborg et
Madsen1 recommandent une antrectomie
chez les malades hypersecreteurs. D’autres comme Hood et collaborateurs10 et
Robbs et collaborateurs11 trouvent egale
ment une valeur predictive respectivement
du BAO et du MAO preoperatoires mais
encore une fois dans des series de vago
tomie de formes variees, avec ou sans
drainage ou antrectomie. Enfin, plus
recemment, Joffe et Primrose12 suggerent de reserver la vagotomie supraselective aux patients dont le PAO se
situe en dessous de 40 mmol/h en pre
operatoire.
La validite des calculs statistiques de
notre etude est entachee par le nombre
limite de cas, par la disproportion existant entre les deux groupes (des nonrecidivants et des recidivants) ainsi que
par la duree relativement courte de l’etude
des suites therapeutiques. Il n’en reste pas
moins que:
1. Les valeurs des BAO preoperatoires
du groupe des recidivants atteignent quasiment le double de celles du groupe des
non-recidivants (tableau I).
2. Deux des quatre malades ayant un
BAO preoperatoire superieur a 10
mmol/h ont eu une rechute de leur mala
die (tableau II).
3. Deux des quatre malades qui ont eu
une inhibition incomplete de leur BAO
preoperatoire par la cimetidine ont eu une
recidive ulcereuse (tableau II).
4. Deux des trois malades presentant a
la fois un BAO preoperatoire de plus de
10 mmol/h et une reponse incomplete a
la cimetidine sont des echecs (tableau II).
Par contre, 1’analyse des PAO preope
ratoires, avec ou sans cimetidine, n’a per-

Temps

Tableau V—Evolution du PAO dans les groupes non-recidivants
et recidivants. Test de suppression a la cimetidine
Non-recidivants
Recidivants
No.
PAO, mmol/h
No.
PAO, mmol/h

Preop

15

45.67 ± 17.0^3—

Cimetidine

15

25.99 ±

2

43.65 ± 15.6

2

28.75 ±

mis aucune distinction entre les deux
groupes.
Bien que le nombre de cas etudies soit
limite, nous pensons que ces observations
permettent quand meme une selection des
candidats a une vagotomie supra-selective
et que la prudence s’impose dans le choix
de l’intervention face aux hypersecreteurs
(BAO superieur a 10 mmol/h) chez qui
le test a la cimetidine n’a pas provoque
une suppression complete du debit basal
en preoperatoire.
Nous proposons done en plus du BAO,
un test preoperatoire de suppression a la
cimetidine pour evaluer les risques de reci
dive ulcereuse. Nous ne possedons pas
suffisamment de donnees pour determi
ner la validite d ’un seul des deux tests pro
poses mais il est permis de croire que
1’usage des deux devrait permettre un
meilleur discernement, le test de suppres
sion a la cimetidine corroborant le BAO
preoperatoire.
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Bilateral Interstitial Cell Tumour of the Testes
The authors report a case of bilateral in
terstitial cell tumour of the testes. A
64-year-old man presented with painless
testicular swellings of many years' dura
tion. No hormonal disturbance was
manifested but the patient was achon
droplastic and diabetic. Bilateral orchiec
tomy was performed. The patient re
mained well. This is a rare tumour and
bilateral involvement is extremely
unusual.
Les auteurs decrivent un cas de tumeur
bilaterale a cellules interstitielles du testicule. Un homme de 64 ans a ete vu en
consultation pour une inflammation testiculaire indolore presente depuis plusieurs
annees. Aucun derangement hormonal
n'etait evident mais le patient etait
achondroplasique et diabetique. Une
orchiectomie bilaterale fut pratiquee. Le
patient est demeure en bonne sante.
Cette tumeur est rare et une atteinte
bilaterale est extremement inhabituelle.

Of the 6000 testicular tumours recorded
in the United States testicular tumour
registry only about 3% are interstitial cell
(Leydig) tumours.1 Of these, only 5% to
9% are bilateral. We report a case of this
rare tumour with bilateral involvement.

on the right. The prostate was normal. Apart
from his achondroplasia no other abnorm ali
ty was found.
At operation both testes were examined
through bilateral groin incisions after the
hydrocele on the right side was aspirated. The
enlarged testes had nodular external surfaces.
Bilateral orchiectomy was performed. The
spermatic cord in each case was ligated and
transected at the internal ring.

Gross and Microscopic Findings

The right testis measured 5.5 cm and
the left 4.0 cm in diameter. On section-

ing, the testes were mahogany-brown and
contained areas of calcification. No nor
mal testicular tissue could be identified
(Fig. 1).
The histologic features of both testes
were identical. Normal tissue was replac
ed by sheets of cells, having oval to round
nuclei with prominent nucleoli. These
cells had abundant eosinophilic cytoplasm
with a ground glass appearance. There
was an accumulation of lipofuscin pig
ment. Fibrous tissue trabeculae and ac
cumulations of fat were scattered through
the lesions and there were areas of
calcification (Fig. 2). The capsules were
thickened.
Discussion

FIG. 1—Excised testes. Normal testicular
tissue has been replaced by tumour and
calcification is present.

Interstitial cells of the testes are poly
hedral and are found in the spaces bet
ween the testicular tubules. These cells
vary from 14 pm to 2lpm in diameter and
have a large central cylindrical nucleus.
There may be one or two nucleoli. Binucleated cells are sometimes found. The
cytoplasm is granular having lipofuscin
granules. Rod-shaped crystalline bodies
of unknown composition called Reinke
crystals are often present.2

Case Report
A 64-year-old man was admitted to Tillsonburg District Memorial Hospital with a history
of swelling of the right testicle after he had been
kicked by a calf 15 years earlier. At the time
of injury the testes became swollen and black.
Treatment was conservative. The right testis
remained larger than the left. His recent history
indicated that the testis was increasing in size.
He had no other notable symptoms relating to
the genitourinary system. He was achon
droplastic and diabetic.
On examination at the time of admission to
hospital, both testes were swollen, the right be
ing larger than the left. There was a hydrocele
From the department o f pathology, Nor
fo lk General Hospital, Simcoe, Ont.
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FIG. 2—Interstitial cell tumour and calcification (hematoxylin and eosin, x2 3 5 ).
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Interstitial cells are few in number at delicate chromatin pattern is present.
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Should Oral Amiodarone Be Used for Sustained
Ventricular Tachycardia in Patients Requiring Open-Heart Surgery?
A patient with sustained ventricular
tachycardia was operated on after an un
successful trial of amiodarone. Profound
myocardial depression and low cardiac
output became evident as he was
weaned from cardiopulmonary bypass.
Despite inotropic support, use of the
intra aortic balloon pump and left heart
assist device, he died.
Because of this experience, the
authors developed a canine model to
determine the effects on left ventricular
function of amiodarone given orally. Left
ventricular stroke work, cardiac output,
ventricular contractility (maximum dP/dt)
and peripheral vascular resistance were
measured in 12 mongrel dogs at a heart
rate of 150 beats/min and at a constant
preload of 10 mm Hg. Six animals
received the drug orally and the remain
ing animals were used as sham-operated
controls. Maximum dP/dt decreased from
2855 mm Hg/s to 1291 mm Hg/s (p <
0.01) and left ventricular stroke work
was reduced from 48.7 g-m/beat to 21.8
g-m/beat (p < 0.05) after the ad
ministration of amiodarone. Cardiac out
put and peripheral vascular resistance did
not differ significantly.
Amiodarone severely depressed left
ventricular function in this experiment.
The prolonged half-life of this antiarrhythmic combined with its adverse ef
fect on myocardial function suggests
that it should not be used in patients
with refractory life-threatening ven
tricular tachycardia who are good can
didates for electrophysiologic evaluation
and endocardial resection.

Un patient souffrant de tachycardie ventriculaire persistante a ete opere apres
I'echec d'un traitement a I'amiodarone.
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Avec I'interruption de la circulation extracorporelle, une depression myocardique
profonde avec faible debit cardiaque est
apparue. En depit d'un soutien inotrope,
de I'usage d'une pompe a ballonnet
intra-aortique et d’une assistance du
coeur gauche le patient est decede.
A la suite de cette experience, les
auteurs ont mis au point un modele ex
perimental chez le chien afin d'evaluer
les effets de I'amiodarone en administra
tion orale sur la fonction ventriculaire
gauche. Le travail systolique ventriculaire
gauche, le debit cardiaque, la contractilite ventriculaire (dP/dt maximum) et la
resistance vasculaire periph6rique ont ete
mesures chez 12 chiens batards a un
rythme cardiaque de 150 battements/min
et a une charge initiale du muscle
cardiaque de 10 mm Hg. Six animaux
ont servi de temoins soumis h une opera
tion factice. Apres I'administration
d’amiodarone, le rapport dP/dt maximum
s'est abaisse de 2855 mm Hg/s a 1291
m Hg/s (p < 0.01) et le travail systoli
que ventriculaire gauche a chute
de 48.7 g-m/battement a 21.8 gm/battement (p < 0.05). Le debit cardia
que et la resistance vasculaire peripherique n'ont pas change de facon
significative.
Dans cette experience, I'amiodarone a
severement deprime la fonction ven
triculaire gauche. La demi-vie prolongee
de cet anti-arythmique associee a son effet indesirable sur la fonction myocardi
que indiquent que ce medicament ne
devrait pas etre utilise chez les patients
souffrant d'une tachycardie ventriculaire
prolongee menacant la vie et qui sont
par ailleurs de bons sujets a la chirurgie
pour une evaluation electrophysiologique
et une resection endocardique.

Amiodarone is a benzofuran derivative
first introduced in Europe in 1967 to
manage angina.1 It has also proven ef
fective in treating supraventricular and
ventricular tachyarrhythmias.2'4 In con
trast to the reports by Charlier and
associates,5'7 describing its hemodynamic
effects, other recent publications8'10 in
dicate that its administration may result
in a marked decrease in myocardial con

tractility associated with low peripheral
vascular resistance and systemic
hypotension.
This report describes a patient with sus
tained ventricular tachycardia who was
operated upon after amiodarone therapy
was unsuccessful. Intraoperatively, severe
left ventricular failure developed and the
patient died of low cardiac output. We
believe the use of amiodarone in this pa
tient may have contributed to his low car
diac output, so we decided to develop a
canine model in an attempt to clarify the
effects of amiodarone on left ventricular
function.
Case Report
A 48-year-old man was admitted to hospital
with an acute myocardial infarction. He con
tinued to experience angina at rest and subse
quently episodes of sustained ventricular
tachycardia developed, requiring up to four
electrical countershocks daily. The ventricular
arrhythmia persisted despite therapeutic doses
of conventional antiarrhythmics and a trial of
amiodarone orally.
Cardiac catheterization revealed the presence
of a large apical aneurysm; the ejection frac
tion was 22%. The coronary angiogram
demonstrated complete occlusion of the left
anterior descending coronary artery and critical
stenosis of both the right and circumflex cor
onary arteries.
Five weeks after the acute infarction, the left
ventricular aneurysm was resected and bypass
grafting carried out. After cardiopulmonary
bypass had been established and the patient
cooled to 25°C, the aorta was clamped and the
heart arrested by crystalloid cardioplegia (us
ing 1000 ml of solution to supply 20
mmol/kgl'1) combined with topical hypother
mia. Myocardial temperature was maintained
below 15°C. After the initial cardioplegia, the
aneurysm was opened and moderate amounts
of thrombus were removed. Saphenous vein
grafts were anastomosed to the proximal right
coronary artery and a large obtuse marginal
branch of the circumflex artery. After each
distal anastomosis had been completed, fur
ther cardioplegic agent was injected into the
aortic root and through the vein grafts, and
topical hypothermia was maintained. Endocar
dial resection was then combined with standard
left ventricular aneurysmectomy. Ischemic ar
rest lasted 42 minutes.
Because of the low ejection fraction, an in
fusion of dobutamine (500 ;tg/min) was started
before attempting to discontinue the bypass.
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After an initial unsuccessful attempt to ter
minate cardiopulmonary bypass, an intra
aortic balloon was inserted and epinephrine (2
/rg/min) infused. Despite these measures, the
patient could not be weaned from bypass. Can
nulas were then inserted into the left atrial ap
pendage and transverse aortic arch and left
heart assistance was established at a flow of
1.5 1/min. Although the patient came off
bypass, he ultimately died of low cardiac
output.

Canine Experiment
Twelve male and female mongrel dogs,
ranging in weight from 22 to 30 kg, were
used. Cardiac output, left ventricular con
tractility as depicted by maximum dP/dt,
left v en tricu lar stroke work and
peripheral vascular resistance were
measured in six animals before and after
the oral administration of amiodarone.
The remaining six animals served as
sham-operated controls.
Operative Protocol fo r Animals
Given Amiodarone
The dogs were maintained under
general anesthesia with a combination of
fentanyl citrate (0.03 mg/kg) and sodium
pentobarbital (30 mg/kg) and ventilated
with room air by a Harvard volume ven
tilator. Employing sterile technique, we
exposed the external jugular vein and
common carotid artery through a right
transverse neck incision. A no. 7 French
thermodilution Swan-Ganz catheter was
then introduced into the vein and passed
into the pulmonary artery, its position be
ing verified by monitoring pressure wave
forms. A Millar, no. 4 French, cathetertip transducer (Millar Instruments Inc.,
Houston, Tex.) (frequency 0 to 24 kHz)
was introduced into the carotid artery and
passed into the left ventricle for measur
ing left ventricular end-diastolic pressure,
d P /d t and pull-back systemic arterial
pressure.
The Millar catheter was connected to
a TCB-10-volt control box (Millar In
struments Inc.) and left ventricular
pressures were recorded on a Gould brush
260 six-channel recorder (Gould Inc.,
Cleveland, Ohio). Maximum dP /dt was
calculated with the pressure wave form
applied to a Gould brush differentiator
(model 11-4123-10). Thermodilution car
diac output was determined with iced
saline using a model 9510 Edwards car
diac o u tp u t com puter (Edw ards
Laboratories, Mississauga, Ont.). The sur
face electrocardiogram was monitored.
All hemodynamic measurements were
taken at a left ventricular end-diastolic
pressure of 10 mm Hg and heart rate of
150 beats/min. The preload was adjusted
to 10 mm Hg by the infusion of Ringer’s
lactate solution or by removal of blood
through a peripheral vein. Cardiac out
put, left ventricular stroke work, max
imum d P /d t and peripheral vascular
356

resistance were recorded at a constant
preload of 10 mm Hg and a heart rate of
150 beats/min.
Amiodarone was given orally (15
mg/kg daily) for 14 days, then a no. 7
French Swan-Ganz catheter was inserted
as already outlined. The chest was
opened through a median sternotomy and
the heart was suspended in a pericardial
cradle. The change in procedure to an
open-chest preparation was necessary
because of the frequent need for atrial
pacing after the administration of
amiodarone. Atrial pacing was instituted
for a bradycardia of less than 150
beats/min, using a model 5300 Medtronic
pacemaker (Medtronic Inc., Minneapolis,
Minn.). On this occasion, the no. 4
French Millar catheter was inserted direct
ly into the left ventricle through a small
apical stab wound. All measurements of
left ventricular function were then
repeated at a left ventricular end-diastolic
pressure of 10 mm Hg and at a heart rate
of 150 beats/min. During both operative
procedures, arterial blood gases were
monitored and hematocrit was recorded.

ventricular stroke work (LVSW, g-m/
beat) was calculated as follows:
LVSW = SV(MSP - LVEDP) x 0.0144,
where SV is the stroke volume, MSP the
mean systemic arterial pressure and
LVEDP the left ventricular end-diastolic
pressure. Peripheral vascular resistance
(PVR, dyn/s-cm ’) was calculated as
follows:
PVR = MSP - RAP,
CO
where RAP is the right atrial pressure and
CO the cardiac output.
Results
A miodarone-treated animals. —Hema
tocrit ranged from 35% to 40% (mean
38%) and did not differ significantly after
amiodarone therapy. Arterial blood-gas
levels remained within normal physiologic
limits; intervention was not needed.
H em odynam ic measurements are
presented in Table I. Maximum dP/dt
was reduced from 2855 mm Hg/s to 1291
mm H g/s after the administration of
amiodarone (p < 0.01), representing a
decrease in myocardial contractility of
55%. Left ventricular stroke work was
similarly affected, being reduced from
48.7 g-m/beat to 21.8 g-m/beat (p <
0.05). Although cardiac output fell from
5.2 1/min to 3.4 I/min, these results were
not significant because of the small sam
ple size. Peripheral vascular resistance
was unchanged after the administration
of amiodarone.
Heart rate was remarkably constant in
all animals under anesthesia, being 150 ±
3 beats/min before the administration of
amiodarone. However, three of six
animals required atrial pacing for sinus
bradycardia (mean 130 beats/min) after

Protocol fo r Sham-Operated Control
Animals
An operative protocol similar to the
one already outlined was used for a fur
ther six animals but no amiodarone was
given. This was necessary to determine the
effect of thoracotomy and pericar
diotomy on left ventricular function.
Analysis
Results were expressed as the arithmetic
mean ± the standard error. The paired
Student’s t-test was used where ap
propriate for statistical comparison. Left
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receiving amiodarone. This decrease in
heart rate reflects the drug’s effect on
sinoatrial conduction.11 Left ventricular
function was measured at a preload of 10
mm Hg by adding or removing fluid or
blood as already outlined. The adjust
ment of left ventricular end-diastolic
pressure to 10 mm Hg required very lit
tle intervention and never necessitated the
addition or removal of more than 150 ml
of fluid or blood.
Sham-operated controls. —Hematocrit
ranged from 34% to 38% (mean 36%).
Hemodynamic measurements before and
after thoracotomy and pericardiotomy
are illustrated in Table II. Left ventricular
stroke w ork, cardiac o u tp u t and
peripheral vascular resistance are not
significantly affected by thoracotomy and
pericardiotomy when measurements of
left ventricular function are carried out
at a constant preload and heart rate.
Discussion
Amiodarone was initially used ex
clusively to manage angina;1 recent
reports indicate that it is safe and ef
ficacious for suppressing supraventricular
and ventricular tachyarrhythm ias.2'4
Sobol and Rakita12 enthusiastically en
dorsed its use, suggesting that it is an ideal
antiarrhythmic because it has no serious
side-effects.
The hem odynam ic effects of
amiodarone were first reported by
Charlier and associates.5'7 Using a canine
m odel, they d em o n strated that
amiodarone given intravenously caused
an atro p in e-resistan t brad y card ia
associated with decreased left ventricular
stroke work, p eripheral vascular
resistance and dP /dt. The effects of
amiodarone on left ventricular function
were, however, dismissed as “ transient
and minor” . By contrast, Singh and
associates,8 Deboer and associates9 and
Sicart and associates10 have shown that
the intravenous adm inistration of
amiodarone may result in marked reduc
tion of dP/dt associated with a decrease
in peripheral vascular resistance and
systemic hypotension. The variability in
these reported data reflects the failure to
control preload and heart rate during
hemodynamic measurements. Left ven
tricular function as expressed by left ven
tricular stroke work, d P /d t and cardiac
output depends directly upon the rigid
control of these parameters.13,14 A fur
ther limitation of these initial investiga
tions is that they all studied the
hemodynamic effects of amiodarone dur
ing parenteral administration; its effects
during intravenous infusion and oral ad
ministration are known to be different.8
Our data clearly demonstrate that oral
ly administered amiodarone causes a
marked reduction in left ventricular con
tractility and left ventricular stroke work.

The recent reports by Installe and
associates15 and
Gallagher
and
colleagues,16 describing their experience
with the drug in patients who undergo
cardiac operations, add further weight to
our experimental results. Installe and col
leagues documented low cardiac output
in five patients following the intravenous
use of amiodarone after open-heart
surgery. They recommended that it be
used with caution in patients with de
pressed left ventricular fu n ctio n .
Gallagher and colleagues reported a pa
tient with a left ventricular aneurysm and
sustained ventricular tachycardia who was
operated upon after an unsuccessful trial
of amiodarone. Profound myocardial
depression became evident during the in
itial attempt to wean the patient from car
diopulmonary bypass. When the patient
left the operating room, intra-aortic
balloon assistance was being used and
megadoses of epinephrine (24 /xg/min)
were being given.
Although the pharmacodynamics of
amiodarone are not well understood, the
therapeutic half-life has been estimated to
range from 30 to 45 days.4 This unusual
property is an advantage in the long-term
management of life-threatening arrhyth
mias where poor patient compliance may
prove fatal. However, the experience of
Gallagher’s group16 and our case report
suggest that this prolonged half-life
coupled with depressed myocardial con
tractility can present serious difficulties
in patients who undergo cardiac surgery.
Frequently, the patient with sustained
ventricular tachycardia is considered for
surgery only after an unsuccessful trial of
amiodarone, which exposes the patient to
an increased operative risk. Our ex
perimental data combined with multicen
tre clinical experience15,16 indicate that
amiodarone should be avoided in patients
with ventricular tachycardia who are can
didates for open-heart surgery.
E lectrophysiologic studies have
demonstrated that re-entrant mechanisms
are responsible for the majority of sus
tained ventricular arrhythmias.17,18 The
development of electrophysiologic tech
niques has facilitated the induction and
mapping of ventricular tachycardia and
has led to operative procedures designed
specifically to eliminate these arrhyth
m ias.19,20 The success o f these new
operations20 and the potential danger
that amiodarone therapy will cause a
severe reduction in left ventricular con
tractility, combined with the prolonged
half-life of amiodarone, suggest that pa
tients with life-threatening sustained ven
tricular tachycardia should be considered
for electrophysiologic evaluation and en
docardial resection after a trial of conven
tional antiarrhythmics.
Conclusions
From our clinical and experimental ex

perience, we believe that surgical interven
tion may be preferable to amiodarone
given orally in patients with sustained lifethreatening ventricular tachycardia who
have failed a trial of conventional antiar
rhythmics and are good surgical can
didates for re-entrant pathway ablation
as indicated by preoperative angiographic
and electrophysiologic investigations.
Amiodarone will nevertheless continue to
be an extremely useful antiarrhythmic for
the management of both ventricular and
supraventricular tachyarrhythmias.
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Gastroduodenal Crohn's Disease:
Diagnosis and Selection of Treatment
Crohn's disease of the stomach and
duodenum is uncommon and difficult to
diagnose. This study reviews 23 patients
with this condition seen at the Toronto
General Hospital between 1970 and
1981. In 12 patients the major symp
toms were due to coexisting lower
intestinal Crohn's disease (primarily distal
disease). Diarrhea and crampy abdominal
pain were the primary presenting com
plaints. None had obstructive symptoms.
Nine of the 12 were treated medically, 7
with success; 1 required surgical in
tervention and 1 continued to have pain
but no evidence of ulceration. In the re
maining 11 patients, the major symp
toms were due to their gastroduodenal
Crohn's disease (primarily proximal
disease) even though 10 had coexisting
disease of the intestine. Their symptoms
included postprandial vomiting, upper in
testinal bloating, hematemesis and
epigastric pain. Only one patient was
successfully treated medically; the others
required surgical intervention. At the
time of writing, 9 of the 11 patients had
no symptoms. The authors conclude that
response to medical therapy occurs only
in patients whose gastroduodenal
disease is relatively mild and whose
symptoms come from distal intestinal
disease. In contrast, patients whose
main symptoms are from gastroduodenal
involvement usually require surgical
treatment. Vagotomy with
gastroenterostomy is the procedure of
choice.
La maladie de Crohn de I'estomac et
duodenum est rare et difficile a
diagnostiquer. Cette etude passe en
revue 23 patients souffrant de cette
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affection qui ont ete vus au Toronto
General Hospital entre 1970 et 1981.
Chez 12 patients, les principaux
symptomes etaient dus a une maladie de
Crohn coexistante de la partie inferieure
de I'intestin (atteinte surtout distale). La
diarrhee et les crampes abdominales
etaient les principaux symptomes au
tableau clinique. Aucun patient n'avait
de symptomes d'obstruction. Neuf des
12 patients ont recu un traitement
medical, dont 7 avec sucees; 1 a
necessite une intervention chirurgicale et
I autre a continue a avoir des douleurs
sans signes d’ulceration. Chez les 11
autres patients, les principaux
symptomes etaient dus a la maladie de
Crohn gastro-duodenale (atteinte surtout
proximale) meme si 10 avaient une
maladie intestinale coexistante. Les
symptomes comprenaient des
vomissements post-prandiaux, de la
distention intestinale haute, de
I'hematemdse et de la douleur
epigastrique. Un seul patient put etre
traite medicalement; les autres ont
necessite une intervention chirurgicale.
Au moment de rediger ce rapport, 9 des
I I patients Etaient asymptomatiques.
Les auteurs concluent que le traitement
medical ne donne de resultats que chez
les patients dont I'atteinte
gastro-duodenale est relativement
moderee et dont les symptomes sont
causes par une maladie intestinale
distale. A I'oppose, les patients dont les
principaux symptomes sont causes par
une maladie gastro-duodenale n6cessitent normalement une intervention
chirurgicale. L'operation de premier
choix associe vagotomie et gastroenterostomie

In 1932, Crohn and associates1 described
13 cases of nonspecific granulomatous in
flammation of the terminal ileum, which
they named regional ileitis. Involvement*
of the stomach and duodenum was first
reported by Comfort and associates in
1950.2 Such involvement is uncommon,
being reported in only 0.5% to 14% of
cases; histologically confirmed cases are
even less common.3,4 Because gastroduo
denal C rohn’s disease is rare and the

diagnosis is often confused with peptic
ulcer disease, experience with treatment
is limited.5
Patients
Between 1970 and 1981,23 patients (15
men, 8 women) were admitted to the
Toronto General Hospital with Crohn’s
disease of the stomach and duodenum.
The diagnosis was made by combining the
history with findings from the physical,
gastroscopic, radiologic and histologic
examinations.
The patients ranged in age from 17
to 58 years (mean 31 years). Follow-up
ranged from 6 months to 7 years (mean
2.5 years).
Of the 23 patients, 1 did not have
Crohn’s disease of the lower intestinal
tract. This patient had upper gastroin
testinal symptoms and had undergone
many surgical procedures over a 5-year
period before a diagnosis of gastro
duodenal Crohn’s disease was made. The
other 22 patients had evidence of lower
intestinal Crohn’s disease. Of these, 17
had Crohn’s disease of the lower intestine
3 to 20 years before gastroduodenal
Crohn’s disease developed. In four pa
tients the disease developed at both loca
tions simultaneously. The remaining pa
tient was found to have Crohn’s disease
of the ileum 1 year after the diagnosis of
gastroduodenal Crohn’s disease.
Sixteen of 23 patients had either
radiologic or histologic changes, or both,
in the stomach and the duodenum. In the
stomach, findings were most common in
the antrum. This feature may help to dif
ferentiate Crohn’s from duodenal ulcer
disease. In six patients, only the duode
num was involved and in seven, only the
stomach.
Histologic Findings
Biopsy was done in 20 of the 23 pa
tients. In 17, acute or chronic inflam
matory changes, increased mononuclear
infiltration, fibrosis and ulceration were
evident (Fig. 1) but no granulomas were
seen. The lack of depth with penetration
into the submucosal layers of the en-
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doscopic biopsy specimen may be the
reason that we did not find granulomas
in these 17 patients. Three patients had
granulomas (Fig. 2).
Analysis of Patients
The patients were divided into two
groups based on their primary presenting
symptoms: 11 patients presented with
gastroduodenal symptoms (primarily pro
ximal disease) — group 1, and 12 patients
had intestinal symptoms (primarily distal
disease) — group 2.
Group 1
In group 1, four patients presented with
postprandial vomiting and bloating. Six
had epigastric pain relieved by antacids.
Two patients presented with acute ob
struction at the gastric outlet. Two had
weight loss (6.8 and 9 kg) and one had
upper gastrointestinal bleeding of low
grade with anemia. No patients presented
with perforation or gastrointestinal
hemorrhage. These patients had symp
toms ranging from 5 days to 5 years
(mean 14.9 months) before the diagnosis
was made.
Investigations.—G astroscopic ex
amination was performed in all 11 pa
tients. Findings, which were located main
ly in the antrum and duodenum, includ
ed stenosis, strictures, hemorrhagic and
erythematous changes and multiple ul
cerations.
Roentgenographic examination after
barium ingestion was performed in 6 of
the 11 patients. Typical findings included
evidence of gastric outlet obstruction,
duodenal strictures and antral and
duodenal thickening (Fig. 3).
In-hospital treatment.—Six of the 11
patients were initially treated with
standard medical regimens for Crohn’s
disease, including the administration of

Salazopyrine, prednisone, Imuran and
total parenteral nutrition. The drugs were
given either alone or in combination. Ant
acids and cimetidine were also given to
these six patients. Only one patient
responded well after 3 months on this
regimen. This patient had involvement of
the stomach and distal disease following
treatment and was asymptomatic after 3
years. In five patients, after a mean of 2.5
months of medical treatment, there was
no notable improvement. Vagotomy and
gastrojejunostomy were performed in
three patients. One patient who already
had vagotomy and Billroth I gastrectomy
underwent conversion to a Billroth II.
The fifth patient had undergone a
vagotomy and gastrojejunostomy 5 years
before diagnosis. This was followed by a
duodenal resection, complicated by
multiple abscesses, enterocutaneous and
biliary-cutaneous fistulas. At the time of
a choledochojejunostomy and Roux-en-Y
construction, a biopsy specimen of the
rem aining duodenum showed the
presence of granulomas. After 3 months
of total parenteral nutrition and pred
nisone for symptoms of gastric outlet
obstruction, the gastrojejunostomy was
revised. Three years after this the patient’s
weight is stable and she is working full
time.
Five of 11 patients underwent primary
operation without in-hospital medical
treatment. The indication for operation
in all these patients was obstruction.
T hree underw ent vagotom y and
gastrojejunostomy, one had a vagotomy
and antrectomy and the fifth only a gas
trojejunostomy.
After a mean follow-up of 46 months,
9 of the 11 patients have no symptoms.
One patient who received initial medical
treatment followed by a vagotomy and
gastrojejunostomy continues to have
occasional vomiting with epigastric pain.
The second patient underw ent a
gastrojejunostomy only; 1 year later a

FIG. 1—Nonspecific increase in mononuclear cells found in sub
mucosal layers in majority of patients. No granulomas are visible
(hematoxylin and eosin, reduced by 51% from x 250).

stomal ulcer developed and she required
a vagotomy.
Group 2
These 12 patients presented with signs
and symptoms related primarily to their
lower intestinal tract. The symptoms were
less severe than those in group 1. They
included diarrhea (eight), crampy lower
abdominal pain (four), epigastric pain not
relieved by antacids (four), vomiting
(three), weight loss (four) and hypo
chromic, microcytic anemia (three).
Weight loss was more profound in this
group (mean 13.6 kg). Four patients
presented with upper and lower Crohn’s
disease simultaneously.
Investigations.—The gastroscopic find
ings in this group were less severe than in
the proximal group. These included
cobblestoning of the mucosa, erythema,
edema, granularity and in one patient a
stenotic duodenum. Two patients had
superficial erosions without discrete
ulcers.
Roentgenographic examination after
barium ingestion was performed in only
seven patients. The findings were milder

FIG. 3—Upper gastrointestinal series shows
pyloric and duodenal involvement (arrow).

FIG. 2—Typical granuloma characterized by encapsulated area of
increased lymphocytes, histiocytes and polymorphonuclear lymphocytes.
Multinucleated giant cell visible is characterized by nuclei lining periphery
of coalesced macrophage (hematoxylin and eosin, reduced by 51% from
X 400).
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than in group 1 and consisted of edema
and mild deformity.
In-hospital treatment.—Nine of the 12
patients received standard medical
treatment for Crohn’s disease and antacid
and cimetidine for their proximal disease
symptoms. After a mean of 26 months,
seven patients are asymptomatic. One
patient continues to have epigastric pain.
This patient has mild granular changes in
the antrum and duodenum with no
evident ulceration. One patient with a
stenotic duodenum on gastroscopic
examination, who failed to improve with
medical management and required a
vagotomy and gastrojejunostom y,
remains asymptomatic.
Three patients had no specific
treatment. Gastroscopic changes were
merely noted. Two presented with
epigastric pain and diarrhea and one
presented with diarrhea only. Two of
these patients have subsequently had
bowel resection for distal disease.
Discussion

Gastroduodenal Crohn’s disease is rare
and the diagnosis is difficult. The absence
of granulomas and of distal involvement
do not exclude the presence of the disease.
There are no consistent criteria for
making the diagnosis. It is made by a
combination of history, gastroscopic,
radiologic and histologic findings.
Noncaseating granuloma, the major
specific histologic finding, has a reported
incidence ranging from 1.2% to
50% .3’5’6 Crohn’s disease of the
gastroduodenum should be considered in
the differential diagnosis of all duodenal
lesions in patients with other
manifestations of Crohn’s disease. Other
lesions that should be excluded include
peptic ulcer disease,2 antral gastritis,
scirrhous carcinoma, eosinophilic
gastroenteritis, benign lymphoid
hyperplasia and lymphoma.7 Differentia
tion between Crohn’s disease and peptic
ulceration may be the most difficult,
especially if the Crohn’s disease does not
cross the pylorus and involves the
duodenum only, as it did in six of our pa
tients. It has been suggested by Wise and
associates6 that if there are ulcer-type
symptoms, treatment should first be for
ulcers; only if there is no response should
medications for Crohn’s disease be used
or steroids given. Crohn’s disease appears
to involve the antrum of the stomach
most frequently.2>8'10
The role of acid secretion in patients
with gastroduodenal Crohn’s disease is
not clearly defined; it seems likely that
even normal levels of acid may produce
ulceration in patients with minor mucosal
changes from their proximal Crohn’s dis
ease. This is the basis of both antacid
therapy and surgical treatment of Crohn’s
disease of stomach and duodenum.
360

In our retrospective review, we were for Crohn’s disease and to antacid and
surprised by the difference in outcome cimetidine treatment. Surgical treatment
based on the presenting symptoms. When is usually required for those whose symp
there were symptoms of serious gastro toms are predominantly due to their up
duodenal involvement (primarily prox per intestinal Crohn’s disease. The
imal disease), medical management did surgical procedure of choice is vagotomy
not help and the obstruction required with gastrojejunostomy.
bypass.
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Conclusions

Gastroduodenal Crohn’s disease is un
common and difficult to diagnose be
cause of its similarity to peptic ulcer dis
ease; there are problems in obtaining ade
quate histologic material. This condition
may be found in a subclinical form in pa
tients with primarily distal disease. It
should be suspected in patients with distal
Crohn’s disease and upper abdominal
complaints.
The diagnosis is confirmed when a
granuloma is found in the biopsy
specimen or, failing that, when there is
diffuse rather than focal ulceration that
tends to involve both gastric antrum and
duodenum.
Medical management is usually effec
tive in patients whose complaints are
related mainly to the lower intestine.
These patients respond both to therapy
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Colles' Fracture: End Results in Relation
to Radiologic Parameters
Thirty-seven patients with unilateral
Colles' fractures were examined clinically
and roentgenographically at least 1 year
after fracture. Statistical analysis of the
data, comparing roentgenographic
parameters with clinical results, showed
that loss of volar tilt directly affected the
final results by decreasing grip and pinch
strength. But regardless of radiologic ap
pearance, all patients had similar levels
of activity, pain and range of motion.
Trente-sept patients atteints d'une
fracture unilaterale et distale du radius
(fracture de Colies) ont ete examines
ciiniquement et radiologiquement au
moins 1 an apres leur accident. Une
analyse statistique de la correlation
Clinique avec divers criteres radiologiques
a demontre qu'une bascule dorsale
residuelle du fragment distal affecte la
force de prehention et de pince au
niveau de la main. Toutefois, quel qu'eut
ete I'aspect de leur poignet a la
radiographie, tous les patients
prPsentaient des niveaux similaires
d'activite, de douleur et d'amplitude des
mouvements.

In 1814 Abraham Colies1 described the
fracture that today bears his name.
Although he described a technique of
reduction and immobilization for this in
jury, he also stated th at should
misdiagnosis occur and mistreatment en
sue, “ one consolation remains, that the
limb at some remote period will again en
joy perfect freedom in all its motions, and
be completely exempt from pain” .
Since then there has been controversy
regarding this conclusion. Specifically, is
the supposition that the patient will have
an excellent functional result, regardless
of therapy, valid? Smaill2 in a 5- to
6-year follow-up of 97 patients conclud
ed that Colies was correct. On the other
hand, Cole and Obletz,3 in an end-result

Patients and Methods
Thirty-seven patients with unilateral
Colles’ fractures were included in the
study. All but two were evaluated clinical
ly and radiologically at least 1 year after
the fracture. All had an anatomically and
functionally normal contralateral upper
limb.
The clinical examination was divided
into four categories; community level of
activity, pain, range of motion and
strength. Each category was allotted 20
points as shown in Table I. Range of mo
tion was studied with respect to flexion,
extension, ulnar deviation, pronation and
supination. Both wrists were measured
using a standard goniometer. All patients
were examined by the same person

T a b le 1— P o in t s A llo t t e d o n C lin ic a l E x a m in a t io n
No. of
C a te g o r y

F in d in g s

C o m m u n ity le v e l

N o c h a n g e in o c c u p a t io n o r

o f a c tiv ity
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p o in ts
20

r e c r e a t io n a l a c t i v i t y
N o c h a n g e in o c c u p a tio n ; m in o r

15

c h a n g e in r e c r e a t io n a l a c t i v i t y
C h a n g e in o c c u p a tio n ; m a jo r

10

r e s t r ic t io n s in r e c r e a t io n
N o t w o r k in g ; m a jo r r e c r e a t io n a l r e s t r ic t io n s
P a in

0

N o p a in

20

P a in o n ly w i t h e x t e n d e d u s e o r

15

c h a n g e in w e a t h e r
P a in w i t h m o s t a c t i v i t i e s

10

P a in w i t h m a r k e d ly r e s t r ic t e d a c t i v i t y

0

R a n g e o f m o tio n
F le x io n

A t le a s t 7 5 %

o f n o rm a l

4

E x te n s io n

50%

to 7 4 %

o f n o rm a l

3

U ln a r d e v ia tio n

25%

to 4 9 %

o f n o rm a l

P r o n a tio n

From the department o f surgery, Royal
Victoria Hospital, McGill University,
Montreal, PQ

(R.M .R.). Each subcategory was scored
separately, giving five separate scores with
a possible maximum score of 4 points
each, for a total of 20 points. Strength
was divided into two categories: grip and
key pinch. Grip was measured using a
P reston hand dynam om eter (J.A .
Preston Corp., Clifton, NJ). Each patient
had three attempts with each hand and
the scores were averaged. Pinch was
measured with a Preston pinchmeter (J.
A. Preston Corp.) in similar fashion.
Then with standardized tables4 that ad
justed for age, sex and right or left
handedness, the scores for each hand
were compared in two subcategories, giv
ing a possible total of 20 points. The max
imum total score was 80 points. A score
of 75 or more points was considered an
excellent result, 55 to 75 points a good
result, 25 to 54 points a fair result and less
than 25 points was considered a failure.
Roentgenograms were obtained of both
wrists in all patients in anteroposterior
and lateral views. Radial tilt, volar tilt and
radial length were measured (Fig. 1). This
technique
has
been
rep o rte d

study, referred to a “ high incidence of un
satisfactory results in the treatment of this
unstable fracture” .
In this study we have attempted to
resolve the debate. We shall also show
which radiologic parameter affects the
final result.

S u p in a t io n
S tr e n g th
P ■
G rip
K e y p in c h

Less th a n 2 5 %

o f n o rm a l

2
0

_

n
-

A t le a s t 7 5 %

o f p r e d ic t e d s tr e n g th

50%

o f p r e d ic t e d s tr e n g th

to 7 5 %

Less th a n 5 0 %

o f p r e d ic t e d s tr e n g th

10
5
0
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previously.5-7 By using the normal wrist roentgenograms showing healing in a of activity, pain and range of motion.
as a control, the amount of absolute shift grossly displaced position, almost all pa Volar tilt was the only radiologic
of the fragments could be measured.
tients had 75% or more of their normal parameter that correlated significantly
range of motion. This included one with the functional scores.
woman whose lateral film showed a 50°
As volar tilt decreased so did grip and
Results
loss of volar tilt (change from 20° volar pinch strength. Loss of strength could
The 37 patients fell into the following to 30° dorsal angulation), but who main only be demonstrated by relatively
functional categories: excellent, 14 (38%); tained full flexion. This preservation of sophisticated means, that is dynamome
good, 14 (38%) and fair, 9 (24%). There motion attests to the adaptive capacity of tric measurement.
were no failures. The results were satisfac the carpal articulations.
tory in 76%. There was no significant dif
Grip and pinch seemed to be the criteria Conclusions
ference between the three groups when that determined whether or not a patient
Volar tilt is the only radiologic
age, sex or time after fracture were had a satisfactory result. Patients were
that has a direct effect on the
considered.
unaware of their actual grip and pinch parameter
functional result in Colies’ fractures.
The excellent, good and fair groups strength. Many who claimed weakness Itfinal
does so by decreasing grip and pinch
were then compared with respect to scores showed no difference from predicted strength.
attained in individual functional values when tested, and many who felt
Within the limits of technical
categories (Table II). Pain, level of activi they had normal power in the hand
sophistication
of 1814, Abraham Colles
ty and range of motion showed no signifi showed marked weakness on dynamo
was correct in his statement that the pacant difference between groups. metric testing.
However, the range of strength scores was
Only Gatland and Werly8 have
wide. It was the one variable that previously noted that volar tilt is a deter
separated the patients into different func mining factor in the final result of
tional categories.
Colles’ fractures, but they did not explain
The groups were then compared with why. In our series loss of volar tilt
respect to radial tilt, volar tilt and radial adversely affected the result and did so
length, giving nine comparisons (Table by decreasing grip and pinch strength.
III). The only comparison that was The average volar tilt of the control limb
statistically significant (p < 0.05, Stu in our patients was about 10°. On the in
dent’s r-test) was the difference in volar jured side all patients lost volar tilt. The
tilt between the excellent and fair groups. excellent group had an average of - 2.4°,
the good group - 5.7° and the fair group
Discussion
- 15.2° of volar tilt. As the loss of volar
tilt
increased, so did the degree of residual
The scoring system used in this study
Although this cannot be readily
is a modification of those previously weakness.
explained,
it may be because of unbalanc
described.8-10 We did not consider ing of the synergism
between flexors and
cosmetic deformity because, although it extensors at the wrist.
may be important to the patient, it has
little bearing on functional activity. Our
system gives equal weighting to subjective Summary
(activity, pain) and objective (range of
When followed up for more than 1
motion, strength) criteria.
year, all patients with Colies’ fractures
The stringent criteria needed for a were subjectively satisfied.
satisfactory result should be noted. A pa
Regardless of the radiologic ap
tient with less than full marks in any two pearance, all patients had similar levels FIG. 1—Roentgenographic measurements.
categories automatically dropped below
an excellent rating. Loss of any marks in
all four categories led to an unsatisfac
tory rating.
The radiologic criteria have also been
reported previously.2'3'8'10’n Recently van
der Linden and Ericson12 showed in a
detailed study of 250 cases that volar tilt
and radial tilt are the only independent
variables in describing deformity in Col
ies’ fractures. They did not, however,
relate these to the functional end result.
All but two patients were satisfied with
the end result. The dissatisfied patients,
whose fractures were the most recent
(within the previous 12 months), com
plained of pain. From the results in the
rest of our series, it seems likely that this
pain will diminish with time.
No patient in our series was forced to
change occupation. Some noted mild
restrictions in activity.
The results with regard to range of mo
tion were surprising. Despite several
362
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T a b le 1 1 - M e a n F u n c t io n a l S c o r e s *

F u n c tio n a l

Range of

g ro u p

P a in

A c t iv it y

m o tio n

S tr e n g th

E x c e lle n t

1 9 .2

1 8 .2

1 9 .6

2 0 .0

G ood

1 7 .8

1 7 .8

1 9 .5

1 1 .4

F a ir

1 5 .6

1 6 .6

1 7 .2

2 .7

" S c o r e s a r e o u t o f a p o s s ib le t o t a l o f 2 0 .

T a b le I I I - - R a d io lo g ic P a r a m e t e r s *

F u n c tio n a l
g ro u p

R a d ia l t i l t , "

C o n tro l

In ju re d

V o la r t i l t , "

C o n tr o l

E x c e lle n t

2 5 .6

18

G ood

2 5 .7

2 1 .2

9 .4

F a ir

2 4 .2

1 5 .6

1 0 .6

1 1 .5

In ju re d

R a d ia l le n g t h , m m

C o n tro l

In ju re d

—2 . 4 +

1 1 .4

8 .4

-5 .7

1 1 .6

9 .5

—1 5 . 2 +

1 2 .3

9 .0

‘ T h e a v e r a g e m e a s u r e m e n t s o f th e t h r e e p a r a m e t e r s f o r e a c h g ro u p . C o n t r o l r e f e r s t o t h e u n in ju re d
w r is t f o r e a c h p a t ie n t ,
tp <

0 .0 5 .

tient with a misdiagnosed or mistreated
Colies’ fracture will eventually have com
plete range of motion and no pain.
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Interstitial Radiotherapy for Localized Carcinoma of the Prostate
F o rty -tw o p a tien ts w ith localized car
cinom a o f the p ro sta te have been treated
w ith in te rs titia l im pla n ta tion o f iodine
1 2 5 seeds a fte r a thorough staging pro
cess. The procedure w as w e ll tolerated
and carried acceptable m o rb id ity and no
m o rta lity . O f m ajor concern, how ever,
w a s th e failure o f local c o n tro l o f the
tu m o u r in a high p ro p o rtion (8 8 % ) of
patien ts at 1 year. Com bined in te r
s titia l and external beam radiotherapy
m ay overcom e this.
Q uarante-deux p a tie n ts porteurs d'un
cancer localise de la prostate o n t ete
tra ite s par I'im p la n ta tio n in te rstitie lle de
p articules d 'io d e s 1 25 apres une in
te rv e n tio n v isa n t a etablir de fa co n
m inu tie u se le stade d e v o lu tio n de la
m aladie. L 'in te rv e n tio n fu t bien toleree et
eut un ta u x de m orb id ite et de m ortalite
acceptable. Le plus inqu ie ta n t to u te fo is
fu t le peu de succes a enrayer la pro
gression locale de la maladie chez une
fo rte p ro p o rtion (8 8 % ) des patien ts
apres 1 an. L 'association de I'irra d ia tio n
in te rs titie lle et d ’ un faisceau externe de
radiotherapie p o u rra it venir a b o u t de ce
problem e.

The technique of interstitial radiotherapy
with iodine 125 was introduced a decade
ago by Whitmore and associates1 to
avoid the complications of external beam
radiotherapy (i.e., proctitis, cystitis, im
potence). Although the technique is well
accepted, long-term follow-up is not yet
available. Data for mid-term follow-up,
however, suggest that the survival rate of
patients who undergo such therapy is
comparable to that of patients treated by
other methods.1'3 If the rates of survival
and control of local disease remain com
parable to those for radical surgery or ex
ternal irradiation, interstitial therapy
would obviously be more acceptable. In
addition to the advantages to the patient
(i.e., shorter hospitalization, lower com
plication rate), the l2sI seeds are easier
and safer to handle than other implan
table isotopes such as radon 222 or gold
198.4
Interstitial radiotherapy was initially in
troduced in Canada at the affiliated
hospitals of Queen’s University in 1975.
We report our experience and mid-term
follow-up with this technique.
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t therapeutic radiology, Queen’s University,
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Patients and Methods

Forty-two patients entered .his pilot
study. They ranged in age from 45 to 76
years (mean 62.8 years). In every case,
primary adenocarcinoma of the prostate
was histologically documented, in 2 cases
by transurethral resection and in the re
maining 40 by transperineal needle biop
sy. The distribution of patients by clinical
stage (Jew ett’s classification1) and
histologic grade is given in Table I. The
grading follows the guidelines described
by Gleason and Mellinger.5
Clinical and Histologic Staging

In all patients a chest roentgenogram
and bone scan were obtained, with roent
genograms of bone only of areas sug
gestive of carcinoma according to the
scan. Serum acid phosphatase levels were
determined by enzymatic methods in all
cases and by radioimmune assay in 31.6
These investigations failed to detect any
evidence of extracapsular spread of the
tumour. A staging lymphadenectomy was
then carried out. During the procedure,

Table 1— Stage and Grade of Cancer in 42 Patients Who Had
Interstitial Radiotherapy with Iodine 125
Clinical
stage
A2
B,
b2
C
Total

Histologic grade (Gleason sum)
2-4
1
10
12
1
24

5-6
0
6
5
1
12
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7-8
1
3
1
1
6

Total no.
of patients
2
19
18
3
42
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nodes from the area of the common iliac
bifurcation and any suspicious nodes
along the pelvic vessels were sent for
frozen-section examination. If there was
no nodal involvement, we proceeded
with 125I implantation and the lymphadenectomy was extended to include
sampling of the common iliac nodes. All
external iliac and obturator lymphatics
were removed bilaterally and permanent
sections were made. Table II shows stag
ing of the patients after lymphadenectomy.
Technique for Implantation of l25I Seeds

The procedure used was essentially that
described by Whitmore and associates.1
The retropubic space of Retzius is entered
and all periprostatic adipose tissue
removed. Great care is taken at this point
to prevent bleeding from the dorsal vein
of the penis and prostatic veins, which are
very friable and difficult to control once
disrupted. No attempt is made to mobilize
the prostate by incision of the endopelvic
fascia or puboprostatic ligaments.
Bimanual palpation of the prostate is then
carried out to assess its size. Using the
apparatus described by Whitmore and
associates,1 we implant the appropriate
number of seeds in the prostate. This
number is determined by dosimetry based
on seed strength and the size of the gland
to provide an ultimate cumulative dose of
18 000 rad to the prostate. Drains are
placed in each obturator fossa and the
incision is closed. A Foley catheter is left
indwelling for at least 48 hours. All urine
is saved and examined for the presence
of seeds. The 11 patients who had
evidence of lymph-node metastases on
final permanent sections received sup
plementary external beam radiotherapy to
the pelvic side walls (average dose 4400
rad).
Results

There were no operative deaths but
there were com plications directly
attributable to the procedure (Table III).

Table II—Final Staging
after Lymphadenectomy
Histologic
stage*

No. of
patients

^2

1
15
14
1
11

B,
b2
C
D,

determination of the serum acid phospha
tase level and isotope bone scanning. In
26 patients, biopsies were done at 1 year
after operation (Table IV), then at yearly
intervals. The results of these biopsies
may permit estimation of the efficacy of
local control of the tumour offered by this
treatment. The results of biopsy 2 years
after implantation are given in Table V.
Of the 42 patients, 33 have been fol
lowed up from 12 to 60 months; none has
died from causes directly or indirectly
related to prostatic cancer. Distant
metastases, however, have been docu
mented in eight patients, all of whom had
lymph-node involvement at the time of
the staging lymphadenectomy. The dis
ease-free intervals are shown in Figs. 1
and 2. The results are compared with a

Table V—Results of Prostate Biopsy
in 19 Patients 2 Years after
125l Implantation
Findings
Negative biopsy
Histologic downgrading
No change in grade
Histologic upgrading

No. of
patients
6
7
4
2

Table Ill-Operative Complications
Complication
Early
Prolonged lymph drainage
0 5 d)
Lymphocele
Prolonged ileus
Wound dehiscence
Seeds passed through urethra
Pneumonia
Deep venous thrombosis with
pulmonary embolism
Stitch abscess
Late
Irritative bladder symptoms
Incisional hernia
Chronic epididymo-orchitis
Osteitis pubis
Obturator nerve entrapment
Lymphedema, leg

No. of
patients

4
2
2
1
1
1
1
1

FIG . 1—Comparative disease-free intervals
for stage B carcinoma of prostate treated by
radical retropubic prostatectomy (R R P )
(n = 12), external beam radiotherapy (D X R )
(n = 46) and interstitial radiotherapy with
iodine-125 seeds (n = 29).

4
2
1
1
1
1

Table IV—Results of Prostate Biopsy
in 26 Patients 1 Year after
125l Implantation

A2 = occult cancer (involving < 5 % of the
gland), B, - single nodule in only 1 lobe of
gland, B 2 - involvement of both lateral lobes,
C - extracapsular extension, 0, - metastases
to regional (pelvic) lymph nodes.
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The most common, prolonged lymphatic
drainage, ceased spontaneously in every
case within 10 days. None of the patients
with lymphoceles required drainage. The
patient who voided a number of seeds had
a small gland and had previously under
gone transurethral resection of the pros
tate. As a result, we decided not to enter
patients into the study if they had recently
undergone simple prostatectomy. Among
the late complications, the most common
was the development of bladder irrit
ability, which responded, to some extent,
to anticholinergic medication; none of
these patients had received supplemental
external radiation. However, the one
patient with chronic leg lymphedema had
received supplemental external radiation
and required stocking support for relief.
Information about erectile function
was available in 31 of the 42 patients 6
to 12 months after operation. Two
patients had been impotent before
operation and remained so afterwards, 10
became impotent after the operation. The
remaining 19 were potent after the
procedure. Of the 10 patients who became
impotent, 4 had received supplementary
external beam radiotherapy. These results
were not confirm ed by in-depth
physiologic and psychologic studies.
All patients were followed up at 6- to
12-month intervals by rectal examination,

Findings
Negative biopsy
Histologic downgrading
No change in grade
Histologic upgrading

No. of
patients
3
14
7
2

F IG . 2— Comparative disease-free intervals
for stages A, B and C carcinoma of prostate
treated by radical retropubic prostatectomy
(R R P ) (n = 14), external beam radiotherapy
(D X R ) (n = 52) and interstitial radiotherapy
with l25I seeds (n = 31).
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concurrent group of patients receiving
6000 rad external beam radiotherapy and
with another group treated by radical
retropubic prostatectomy for the same
stage of the disease and clinically assessed
in a similar way. The calculations of the
curves were done according to the
technique of Kaplan and Meier.7
Discussion
Current treatm ent for localized
carcinoma of the prostate remains con
troversial. The excellent survival rates
obtained by radical prostatectomy apply
only to those patients with limited
intracapsular disease and well-differen
tiated neoplasms.8 Moreover, the higher
m orbidity of radical surgery has
prompted the search for alternative forms
of treatment. Bagshaw and associates9,10
championed the use of external beam
radio th erap y , while C arlto n and
associates4 and
W hitm ore
and
associates1 initially advocated interstitial
radiotherapy with gold and iodine
isotopes respectively. A major common
problem for all forms of radiotherapy has
been the finding of residual tum our cells
in the gland, many m onths after
treatment. We have previously reported
that these cells are alive and actively
metabolizing acid phosphatase.11 The
biologic and metastatic potential of such
cells remains speculative, but the
inescapable conclusion
is that
radiotherapeutic modalities presently
available do not appear to be curative in
an appreciable proportion of patients.
Our results of 88% positive biopsies after
1 year and 68% positive biopsies at 2
years are not encouraging, nor are the
better figures of 50% reported by Lytton
and associates2 in their series of patients
also treated with interstitial radiation. It
is doubtful that the figures for local
control beyond 3 years after treatment
will be any better.
Lymph-node involvement at the time
of staging laparotomy is an ominous find
ing. All patients with evidence of distant
metastases during follow-up had lymphnode involvement at laparotomy. Despite
the addition of external beam
radiotherapy, we subsequently found
widespread soft-tissue and skeletal
tumour deposits. The possibility remains
that the field of radiation did not
encompass ail the nodes involved by
tumour. Alternative explanations, as yet
speculative, include radioresistance of
some of these lesions, early hematogenous
spread or the subclinical presence of
metastases before radiotherapy.
The morbidity of the procedure is
acceptable and the mortality is negligible.
The preservation of sexual function is
important to most men and in this series
61% of the patients were able to sustain

an erection of sufficient quality for NOTICES
penetration. These figures, however, are continued fro m page 309
an estimate, as only the patient’s report surgery; orthodontics; orthopedics;
was considered.
pediatrics and pedodontics. Abstracts
We no longer use this form of treat should include purpose, method and
ment for the patient who has previously material, results and conclusions. They
undergone simple prostatectomy. Besides should be submitted for consideration as
not being able to insert an adequate soon as possible, but no later than June
number of seeds to deliver a therapeutic 30, 1984. Attendance will be limited. The
dose of radiation, in one patient a number proceedings of the conference will be
of seeds were voided in the days im published.
mediately after operation necessitating
For further information contact An
supplementary external beam radio drew D. Dixon or Bernard G. Sarnat,
therapy.
Dental Research Institute, School of Den
The comparative disease-free figures tistry, School of Medicine, Center for
for patients with carcinoma of the pros Health Sciences, University of California
tate who had radical prostatectomy, Los Angeles (UCLA), Los Angeles, CA
external beam radiotherapy or interstitial 90024, USA.
radiotherapy with l25I seeds show an
obvious advantage for radiotherapy.
However, the patients were not ran
Biomechanics
domized and the follow-up is still short.
of Trauma Symposium
The fundamental premise of interstitial
radiation for treating prostatic cancer The 1st International Symposium on
is sound. The two major drawbacks are Biomechanics of Trauma will be held
the difficulty in achieving an accurate, Oct. 20-21. 1983 in San Diego, Cali
even distribution of the radiation and the fornia. Further information may be
failure to detect and treat limited (stage obtained from the Institute for M ed
C) extracapsular disease. To this must be ical Education and Research, 135
added the concern that 125I seeds may Dickinson. San Diego, CA 92103.
fail to control progression of the disease
in a considerable number of patients.
Coronary Artery and Valvular
Perhaps a combination of interstitial and
Heart Disease
external beam radiotherapy will overcome
these problems and is worth pursuing. A To commemorate the completion of
multicentre, national study would make the University of Ottawa Cardiac Unit,
an im portant contribution to the an international symposium will be
treatment of this common cancer.
held from Sept. 10-12, 1983 in Ottawa,
Ont. The title of the symposium is
“ Perspectives in Coronary Artery and
Valvular H eart D isease” . F urther
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Symposium on Musculoskeletal
Disorders
The 1st International Symposium on
Musculoskeletal Disorders will be held
Jan. 20-21, 1984 in Bad Ragaz and Jan.
22-28 in St. Moritz, Switzerland.
This symposium will focus on the or
thopedic, rheumatologic and physical
management o f arthritic disorders.
Selected topics such as spinal disorders,
chronic pain, fractures, ski injuries and
morbid conditions of the foot will be
presented. Highlights will include the
essentials of spa therapy and there will be
a treatment program for physicians and
guests. This symposium is approved for
Category I credit.
The registration fee is $325. up to Nov.
15, 1983 and $360. thereafter. For further
information and registration write: Sym
posium Secretary, UCLA M edical
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Aortoiliac Arteriovenous Fistula Simulating Iliac Vein
Thrombosis following Intervertebral Disc Surgery
T his re p o rt describes an unusual presen
ta tio n o f a rteriovenous fis tu la secondary
to in te rv e rte b ra l disc surgery. A 6 1 -yearold obese w o m an u n d e rw e n t operation
fo r a herniated in te rv e rte b ra l disc. One
m o n th la te r she w a s readm itted w ith
p a in fu l sw e llin g o f th e le ft calf. The co n 
d itio n progressed to include pigm e n ta tio n
o f th e w h o le e x tre m ity w ith varicosities
and u lce ra tio n s. The fem oral vein was
fo u n d to be occluded and there were
m u ltip le collateral vessels in th e thigh.
In itia lly , p h le b itis w as diagnosed, then
iliac ve in th ro m b o sis. Her sym pto m s im 
p ro ve d s lig h tly w ith rest and a n ti
c o a g u la n t th e ra p y. Finally, a fte r 2 years,
an a rte rio ve n o u s fis tu la w a s suspected
because o f a b ru it in th e presacral region
and o xy g e n sa tu ra tio n o f venous blood
in th e th ig h . The diagnosis w as co n 
firm e d by a o rto g rap h y. The fistu la was
tra n s e c te d and th e a rte ry and vein in d i
v id u a lly sutured, p roducing im m ediate
im p ro v e m e n t. The p a tie n t was
s y m p to m -fre e 3 years later.
W h e n chronic venous o b stru ctio n ,
un u sua l d is trib u tio n o f collateral circu la 
tio n and p ig m e n ta tio n o f a lo w e r
e x tre m ity are fo u n d a fte r disc surgery,
an a rte rio ve n o u s fis tu la should be
s u sp e cte d . The d ia g n o stic procedures
should include a u s c u lta tio n o f the ab
dom en and back, ve nography, m easure
m e n t o f blood oxyg e n levels in the c o l
la te ra l venous circ u la tio n and
a o rto g ra p h y .

une hernie discale. Un m ois plus ta rd elle
a ete rehospitalisee s o u ffra n t d'une
in fla m m a tio n douloureuse du m ollet gau
che. Son e ta t em pira, laissant apparaitre
une p ig m e n ta tio n co u vra n t to u te la
jam be, accom pagnee de varices et d'ulcerations. On co n sta ta Tobliteration de la
veine fe m o ra le et la presence de nombreux va isseaux co lla te ra u x dans la
cuisse. A u d e b ut, on pensa a une phleb ite ; puis le d ia g n o stic se porta vers une
th ro m b o se de la veine iliaque. Les
sym pto m e s s 'a tte n u e re n t legerem ent
avec le repos et un tra ite m e n t an tico ag u 
la n t. Finalem ent, apres 2 ans, une fistu le
a rterio-veineuse fu t soupconnee a cause
d 'u n b ru it dans la region presacree et de
la sa tu ra tio n en oxygene du sang veineux dans la cuisse. Le d ia gnostic fu t
co n firm e a T aortographie. On pratiqua
une d isse ctio n transversale de la fistu le
avec sutures in d ividuelles de Tartere et
de la veine. L 'a m e lio ra tio n fu t im m ediate.
T ro is ans plus tard, la patiente n 'a va it
aucun sym pto m e .
On d e vra it soupconner la presence
d 'u n e fis tu le arterio-veineuse quand il y a
une o b stru c tio n veineuse chronique, une
d is trib u tio n inh a b itue lle de la circulation
c o lla te r a l e t une pig m e n ta tio n d 'un
m em bre in fe rie u r. Les examens diagnostiques d o iv e n t inclure I'a u scu lta tio n de
I'abdom en e t du dos, la phlebographie, la
d e te rm in a tio n de I'oxyg& ne sanguin dans
la c ircu la tio n veineuse c o lla te ra l et
Taortographie.

Cet a rtic le decrit un tableau clinique
in h a b itu e l dans un cas de fis tu le arteriove ineuse co n se cu tive a Toperation d 'un
disque in te rv e rte b ra l. Une fem m e obese
de 61 ans a subi une in te rve n tio n pour

Since the initial description by Linton and
W hite1 o f an arteriovenous fistula
following intervertebral disc surgery,
there have been several reported cases and
reviews in the literature.2'4 The case we
describe is o f particular interest to the
practising physician because the unusual
and insidious nature of the clinical presen
tation mimicked episodes of iliac vein
thrombosis. The true nature of the fistula
was not recognized during the first few
hospitalizations after the initial trauma.

From the departments o f *surgery,
fmedicine and tradiology, Graduate
Hospital, University o f Pennsylvania,
Philadelphia, Pa., USA
Accepted fo r publication July 23, 1982
Reprint requests to: Dr. Manucher
Fallahnejad, Department o f surgery,
Graduate Hospital, Ste. 1100, Pepper
Pavilion, One Graduate Plaza,
Philadelphia, PA 19146
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Case R e p o rt

A 61-year-old obese woman (height 163 cm,
weight 97.6 kg) was transferred to our hospital

because she had had painful swelling of her left
leg for 2 years and several recent painful ulcera
tions of the left calf. Her medical history in
cluded two episodes of subendocardial infarc
tion, the first 6 years and the second Vh years
before.
Her presenting illness had begun 2 years
earlier, following operation for a herniated in
tervertebral disc with spondylosis and nerveroot amputation at the L4-5 and L5-S1 levels.
At the time of operation, there was bleeding
that was easily controlled with Gelfoam pack.
Blood tranfusions were not required. She was
discharged from the hospital 20 days after
operation. One month later, she was readmit
ted with painful swelling of her left lower ex
tremity and our examination showed swelling
of her left leg and calf tenderness; phlebitis was
diagnosed. Her symptoms lessened with rest
and elastic support of her leg.
Six months later she was readmitted with
shortness of breath, chest pain and further pro
gression of the painful swelling of her left leg.
Examination of the lower extremities showed
edema, tenderness, marked enlargement of the
left leg and cyanotic discolouration of the left
hip area, buttocks, thigh and calf. Bounding
pedal pulses were present. The electrocar
diogram showed some ischemic changes and
the chest roentgenogram showed cardiac
enlargement with patchy densities in the right
lung base. Her condition was diagnosed as il
iac vein thrombosis and possible pulmonary
embolism. The patient gained some relief from
rest and anticoagulant therapy with Coumadin.
Her symptoms never completely resolved and
the leg remained painfully edematous.
Two years after her disc operation, the
edema extended to both lower extremities, with
marked discolouration of the entire left ex
tremity, and several painful ulcerations
developed. She was readmitted with a provi
sional diagnosis of iliac vein thrombosis. A
venogram showed extensive varicosities and
complete occlusion of the femoral vein from
its origin at the opening of the adductor hiatus.
Multiple, tortuous, collateral veins, arising in
the thigh and extending to the opposite groin
and subcutaneous tissues, were visualized (Fig.
1). The left iliac vein could not be seen, but
the right iliac vein was faintly visible.
Because her condition did not improve on
the medical regimen she was transferred to the
surgical service. Our examination revealed
severe, diffuse tender swelling of the left lower
extremity, varicosities, numerous painful
ulcerations primarily involving the calves, and
cyanosis of the buttocks, thigh and labia ma
jor (Fig. 2). There was a continuous bruit of
maximal intensity in the presacral region.
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Simultaneous oxygen levels in blood from the
radial artery, cephalic vein and a collateral vein
of the left thigh were measured; they were 85,
52 and 78 mm Hg respectively, with 95%
saturation.
An arteriovenous fistula was suspected and
aortography was performed through the right
femoral artery; this showed a fistula from the
distal aorta to the left common iliac vein at the
level of L4-5 and severe dilatation of the iliac
vein (Fig. 3). At operation, a fistula 7 mm long
was found between the distal aorta and left il
iac vein, and aneurysmal dilatation of the left
iliac vein with multiple secondary venous com
municators was noted. The fistula was
transected and the artery and vein were in
dividually sutured. The excessively dilated il
iac vein was plicated. The thrill immediately
disappeared, the woman’s clinical condition
improved, the swelling was remarkably reduced
and the ulcerations healed rapidly. She has
been followed up regularly and remains
symptom-free 5 'h years later.

FIG. 1— Venogram sh ow s com plete
occlusion of femoral vein and extensive
collateral venous circulation in thigh.

Discussion

Accidental injuries to the great arteries
during surgery on the lumbar vertebrae
are rare, but are probably more common
than reported in the literature.5 The
vessels surrounding the aortic bifurcation
lie on the anterior surfaces of the lower
lumbar vertebrae and the great vessels are
relatively fixed in the retroperitoneal
space; these facts alert the physician to
the possibility of this complication. Un
fortunately, awareness and careful tech
nique do not always guarantee
prevention.6 Prompt and appropriate
measures can be taken when such com
plications occur and are suspected
because of excessive bleeding at the time
of operation or because of tachycardia,
widening of the pulse pressure, raised
jugular venous pressure, hepatomegaly or
a bruit over the abdominal aorta.
The clinical presentation of our patient
was insidious and complicated. The
history of myocardial infarction,
moderate response to anticoagulation and
rest and the predominance of symptoms
primarily in the left leg led the physician
to believe that the patient had a long
standing venous obstruction. Although
such obstruction can result in extensive
collateral circulation, venous stasis and
pigmentation at the ankle and lower leg,
this patient’s extensive collateral circula
tion and pigmentation at the hip, buttocks
and thigh could not be explained by sim
ple venous obstruction.
Initially, this patient’s extreme obesity
and large abdominal pannicule may have
prevented the examiner from hearing the
bruit that was so clearly audible in the
back. It is also conceivable that slow
enlargement of her fistula was ac
comodated by aneurysmal dilatation of
her iliac vein, thus obscuring the true
nature of the lesion. The venogram also

was misleading because the rapid flow of
blood through the fistula washed out the
contrast material to the level of the first
competent valve and consequently gave
the impression of primary venous
obstruction. Arteriography in these pa
tients is of paramount importance in
diagnosing and showing the nature, ex
tent and anatomical site of the lesion.7,8
It should be used whenever there is the
slightest suspicion of arteriovenous fistula
or unexplained long-standing venous
obstruction.
The combination of remote disc
surgery, chronic venous obstruction,
unusual distribution of collateral circula
tion and pigmentation should suggest an
arteriovenous fistula, even though there
may be mild clinical improvement on a
medical regimen. The abdomen and back
should be auscultated systematically. A
normal venogram alone does not exclude
the presence of an arteriovenous fistula.
Oxygen saturation of the collateral
venous blood of the lower extremity is
helpful in the clinical detection of such
a fistula. Arteriography is the final step
in the diagnostic evaluation.
References
1. LINTON RR, W hite PD: Arteriovenous fistula between
right common iliac artery and inferior vena cava; report
of a case of its occurrence following operation for ruptured
intervertebral disk with cure by operation. Arch Surg 1945;
50: 6-13
2. BlRKELAND 1W, TAYLOR TKF: M ajor vascular injuries
in lumbar disc surgery. J Bone Joint Surg [Br] 1969; 51:
4-19
3. Boyd DP, FARHA GJ: Arteriovenous fistula and isolated
vascular injuries secondary to intervertebral disk surgery:
report of four cases and review of the literature. A n n Surg
1965; 161: 524-31
4. RICH NM, SPENCER FC: Vascular Trauma, Saunders,
Philadelphia, 1978
5. Seeley SF, H ughes CW, J ah nke EJ j r : Major vessel
damage in lumbar disc operation. Surgery 1954; 35: 421-9
6. HOLSCHER EC: Vascular complication o f disc surgery. J
Bone Joint Surg [Am] 1948; 30: 968-70
7. Davies JM: Ilio-iliac arteriovenous fistula following
laminectomy. Clin Radiol 1969; 20: 103-4
8. S a l d in o RM, w h it e a a , P a l u b in s k a s A J:
Arteriovenous fistula, a complication of lumbar disk
surgery. Angiographic demonstration. Radiology 1971; 98:
565-7

NOTICES

continued from page 365
Center, 10833 Le Conte, Rm. 76-139
CHS, Los Angeles, CA 90024, USA.

Renal Transplantation

FIG. 2—Discolouration of buttock (arrow)
and left thigh with varicosities and ulcer of left
leg (arrow).

FIG. 3—Arteriogram shows arteriovenous
fistula from distal aorta to left common iliac
vein at L4-5 level and marked dilatation of left
iliac vein.

The 2nd International Course of Renal
Transplantation will be held Dec. 12-15,
1983 in Barcelona, Spain, at the Palacio
de Congresos. The course will address
significant medical and immunologic
aspects of renal transplantation and will
offer scientific lectures and practical
courses in immunology. Surgical pro
cedures will be broadcasted on colour
television.
For further information contact Dr. F.
Oppenheimer, Unidad de Trasplante
Renal, Hospital Clinico, Casanova 143,
Barcelona-36, Spain.

VOLUME 26, NO. 4, JU LY 1983 / THE CANADIAN JOURNAL OF SURGERY

367

Marilyn Kaplow, b sc pt , m sc (A); F aigy Muroff, b sc pt ; W illiam F ish , md;
Dorothy Stillw ell , md, frcpicj; Nelson Mitchell , md, frcpic ]

The Dysvascular Amputee: Multidisciplinary Management

Les auteurs decrivent 8 ans d'experience
aux soins des amputes souffrant de ma
ladies vasculaires en utilisant une approche multidisciplinaire. Ms comparent cette
methode de readaptation des amputes
avec une autre utilisant le meme person
nel mai? sans le concept d'equipe. Dans
I'hopital ayant une approche multidis
ciplinaire, il y avait beaucoup plus d'amputes en dessous du genou, un plus
grand nombre d'ajustements de prothe
ses dans un plus court laps de temps et
plus d'ajustements chez des patients
plus ages que dans I'hopital temoin.

In 1971, a multidisciplinary amputation
team was formed at the Royal Victoria
Hospital in Montreal. This team consisted
of physiotherapists, occupational thera
pists, nurses, prosthetists, a physiatrist
and two orthopedic surgeons. The objec
tive was to coordinate a program of com
prehensive care preoperatively with
follow-up through the final stages of
re h a b ilita tio n . All patients were,
therefore, treated in hospital, in an
associated rehabilitation facility and in
the out-patient department where they
were reviewed by the team on a regular
basis, either when prosthetic problems
arose or every 6 months. The team was
led and coordinated by a physiotherapist

who directed ward rounds and organized
the weekly out-patient review clinics. All
decisions concerning the indications for
amputation and revision, postoperative
surgical care and rehabilitation, including
prosthetic fitting, were made by members
of the team together.
This paper reports the results achieved
in this hospital (the team hospital) after
8 years using this approach; they are com
pared with those obtained in an adjacent
hospital (control hospital) of similar size
and type, in which the custom was to treat
amputees individually using the same
medical and paramedical staff, but with
out coordination.
Patients
The records o f in-patients and
out-patients from both hospitals during
the period 1971 to 1979 were examined
retrospectively. There were no differences
in the two groups with respect to age, sex
and disease process leading to amputation
(Figs. 1 to 3). The team hospital treated
304 patients of whom 37 (12%) were
bilateral amputees; the control hospital
treated 352 patients of whom 46 (13%)
were b ilateral am putees. In both
hospitals, 82% of lower limb amputations
were carried out for dysvascular disease,
either peripheral or diabetic vasculopathy.
A patient was defined as having
peripheral vascular disease if there were
ischemic changes in the absence of
laboratory evidence of diabetes mellitus.
If the patient had ischemic changes
and diabetes mellitus, a diagnosis of
diabetic vasculopathy was made. Since

From the departments o f physiotherapy,
physical medicine and orthopedic surgery,
Royal Victoria Hospital, Montreal, PQ
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Results
Of patients with peripheral vascular
disease, 21% died within 2 years of their
first amputation, while 17% of all
diabetic dysvascular patients died within
the same period. Furthermore, 9% of
dysvascular amputees lost their second
limb within 1 year, 12.5% within 2 years
and 18% within 3 years.
In the team hospital, 56% of the
am putations were below the knee,
compared with only 23% in the control
hospital (Fig. 4). At the team hospital, the
lowest level of amputation that seemed to
have any chance of success was chosen.
While this resulted in a large percentage
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FIG. 2—Amputations related to age in men.
Black bars = team hospital, dotted bars =
control hospital.
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dysvascular amputees, encompassing
both diabetics and nondiabetics, con
stituted the majority of the patients seen
and were the most difficult to rehabilitate,
this paper will concern itself with the
management of these patients only.
The team hospital treated 248
dysvascular amputees of whom 35 (14%)
were bilateral. The control hospital
treated 294 dysvascular amputees of
whom 44 (15%) were bilateral.

% OF AMPUTATIONS

The authors describe 8 years of ex
perience in the care of amputees with
dysvascular diseases using a
multidisciplinary team approach. They
compare this method of amputee
rehabilitation with one using similar per
sonnel but no team approach. In the
hospital using the team approach, there
were many more below-knee amputees,
a higher number of prosthetic fittings in a
shorter period and more fittings in older
patients than in the control hospital.
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FIG. I—Comparison of patients and reason
for amputation in team hospital (black bars)
and control hospital (dotted bars).

FIG. 3—Ampulations related to age in
women. Black bars = team hospital, dotted
bars = control hospital.
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of successful below-knee amputations, it
also produced many more revisions of the
original procedure. The revision rate at
the same level was 25% at the team
hospital compared with 11% at the
control hospital. Revision to a higher level
accounted for 15% of the team hospital
cases whereas only 6% were so revised at
the control hospital.
Such a high revision rate might be
thought to be responsible for an increased
mortality, but, when expressed as patients
dying within 2 months of amputation, the
rate was 15% at both hospitals in those
patients who did not require revision and
5% and 11% respectively for the team
and control hospitals in those whose
amputation was subsequently revised.
The attempt to achieve the lowest possible
level of amputation increased the time in
hospital. At both hospitals, revision
increased the average patient stay from
51 to 81 days. Although a variety of
postoperative dressings were used at both
hospitals during the 8-year period, no
appreciable difference was noted in terms
of stump healing or patient survival,
whether soft elastic dressings, Unna boot
or plaster dressings were used. The team
hospital ’successfully fitted 128 of the 194
surviving amputees for a success rate of
66%, whereas the control hospital fitted
62 of 218 surviving amputees for a success
rate of only 28%. Eighty percent of the
patients at the team hospital and 70% at
the control hospital were successfully

fitted within 4 months of amputation.
The time from operation to fitting was
shorter at the team hospital. Further
more, the team hospital fitted a greater
proportion of patients at all ages (Fig. 5)
and had more success in fitting patients
in the older age groups with both
above- and below-knee prostheses (Figs. 6
and 7).
Discussion
A multidisciplinary team approach has
long been thought desirable in many fields
of health care. A comparison of the
multidisciplinary approach to the more
conventional methods of rehabilitating
amputees has not been reported. This
study reports only the results in
dysvascular amputees. In this respect, the
hospitals were well matched. The major
difference was in the approach to
treatment. In one hospital, the patient
was managed by a multidisciplinary team
composed of medical and paramedical
professionals who had specialized training
in amputee surgery and rehabilitation. In
the other, the same types of health
professionals cared for the patients, but
the approach was not coordinated. The
team ap proach encouraged the
achievement of the lowest possible level
of amputation, the most rapid prosthetic
fitting and the best possible rehabilitation.
Successful prosthetic fitting in elderly
patients with dysvascular disease is more

likely if the knee is preserved.1 Studies of
energy consumption in walking show that
below-knee amputees expend less energy
than comparably matched above-knee
am putees.2 For this reason alone,
preservation of the knee is desirable for
successful gait training in geriatric pa
tients. Moreover, acceptance of a pro
sthesis is greater in below-knee amputees.
This strong commitment to preserve the
knee at the team hospital resulted in a
revision rate higher than that at the con
trol hospital. When revisions at the same
level were compared, the team hospital
had a 25% rate and the control hospital
11%. In the team hospital, 15% of am
putations were revised to a higher level
while at the control hospital, only 6%
were revised. Mortality did not increase
following revision, although the duration
of hospital stay doubled. The cost to the
patient and to the province of a longer
hospital stay has to be weighed against the
greater number of prosthesis wearers.
This paper has made no attempt to
evaluate the usefulness of the prosthesis
to those patients using them. It is as
sumed, however, that patients who were
successfully fitted with a prosthesis and
continued to wear it at least derived
assistance in transferring in the home or
institution and in many cases were able
to walk or return to work. For the elderly
dysvascular amputee, the use of the
prosthesis, whether it be only in the home
or institution or in the community, must
add to the quality of life after operation.
It is likely that the energy and enthusiasm
of the team approach evoke greater re
sponse from patients than could be
achieved by those working with individual
surgeons and therapists.
Orthopedic surgeons concerned with
the care of amputees may find this team
approach not only useful to the amputee,
but also important in the teaching of
amputee surgery and rehabilitation to the
professionals involved.
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Septic Complications of Perforated Peptic Ulcer

The septic complications of peptic ulcer
perforation have not been adequately
described in the literature because the
sparse microflora usually present in the
upper gastrointestinal tract is generally
believed to represent a minimal risk. One
hundred and eighty-two peptic ulcer
perforations (150 duodenal, 32 gastric),
seen over 15 years, are reviewed.
The septic complications relating to
intestinal perforation included
intra-abdominal abscess (22 cases),
wound infection (26 cases) and
generalized bacterial peritonitis (18
cases). The incidence of postoperative
abscesses was significantly (p < 0.05)
greater in patients with gastric than with
duodenal perforation. In both groups,
abscesses were much more frequent
when perforation occurred more than 24
hours before operation.
The risk of intra-abdominal sepsis
following acute peptic perforation is
substantial. In such cases, routine
anaerobic and aerobic cultures should be
done of fluid taken from the peritoneal
cavity at operation.
Les complications infectieuses de I'ulcere
gastro duodenal perfore n'ont pas ete
decrites de facon satisfaisante, car on
croit generalement que la rare microflore
habituellement presente dans les voies
digestives superieures presente un risque
minimal. On a done etudie 182 ulceres
gastro-duodenaux perfores (150
duodenaux, 32 gastriques) observes au
cours d'une periode de 1 5 ans.
Les complications infectieuses
associees aux perforations intestinales
incluaient des abces intra-abdominaux
(22 cas), des infections de plaie (26 cas)
et des peritonites bacteriennes
generalisees (18 cas). La frequence des
abces postoperatoires etait
significativement plus grande (p < 0.05)
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chez les patients ayant des perforations
gastriques que chez ceux qui avaient des
perforations duodenales. Chez les deux
groupes, les abces etaient beaucoup plus
frequents quand la perforation etait
survenue plus de 24 heures avant
I'operation.
Le risque d'infection intra-abdominale
consecutive a une perforation
gastro-duodenale aigue est appreciable.
Dans de tels cas, on doit faire la
recherche systematique des anaerobies
et des aerobies par culture du liquide
preleve dans la cavite peritoneale au
moment de I'operation.

The incidence of sepsis following in
testinal perforations or surgery is related
to the nature of the gastrointestinal
microflora. Recent studies have stressed
the importance of endogenous micro
organisms, especially anaerobes, of the
lower intestinal tract in the development
of sepsis following colonic ruptures or
resection. Septic complications associated
with perforation of the upper gastro
intestinal tract have not been adequately
noted in the literature because the sparse
microflora usually present in this area of
the gastrointestinal tract is generally
believed to represent a minimal risk of
sepsis. Several studies1'3 showed that
individuals with normal gastric acid
output and motility harboured few, if
any, bacteria in the stomach or proximal
intestine. Others4'6 have shown that
heavy bacterial growth with mixed oral
flora and coliform organisms can occur
when there is altered acidity and motility,
such as in gastric carcinoma, bleeding
peptic ulcers and obstruction, and these
conditions are associated with a higher
proportion of postoperative infections.
For acutely perforated peptic ulcer, some
have recommended either not to give
antibiotics preoperatively or to give peni
cillin for the oral flora. However, in our
hospital we have found several cases of
perforated peptic ulcer in which mixed
coliforms were recovered from the peri
toneal cavity.
The purpose of this study was to assess
the infectious com plications of
perforation of the upper intestine, to

determine any differences in infection
rates related to the site of perforation and
duration of symptoms of perforation
before operation and to examine the
microflora of the peritoneal cavity after
acute perforation of peptic ulcers.
Patients and Methods

A list of all patients with a diagnosis
of perforated stomach or duodenum,
secondary to peptic ulcer, or crossreferenced as having perforated peptic
ulcer or ruptured upper intestine, was ob
tained from the medical records depart
ment for the period 1965 to 1980. The
numerical system of diagnostic coding us
ed by the hospital during this 15-year
period was the International Classifica
tion of Diseases, adapted (ICDA).7 The
chart for each patient was reviewed in
detail and data were extracted by the
method of Feinstein and associates,8
with modification. The duration of per
foration was the time from the initial
symptom attributable to the perforated
viscus to the time of operation. Wound
infection was defined as inflammation of
the wound with purulent drainage and
culture of a bacterial pathogen. Super
ficial inflammation and stitch abscesses
were not included. Bacterial peritonitis
was the presence of purulent peritoneal
fluid with the growth of one or more
bacteria.
Findings

There were 182 patients, 150 having
duodenal perforation and 32 gastric
perforation. The mean age for all patients
was 55.9 years (range from 18 to 96
years). A comparison of the characteris
tics and underlying diseases of the two
groups is shown in Table I. Those with
gastric perforation were significantly (p
< 0.0025, Student’s /-test) older by an
average of 10 years and there was a
greater prevalence of chronic underlying
disease than in patients with duodenal
perforation.
Septic Complications (Table II)
The septic complications directly
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related to intestinal perforation for all
patients included intra-abdom inal
abscesses, 22 (12.1%); wound infection,
26 (14.3%) and generalized purulent
bacterial peritonitis, 18 (9.9%). Fifteen

(68.2%) of the intra-abdominal abscesses
occurred postoperatively; the other 7 were
found either at initial operation or at
autopsy in patients who were not
operated upon. The incidence of intra

Table 1—Ch aracteristics of Patien ts w ith
Peptic Ulcer Perforations
Duodenal
perforation
(n - 1 5 0 )

C haracteristic
Mean age, yr ± SD

G astric
perforation
In - 3 2 )

5 3 .3 ± 16.1
1 8-9 3

Age range, yr
Male/female ratio
Underlying disease, no. (% )
None

62 ±

1 1 2 /3 8
7 0 (4 6 .7 )

Heart disease
Chronic lung disease

8 (2 5 .0 )
14 (4 3 .8 )

2 0 (1 3 .6 )
9 (6 .0 )
3 (2 .0 )

Diabetes meliitus
Cerebrovascular accident/
arteriosclerosis
Rheumatoid arth ritis
M alignant tumour

5 (1 5 .6 )
4 (1 2 .51

6 (4 .0 )
4 (2 .7 )

Multiple
Receiving steroids, no. (%)

15.1

3 1-9 6
1 9/1 3

2 (6 .3 )
3 (9 .4 )

7 (4 .7 )

2 (6 .3 )

2 0 (1 3 .3 )
9 (6 .0 )

10 (3 1 .3 )
2 (6 .3 )

Table II—Duration of Perforation in Relation to
S ep tic Complications of Peptic Ulcer
Duration of perforation, h
G astric ulcer, no. (%)

Duodenal ulcer, no. (%)
>24

<24
(n - 1 1 5 )

Complication
Postoperative
ab scess
A b scess at
operation
Wound infection
Death

(n -

3 5)

3 (3 .5 )

5 (1 4 .3 )

0
11 (9 .6 )
6 (5 .2 )

4 (1 1 .4 )
7 (2 0 .0 )
13 (3 7 .1 )

<24
(n - 16)

>24
(n - 16)

1 (6 .3 )

5 (3 1 .3 )

0

4 (1 5 .0 )

4 (2 5 .0 )

4 (2 5 .0 )

6 (3 7 .5 )

9 (5 6 .3 )

Table Ill-M icro b io lo g y of Intra-abdominal A b scess of
Perforated Peptic Ulcer
Duodenal perforation
Microbiology

(n -

Single organisms

2
6

2 organisms
> 3 organisms
Coliforms

1
2
5

3
5

Streptococcus sp.

7
7
4

6
4

Anaerobes

G astric perforation
In > 8)

11)

abdominal abscesses postoperatively was
significantly (p. < 0.05, x2 test with
Yates’ correction) greater in patients with
gastric (18.8%) than with duodenal
(5.3%) perforation and when operation
was delayed more than 24 hours after
perforation (Table II). The wound
infection rate was not significantly
different between the two groups (12%
for duodenal perforation and 25% for
gastric perforation). There was an
increased, although not significant,
incidence of wound infection in duodenal
perforation of longer than 24 hours.
There was no relation between preopera
tive use of antacids and cimetidine, and
infectious complications.
Microbiology (Table III)
Multiple bacterial isolates were usually
found from abscesses, with recovery of
coliforms in most cases of gastric perfora
tion (87.5%) and in nearly 50% of those
with duodenal perforation. Streptococci
(commonly Streptococcus viridans) were
frequently isolated and anaerobes were
recovered in over 40% (8 of 19) of all
cases. Most of the anaerobes were Clos
tridium sp. but anaerobic Streptococcus,
Fusobacterium and, rarely, Bacteroides
sp. also were recovered.
Bacterial cultures of the peritoneal fluid
or swabs from the peritoneal cavity were
available in only 79 patients following
acute perforation. This probably reflects
the teachings of surgeons that acute peptic
perforations occur in a “ sterile”
microbiologic environm ent. Most
specimens taken were peritoneal swabs
and few aspirates for proper anaerobic
cultures were done. The results provided
are most likely inaccurate for anaerobic
representation. In 23 of the 79 patients
(29%), no organism was recovered but in
56 patients, 122 organisms were cultured,
representing 17 different species.
Streptococcus viridans was grown from
31 patients and coliform organisms from
34. Anaerobic organisms were cultured
from 10, Clostridium sp. from 8 and
Bacteroides sp. from 2 patients (reflecting
the more aerotolerant, less fastidious
anaerobes). Candida sp. (mostly C.
albicans) was cultured from 14 patients.
Mortality (Table IV)

Table IV--M ortality in Perforated Peptic Ulcer

Cause of death
Total deaths
Perforation
Prim ary cause of death
Secondary cause of death
Unexpected, at autopsy
Sepsis major cau se of death
Intra-abdominal sepsis
major cause of death

Duodenal
perforation.
no. (%)

G astric
perforation
no. (% )

2 0 (1 3 )

15 (4 6 .8 )

12
5
6
10

13
2
3
13

(6 0 )
(2 5 )
(3 0 )
(5 0 )

8 (4 0 )

(8 6 .7 )
(1 3 .3 )
(2 0 .0 )
(8 6 .7 )

10 166 .7 )

The overall mortality was 19.2%. In
nine patients the perforation was found
at autopsy. It was not previously
suspected.
Discussion

Recent studies6’9 have shown that the
infection rate after peptic ulcer surgery is
related to the endogenous gastric
colonization of microorganisms. Altered
acidity or motility with high rates of lumi
nal bacterial colonization post-
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operatively is associated with increased
risk o f infection. The highest infection
rate (33% ) occurred in patients who
underwent emergency operation for
bleeding ulcers, while there was no
infection in patients who underwent
elective
operation
fo r
chronic
nonobstructing duodenal ulcer.6
Few studies have reported on the
infection rate associated with perforated
upper intestine, and the microbiologic
data o f the soiled peritoneal cavity are
very sparse. Hennessy10 in 1969 reported
an overall wound infection rate o f 31.9%
and intra-abdominal abscesses in 8.4%;
16.1% o f the abscesses occurred in gastric
ulcer perforation and only 6.1% in
du odenal ulcer p e rfo ra tio n .
No
microbiologic data were provided. In
comparison, the incidence o f wound
infection in our study was much lower
(1 4 .3 % )
and
the
incidence
of
intra-abdominal abscesses was slightly
higher (12%). A higher incidence o f post
operative intra-abdominal abscesses with
gastric (18.8%) compared with duodenal
(6 % ) perforation was similarly found in
our study. This observation may be
explained by the fact that in 50% o f the
patients with gastric ulcers, perforation
occurred more than 24 hours before
operation compared with 23% in the
patients with duodenal ulcer. It should be
noted that concomitant intestinal bleeding
and obstruction only occurred in nine and
two patients o f each group respectively,
and infection in these patients did not
significantly affect the overall infection
rate.
The m icrobiologic milieu o f the
peritoneal cavity after upper intestinal
p e rfo ra tio n was not adequ ately
documented by this study. Over 50% o f
the patients had no peritoneal cultures
and adequate specimens for anaerobic
cultures were not obtained in the majority
o f cases. Despite these shortcomings, we
demonstrated that the peritoneal cavity
does not remain sterile in the majority o f
the patients. There was also a substantial
recovery o f coliform organisms from the
peritoneum with 59% to 63% from
perforations that occurred more than 24
hours before operation. The source o f
these organisms was unlikely the oral
flo r a and may have represented
retrograde colonization from the small
bowel because o f decreased bowel
motility.
It appears from the results o f our study
that a prospective evaluation with proper
anaerobic cultures o f the peritoneal fluid
is needed to define further the importance
o f anaerobes in septic complications o f
'peptic ulcer perforation. Immediate
operation or earlier diagnosis after
perforation is most important in reducing
morbidity or mortality from sepsis. It is
probably not necessary to give antibiotics
when acute perforation o f the stomach or
372

duodenum has occurred less than 12
hours b efore operation. H ow ever,
antacids and cimetidine could alter the
bacterial concentration by decreasing the
bactericidal effect o f the acidic secretions.
When operation or diagnosis is delayed
more than 24 hours after perforation has
occurred, the routine use o f antibiotics is
warranted to cover Streptococcus
organisms, coliforms and oral anaerobic
bacteria until the results o f culture o f the
peritoneal fluid are available.
Aspiration o f peritoneal fluid for pro
per aerobic and anaerobic cultures should
be a routine practice at operation for pep
tic ulcer perforations. There is clear
evidence that the peritoneal cavity is not
sterile in the majority o f the cases and
serious infectious complications can oc
cur. Knowledge o f the bacteriology
o f the peritoneal cavity may be used as
a guide to the antibiotic management o f
such patients and may be a prognostic
indicator o f postoperative sepsis.

1 thank Dr. Norman A. Hinton for reviewing
this manuscript, and for his advice and
criticism.
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Familial Polyposis Coli: an Unusual Family
Familial polyposis is an autosomal,
dominantly inherited disorder. Usually
less than 50% of siblings are affected
because of incomplete penetrance by the
responsible gene. The family described in
this paper was unusual in that all seven
siblings of one son had the disorder. The
chances of this occurring, assuming com
plete penetrance, is 1 in 128. Moreover,
several members of his family had Gard
ner's syndrome with associated ex
tracolonic manifestations, including a
rarely associated papillary carcinoma of
the thyroid. There was no evidence of a
cosanguineous marriage. Patients with
familial polyposis are advised to adopt
children, otherwise surveillance of their
children must be lifelong, beginning at
puberty.
La polypose familiale est une maladie
hereditaire autosomale dominante.
Habituellement, environ 50% d'une
fratrie est touchee a cause d'une
penetrance incomplete du gene
responsable. La famille decrite dans cet
article se distinguait du fait que les sept
enfants d’un fils en etaient affectes. La
probability d'un tel evenement, en
supposant une penetrance complete, est
de 1 dans 128. De plus, plusieurs
membres de sa famille souffraient du
syndrome de Gardner avec
manifestations extra-coliques, incluant
une tumeur maligne associee tres rare, le
cancer papillaire de la thyroide. On ne
relevait aucune preuve d'un manage
consanguin. On conseille aux patients
souffrant de polypose familiale d'adopter
des enfants. Autrement, leurs enfants
biologiques doivent faire I'objet d'une
surveillance durant toute leur vie, a partir
de la puberte.
Familial polyposis may be associated with
many extracolonic tumours and cysts.1-6
Since Gardner and Richards7 first
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reported a fam ily su fferin g from
polyposis coli as well as osteomas and
soft-tissue tumours, many have reported
cases linking familial polyposis and ex
tracolonic tumours. In the literature, these
patients are grouped under Gardner’ s
syndrome.811 Thomas and associates12
pointed out that many patients have not
undergone extensive studies, including
radiologic examination o f their bones, so
that the incidence o f Gardner’ s syndrome
is probably understated. Their experience
with one family was that “ o f all the pa
tients who were completely evaluated, not
one showed polyposis alone” . Bussey13
examined the large experience o f St.
Marks Hospital in London and found
that 14% to 19% o f patients with familial
polyposis had features o f Gardner’ s
syndrome.13 The common thread ac
cepted by most is the polyposis coli.
Opinion varies about the mode o f in
heritance o f familial polyposis and Gard
ner’ s syndrome. As recently as 1980,
Gardner14 indicated that some question
still remains as to whether the syndrome
is separate from familial polyposis or a
variant explained by differences in
penetrance and expressivity. McConnell15
holds that “ the evidence now indicates
that classic familial polyposis coli and
Gardner’ s Syndrome are not distinct gene
tic entities” . Obviously, complete agree
ment in this regard has not been reached.
The hypothesis o f Veale reported by
Danes and associates16 best explains
what we see clinically. This hypothesis
states that it is a fault in a single, major
pleiotropic gene, with alleles that are in
fluenced by other genes, that causes the
wide variability in the phenotype.
For practical management the physi
cian must remember that in individuals
with multiple polyps, multiple osteomas,
fibromas, epidermoid cysts or a family
history o f these lesions, there may be a
propensity for carcinomas to develop.
In this paper we document an unusual
family that had a peculiar pattern o f in
heritance. In familial polyposis coli,
usually less than 50% o f the offspring are
affected but in this family all seven sib
lings o f one son had polyposis coli, as did
all three siblings o f another son. Less than
50% o f siblings are usually affected

because o f incomplete penetrance o f the
responsible gene. By simple mendelian in
heritance, assuming complete penetrance,
the chances o f all seven children in a fami
ly being affected is 1 in 128.

Patients
When two brothers, I I - 1 and II-4, died
at ages 42 and 46 years from carcinoma
o f the bowel, another brother, II-2 (the
propositus), went to his doctor when he
noted the passage o f bloody stools. In
vestigation revealed the presence o f
polyposis coli and carcinomatous changes
were already present. He underwent a
proctocolectomy and ileostomy. The
familial nature o f the disorder was
recognized and the other members o f the
family were investigated.
His father (1-2) had married twice. The
first marriage was to I- 1, who had five
children, three o f whom had carcinoma
o f the colon. One o f these is our pro
positus (11-2) who was found to have
polyposis coli (Fig. 1). The second mar
riage (1-3) produced two children, II-6
and II-7, who are reported to be well. N o
other information is available about 1-1
except the report that she died from
“ cancer o f the bowel” .
The children o f three brothers 11-1, 11-2
and 11-4 are in our follow-up program.
Brother 11-5 is reported well and lives
beyond our region. Attempts to follow 
up his children have so far failed.
Table I documents the details o f the
family.

Extracolonic Manifestations
Patient 111-12, the daughter o f II-4,
underwent subtotal colectomy with ileorectal anastomosis. One year later a
desmoid tumour developed in her small
bowel mesentery. This was excised but
recurred and grew so large that it even
tually caused her death. Four years after
her colectomy a papillary carcinoma o f
the thyroid developed.
Patient 111-15 (son o f II-4) underwent
subtotal colectomy. A desmoid tumour
was present in the cecum.
In patient 111-18 (son o f II-4) biopsies
o f the polypoid lesions in the rectum were
done before subtotal colectomy. They
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showed that carcinoma was present. A
proctocolectomy was done. On follow
up, a biopsy-proven adenomatous polyp
was found in the ileostomy mucosa.
Discussion

Familial polyposis coli may be

associated with abnormalities arising in
endoderm, ectoderm or mesoderm.7 In
the full-blown disorder, all three germ
layers are affected. The family reported
here demonstrates excessive proliferation
of tissue of endodermal and, in two, of
mesodermal origin. More extensive in
vestigation may reveal even more lesions.
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FIG. 1—Graphic pedigree of family showing occurrence of polyposis coli, extracolonic
manifestations and course.
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t u m o u r f o u n d in o p e r a t iv e s p e c im e n

Extracolonic abnormalities associated
with Gardner’s syndrome have been
reported increasingly in the literature.8
Our patient III-12 had papillary car
cinoma of the thyroid, which has been
reported by others.8’9 Tumours arising in
extracolonic sites have been reported with
familial polyposis coli and have been in
the stomach and duodenum, although
tumours of the lower small bowel have
also been reported.3’9’1719 Since only
about 20% of patients with familial
polyposis coli demonstrate Gardner’s syn
drome, the development of these extraor
dinary tumours is, in Bussey’s experi
ence,13 rare.
The family reported here not only had
an exceptional incidence of polyposis but
Gardner’s syndrome has appeared in
several members and one of the very rare
associated tumours, papillary carcinoma
of the thyroid, has been found. This sug
gests that patients with Gardner’s syn
drome and, indeed, families that have a
high incidence of this syndrome, inherit
a more penetrating gene or that the gene
is modified by neighbouring alleles so that
there is less suppression; this would allow
tumours in areas other than the colonic
mucosa to develop.
We advise that patients from families
with polyposis coli should adopt children
rather than have their own. Those who
do have children are advised that each
child will require lifelong surveillance
beginning at puberty, unless symptoms
develop at an earlier age. If adenomatous
polyps are discovered, subtotal colectomy
with ileorectal anastomosis has, until
recently, been our procedure of choice.
The diagnosis must be confirmed by biop
sy. The presence of multiple polyps at
sigmoidoscopy is not sufficient to make
the diagnosis. Adenomatous degenera
tion in the biopsy specimen must be
shown microscopically. In those
with Gardner’s syndrome or with
polyposis in families that have a high in
cidence of this syndrome, careful atten
tion should be paid to the possibility of
extracolonic lesions. The surgeon must
make certain malignant change has not
already occurred in the rectum if ileorec
tal anastomosis is planned. We recom
mend removing and histologically ex
amining all polyps from the rectum
before making the ileorectal anastomosis.
Investigation of the stomach and small
bowel should be carried out before opera
tion in all patients with polyposis coli.
This is particularly important in families
in which there is a high proportion of
Gardner’s syndrome.
Parks and associates20 have advocated
mucosal proctectomy with formation of
an ileal pouch and ileoanal anastomosis.
This is an attractive proposal for manage
ment and with further experience may
become the operation of choice. We have
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not had experience with this procedure in
managing polyposis coli.
Follow-up o f all patients is essential.
The rectal stump is a potential site of
malignant degeneration and patients with
some or all of the elements of Gardner’s
syndrome may subsequently have other
lesions o f importance. Proctoscopy
should be carried out every 6 months.
Fulguration of residual polyps found in
the rectum at follow-up will control the
disease in most patients. Constant
awareness by the surgeon is necessary to
diagnose extracolonic lesions since Gard
ner’s syndrome may occur sporadically in
familial polyposis. Families in which
Gardner’s syndrome has been identified
should be investigated more extensively.
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Intrauterine Intussusception:
Case Report and Literature Review
Intussusception in the newborn is a
unique clinical entity, and one of the
most unusual causes of intestinal
obstruction in infants. Its cause can be
idiopathic, secondary to a local lesion or
a complication of disease. Early
diagnosis and treatment are important,
because survival depends on them.
The authors report a case of jejunal
atresia secondary to intrauterine
intussusception, followed by a literature
review. Less than 30 cases have been
adequately documented in the world
literature. Eight reports from the
literature are selected to highlight clues
for early diagnosis, such as vomiting,
with or without bile, abdominal
distension and bloody stools, because of
their prognostic implications.
Intussusception is rare under the age
of 3 months; the incidence is 0 .3 % in
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the neonatal period. Previous reports
indicate that a confusing clinical picture
has led to a delay in operation and a
high mortality. The ultimate outcome
depends on an acute awareness of the
condition in the presence of the
diagnostic clues in a newborn.
L'intussusception chez le nouveau-ne est
une entite clinique exceptionnelle et une
des causes les plus inhabituelles
d'obstruction intestinale chez le jeune
enfant. Sa cause peut etre idiopathique,
secondaire a une lesion locale ou la com
plication d'une maladie. Un diagnostic
precoce et un traitement immediat sont
importants car la survie en depend.
Les auteurs decrivent un cas d'atresie
jejunale consecutive a une intussuscep
tion intra uterine. Suit, une revue de litterature. IVIoins de 30 cas ont ete adequatement etablis dans la litterature
mondiale. Huit rapports ont ete choisis
afin de souligner les indices en permettant un diagnostic precoce a cause de
leurs implications pronostiques:
vomissements accompagnes de bile ou
pas, distention abdominale et selles
sanglantes.
Chez I’enfant de moins de 3 mois, ('in
tussusception est rare; son incidence

durant la periode neonatale est de 0.3% .
Des rapports anterieurs indiquent qu'un
tableau clinique deroutant a retards
I'intervention chirurgicale et entraine une
forte mortality. L'issue finale depend
d'une reconnaissance immediate de la
maladie devant les indices diagnostiques
chez le nouveau-ne.

Intrauterine intussusception is rare. We
describe an example of this condition and
suggest that it may be one cause of
congenital intestinal atresia. We also
review the literature.
Case Report
A girl, weighing 2625 g, was delivered
vaginally at 37 weeks of gestation to a
27-year-old primigravida whose pregnancy was
uncomplicated. Apgar scores were 9 at 1
minute and 10 at 5 minutes.
The infant started to vomit at 12 hours of
age. The vomitus initially appeared to be
swallowed amniotic fluid but it became obvious
after 3 hours that the vomitus was bile. At 15
hours of age, the physical examination revealed
abdominal distension and mild dehydration.
No meconium had been passed since birth.
Roentgenograms in the supine and erect
positions revealed marked distension of
numerous bowel loops throughout the
abdomen with no gas in the true pelvis and

VO LU M E 26, NO . 4, J U L Y 1983 / THE CANADIAN JOURNAL OF SURGERY

rectum. In the erect position, numerous
gas-fluid levels were visible in the bowel, the
appearance being consistent with a small-bowel
obstruction (Fig. 1). The infant was hydrated,
kept without oral intake, and ampicillin and
gentamicin therapy was started. She was
operated upon at 29 hours of age.
At laparotomy through a transverse incision,
a mid-small bowel obstruction with early
necrosis of the upper pouch was found. A
V-shaped mesenteric defect was present. The
distal bowel adjacent to the obstruction was
greater in diameter than the more distal small
intestine, suggesting the possibility of
intussusception in this segment. Eighteen cm
of the proximal pouch and 7 cm o f the distal
intestine were resected. Continuity was restored
by end-to-side anastomosis.
The baby made a smooth postoperative
recovery and has had no more problems. She
was 10 months of age at the time of writing,
and growth and development were normal.

contained an intussusceptum (Fig. 2).
Inspissated meconium was present in the
lumen of the intussuscipiens. Focal
chronic inflammation was present on the
serosal surface of the distal segment (Fig.
3).
The lumen of the proximal segment
was dilated. Portions of the wall were
replaced by granulation tissue, especial
ly in the submucosa. The epithelium was
lost but foci of regenerating epithelium
were present. A full-thickness fold of the
intestinal wall protruded into the lumen
adjacent to the mesentery (Fig. 4). This
was thought to be a residuum of the
intussusceptum.
An intussusception was present in the
distal segment and a remnant of in

tussusceptum was identified in the prox
imal segment. Changes in the intestinal
wall of the proximal segment were
consistent with ongoing ischemia. The
pathologic findings supported the concept
of an intrauterine intussusception, with
subsequent ischemia of a portion of the
involved intestine producing an atresia.
Literature Review
Only 11 cases of intrauterine in
tussusception have been reported in suf
ficient detail to allow analysis of the data
(Table I18).
Seven of nine infants were boys. Three
of nine weighed less than 3000 g at birth.
Eight of the 11 infants presented with
vomiting as an important symptom. Ab-

Pathologic Features
The lumen of the distal segment

FIG. 2—Cross-section of distal segment with intussusception. Intussusceptum is between
arrows and intussuscipiens between arrowheads. Lumen contains inspissated meconium (A)
(hematoxylin and eosin, reduced by 33% from X 17).

Fig. lb
FIG. 1—(a) Supine view showing distended
bowel loops, (b) Erect view showing multiple
gas-fluid levels.

FIG. 3—Serosal surface of distal segment. Arrow indicates focus of chronic inflammation
with calcification (hematoxylin and eosin, reduced by 33% from x40).
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dominal distension was noted in 7 of the
11 patients; it was not mentioned in 4. In
4 of the 11 infants, bowel loops were visi
ble. Seven of the 11 babies died, 6 follow
ing operation.

production of intestinal atresia in two dog
fetuses born after intrauterine interrup
tion of the blood supply of a small seg
ment of the intestine. This hypothesis
gains some support from the work of
Laufman and associates11 who showed
that isolated, devascularized, sterilized
loops of bowel left in the peritoneal cavity
became converted into fibrous bands or
disappeared entirely.
Our patient had a V-shaped mesenteric
defect. There was early necrosis of the
proximal segment at 29 hours of age, sug
gesting a decreased blood supply. The
distal segment clearly showed an in
trauterine intussusception. Epithelial
squames indicate late onset of the atresia.

Discussion
Intrauterine intussusception is a rare
condition; its pathogenesis is still not fully
understood. Louw9 in 1952 suggested
that intestinal atresia could be secondary
to interference with intestinal blood supp
ly. In one of his patients there was a seg
ment of distal bowel that appeared to be
a remnant of an intussusception. In 1955,
Louw and Barnard10 reported successful

As noted in the literature review,
passage of necrotic tissue has been
reported in some cases. In those cases and
in the present case, it is possible that a
necrotic intussusception might disin
tegrate entirely in time, leaving only un
recognizable scar.
Thus, some cases of intestinal atresia
of the newborn may, indeed, have come
about as a result of an intussusception in
fetal life. The case reported here lends
some support to such a possibility.
We gratefully acknowledge the editorial sug
gestions of Drs. G.H. Valentine and James
Boone. We thank Mrs. Esther Borer for
secretarial assistance.
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Table 1—Diagnostic Clues in Eight Reports of Intussusception of the Intestine in the Newborn

Authors
Koop, 1 9 5 3 1
Lannin and
associates, 19552
Shnitka and Sherbaniuk,
19563
Parkkulainen, 19584

Gherardi
and Fisher, 19615
Ueda and
Satani, 19676
Grosfeld and
Clatworthy, 19707
Todani and
associates, 1975s

ige at onset of
;igns/symptoms
At birth

Abdominal
distension
7

Vomiting
(bile)
+

Stool, meconium,
blood, necrotic
tissue
M, B, Mu

Method
-

Findings
(Abdominal
mass)
-

At birth

+

?

At birth

+

?

?

-

-

At birth

?

+

M

Ba enema

1d

+

+ (B)

M

Plain film

At birth
1st d

?
+

+
-MB)

M
NT

Plain film
Ba enema

2 h

+

MB)

B

Ba enema

12 h

+

NT

Ba enema

24 h

?

Visible bowel
loops
Signs of
peritonitis
Fluid levels
Visible bowel
loops
Visible bowel
loops
Visible bowel
loops
?

MB)

M, B

Gastrografin
enema
+
Soon after
MB)
M
Gastrografin ?
birth
enema
+ - present, - - absent, B) = bile, M - meconium, B - blood, Mu = mucus, NT - necrotic tissue, Ba - barium.
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Age at
operation, d

Outcome
Shortly after Well
birth
0.5
Well 57 mo
6

Died 3 min
after birth
Died 2 wk

4

Well 3 wk

6
3.5

Well 27 d
Well 18 mo

1

Well 17 mo

1

Well 2 mo

4

Well 20 mo

5

Well 15 mo
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Norman Bethune, Canadian Surgeon:
His Chinese Connection
Norman Bethune, a Canadian thoracic
surgeon who dabbled in painting, poetry,
criticism, teaching and invention, was a
member of the Communist Party of
Canada. He became involved in two civil
wars on opposite sides of the world and
amassed both criticism and respect from
colleagues and national leaders. The
author describes Bethune’s time in
China, during which he developed front
line field hospitals for Mao Tse-tung and
his guerrillas in their struggle against the
Japanese during 1938 and 1939. His
efforts in China on behalf of the
wounded brought him into contact with
the primitive military medicine of the
country and the poverty of its people; it
earned for him a local reputation as
saviour and benefactor and gave him an
honoured place in Chinese military
history.
Norman Bethune, un chirurgien
thoracique canadien qui toucha a la
peinture, la poesie, la critique,
I'enseignement et I'invention, etait
membre du Parti communiste canadien. II
s'impliqua dans deux guerres civiles se
deroulant aux antipodes de la planete et
s'attira aussi bien la critique que le
respect de ses collegues et des
dirigeants nationaux. L'auteur decrit le
sejour de Bethune en Chine, durant
lequel il mit sur pied les hdpitaux de
campagne pour Mao Tse-tung et ses
guerilleros, lors de leur bataille contre les
Japonais en 1938 et 1939. Ses efforts
depenses en Chine aupres des blesses le
mirent en contact avec la medecine
militaire primitive de ce pays et la
pauvrete de son peuple; ils lui valurent
une reputation locale de sauveur et de
bienfaiteur et lui assurerent une place
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d'honneur dans I'histoire militaire
chinoise.

Although he died prematurely at the age
of 49 years, Dr. Norman Bethune (Fig. 1)
managed to win a measure of fame as
thoracic surgeon, to dabble in painting,
poetry, criticism, teaching and invention,
to espouse a political philosophy contrary
to that of Canada, to become involved in
two civil wars on opposite sides of the
world and to amass both criticism and
respect from colleagues and national
leaders.
The Early Years

Bethune was born in Gravenhurst,
Ontario in 1890, the son of a Presbyterian
minister father, Malcolm Nicholson
Bethune, and a Presbyterian mother,
Elizabeth Ann Goodwin.
From his earliest years his venturesome spirit
and his intention of being a surgeon were taken
for granted. By the time he was eight he had
begun the messy but scientifically necessary job
of dissecting flies and chicken bones. Later his
personal investigation of anatomy led his
mother to an investigation of her own when
a dreadful odor suddenly pervaded the house
one afternoon. She traced it to the attic where
she found Norman carefully cutting away the
flesh from a cow’s leg he had just boiled.1

At an early age he contracted
tuberculosis and entered the famed
Trudeau Sanatorium where he was given
slim chance of recovery. While there, he
studied deeply the comparatively new
techniques of thoracic surgery, which
persuaded him that they could be applied
to his case — and he was right. The
successful experience influenced him to
specialize in thoracic surgery.
Bethune received his medical degree
from the University of Toronto, then
took a 3-year internship in London,
England, at the Hospital for Sick
Children. He obtained his fellowship in
surgery in Edinburgh, practised for a time
in Detroit and did postgraduate work in
London and Vienna.

Political Development

During the 1930s, Bethune’s social
consciousness was aroused. He became
aware of the gap between the public need
for medical care and facilities available
for treatment. Socialized medicine
became his forte and, when the Spanish
Civil War broke out in 1936, he went to
Madrid to organize the first mobile blood
transfusion unit to be used anywhere. The
following year he joined the Communist
Party of Canada and in 1938 he went to
China, where he offered his medical
services to Mao Tse-tung in the struggle
to envelope China within the arms of
communism.
The Chinese Experience

The reason behind Bethune’s decision
to go to China is not completely clear.
According to the biography, The Scalpel,
the Sword, by Ted Allan and Sydney

FIG. 1—Dr. Norman Bethune in China with
one of his young medical students. (Repro
duced by permission from Allan T, Gordon S:
The Scalpel, the Sword, Little, Brown & Co.,
Boston, 1952.)

VOLUME 26, NO. 4, JU LY 1983 / THE CANADIAN JOURNAL OF SURGERY

379

Gordon, Bethune had just returned to
Canada from Spain and was planning to
go back; however, a group of American
doctors had just left for Spain, and events
in the Far East were focusing attention
on the battle of the Chinese people against
Japanese invasion. Spain needed help, but
help was being given and China needed
doctors even more urgently.
Bethune arrived in Hong Kong on Jan.
20, 1938. Three days later he flew to
Hankow, the seat of the Nationalist
government headed by Chiang Kai-shek.
On Mar. 4, in Ho-Chin, he recorded in
his diary that, “ Today is my birthday —
my 48th . . . I celebrated by dressing
wounded soldiers (arms and hands), find
ing that the only wounded around had
nothing but neglected minor injuries, and
that all others had died on the way.” 2
On Mar. 9, 1938 he continues, “ Woke
this morning to hear one of our Chinese
soldiers singing the Marseillaise. A
strange reveille on the banks of the Yellow
River. During the morning a child took
convulsions and the mother rushed out of
the cave, calling the child’s name loudly
— to bring back his soul which had
temporarily, she believed, left his body.
Demons and Marseillaise!” 3
Bethune moved on to Yenan where
probably the most complex political
development of the 20th century was
taking place. It was “ an autonomous
region led by Marxist revolutionaries
within the framework of semifeudal,
semicolonial China” .4 When Bethune
arrived in the centre of the city, he was
greeted by a delegation headed by an
American who introduced himself as Dr.
Ma Hai-teh. This man had come to China
a few years earlier, changed his name,
taken a Chinese wife, learned to speak the
language and become a medical adviser
to the eighth route army in Yenan.
It was on the eve of his second day in
Yenan that Bethune met Mao Tse-tung.
The interview took place in a home where
Dr. Chiang, chief medical officer of the
eighth route army, and an interpreter
were seated with Mao.
As I sat in the bare room opposite Mao,
listening to his calm comments, 1 thought back
to the Long March, to Mao as he and Chu Teh
had led the Communists on the great trek from
the south — six thousand miles to the loess
country of the hills. It was their strategy then
that made it possible for their strategy now to
harass the Japanese by guerrilla warfare, to
nullify the effects of the invaders’ superior
equipment, and to save China . . . The man
is a giant! He is one of the great men of our
world.4

Bethune suggested to Mao that mobile
operating units should be constructed to
function near the front lines to care for
the wounded.
In Bethune’s first report to the China
Aid Council written from Hu Chia
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Ch’uan, he described a little village of 50
houses. Conditions were primitive,
transportation was by foot and mules.
There are 175 wounded here, scattered among
the houses. This is what is meant by a
“ hospital” here. It would break your heart to
see them — lying on the brick k ’angs with only
a little straw beneath them. Some have no
coverlets — none have blankets . . . The
wounded are crawling with lice. They all have
only one uniform, and that they have on . . .
Their bandages have been washed so often they
are now nothing but dirty rags. Three men, one
with the loss of both feet through frost-bite
gangrene, have no clothes at all to wear. There
is only a coverlet for them. Their food is
boiled millet — th at’s all . . . Most of them
are slowly dying of sepsis and starvation. Many
have tuberculosis.5

Bethune arrived in Chin-Cha-Chi at the
beginning of July 1938. Here, he found
himself in the centre of the conflict and
had the experience of being inside
Japanese lines, yet in free territory. What
he found in Chin-Cha-Chi caused him to
conclude that real hospital facilities for
the eighth route army and the guerrillas
were nonexistent. The so-called base
hospitals had a total of 350 beds. It was
difficult to call them “ beds” ; in fact, it
was difficult to call the hospital a
“ hospital” . The wounded lay on
straw -covered, clay-topped k ’angs.
Patients wore their dirty uniforms. There
were no trained personnel or anesthetic
agents. After bandages were used, they
were carefully washed and hung out to
dry. W ounds were sewn up with
home-made thread. Wire probes and
locally manufactured pills (of dubious
value) were part of the equipment.
E d u catio n al train in g for medical
personnel was completely lacking.
The lack of training was intolerable to
Bethune, who instituted a series of lec
tures under the slogan “ learn while you
work” . Surrounded by staff members,
who sat cross-legged at his feet, he lec
tured with a blackboard on anatomy, the
treatment of wounds, physiology and
other subjects. This activity led to the
founding of a school, associated with the
hospital for the training of nurses and
doctors. Bethune not only constructed a
complete curriculum but also wrote his
own textbooks, illustrating many of the
pages.
The book was translated into Chinese
by his associate, Tung. When it was final
ly published by the Chin-Cha-Chi govern
ment, the textbook had the distinction of
being the first medical handbook for
guerrilla warfare published anywhere in
the world.
One example of Bethune’s courage and
impact on his Chinese friends is illustrated
by the following incident. A group of 56
wounded guerrillas were carried across
the mountains to Bethune’s unit, Bethune
examined them and found that most

would live, although seriously wounded.
Among the group was one man who ar
rived unconscious on his k ’ang. One of the
nurses asked if the unconscious man was
dead, but Bethune said not. His wounds
were not serious but he had lost much
blood. Bethune then instructed Tung to
call a meeting of the entire village. When
the villagers had assembled, Bethune
directed that the inert soldier be placed
before the solemn village. Sometime
before, Bethune had appealed to the peo
ple for blood donations when a wound
ed soldier had arrived at a critical stage,
only to be rebuffed. This time, Bethune
appealed again for a donation of blood.
There was no response. Bethune, in
anger, drew his own blood. While the au
dience watched, he administered the
transfusion and they saw the colour
return to the soldier’s cheeks. Many of
the villagers and Bethune’s assistants were
men whose bravery was unquestioned.
They could fight the enemy with dauntless
courage, but they were afraid to take part
in something unknown to them. The
enemy they had seen, but they had never
seen a blood transfusion. It was difficult
for them to understand. He wrote in his
diary
. . . what we don’t understand, we fear. They
and 1 and all men. More than anything else,
it is understanding and knowledge that defeat
fear. When they saw how I drew my own
blood, with no ill effects to myself, there was
no longer anything mysterious, anything
unknown, anything to fear. Then they saw how
the patient was saved, saw the connection and
they were ashamed. And my rage at them had
as little basis as their fear of giving blood. What
was it Mao Tse-tung said to the writers and in
tellectuals of China? “ You can teach the peo
ple only when you become their pupil.” How
profoundly it fits . . . To be a better teacher
one must be a better pupil . . .6

Death of Bethune
Death came quickly to Bethune. As the
result of an infected finger wound, blood
poisoning developed. He wrote his last
Will and Testament to staff headquarters:
Dear General Nieh: I am fatally ill. I am go
ing to die. 1 have some last favours to ask of
you. Please inform T.B., Toronto, Canada, of
my fate . . . and also the China Aid Council
(of New York). Tell them 1 have been happy
here, and my only regret is that I shall not be
able to do more. To B— (New York) 1 send
my Japanese and Chinese swords . . . All my
photographs, diaries, narratives and all the mo
tion pictures of our army are to be turned over
to T.B. Inform him that a motion picture will
be completed soon. [No motion picture ever
arrived.] I should like you to ask the China Aid
Council to remit some money to my divorced
wife, on my behalf — perhaps in instalments.
My responsibility to her is undeniable, and I
cannot leave her cut off simply because I myself
have no money. Tell her that I have been very
happy . . . Give my everlasting love to T.B.
and all my Canadian and American friends.
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Tell them I have been very happy. My only
regret is that 1 shall now be unable to do more.
The last two years have been the most signifi
cant, the most meaningful years of my life.
Sometimes it has been lonely but I have found
my highest fulfillment here among my belov
ed comrades. I have no strength now to write
more . . . To you and to all my comrades, a
thousand thanks. Norman Bethune.7

Bethune died on the morning of Nov.
13, 1939. He was buried in the valley in
East Shansi. Later, the Japanese captured
the valley and destroyed most of the
memorial built by the soldiers. However,
after the enemy had been completely
eradicated from China, the monument
was rebuilt. There are black panels on the
four sides of the tomb with inscriptions
in English and Chinese, lettered in gold:
“ The internationalist spirit of Comrade
Norman Bethune is worthy to be learned
by all Chinese Communists and respected
by all Chinese people. Central Commit
tee of the Communist Party of China.”
Tributes
To mark the 40th anniversary of
Bethune’s death, a conference was held
at McGill University in Montreal from
Nov. 16 to 18, 1979,8 and the Chinese
Ministry of Health invited the Canadian
government to send an official delegation
to participate in large-scale com
memorative activities in Peking and the
inauguration of Bethune University in
Shihchauchuang. Thus, in November
1979, Dr. E.W. Barootes, former depu
ty president of the Canadian Medical Asso

ciation and a practising urologist in Regina,
Saskatchewan, led an eight-person Cana
dian delegation to China. The deputy
leader of the delegation was Canada’s
ambassador to China, Arthur Menzies.
Other members were: Jean Rochon, dean
of the faculty of medicine at Laval
University; Francis L. McNaughton, a
Montreal neurologist and a personal
friend of Bethune; Roderick Stewart,
author of a biography of Bethune; and
Janet Cornell, Ruth Reilly and Joan
Lindley, Bethune’s three nieces. John
Blackstone, a medical journalist, also ac
companied the delegation.

for Canadians, and repeated witness of the
“ legends” of Bethune were truly incredible.9

This small Canadian group was treated with
the gracious hospitality characteristic of the
Chinese, and with full state honours and im
peccable protocol. Our motorcades were led
down the wide streets of Peking and elsewhere,
flanked by welcoming banners; we lodged in
state-owned houses where accommodation, at
tention and hospitality were superb.9

. . . As you say, 1 did know him [Bethune]
pretty well. He was my assistant in the Royal
Victoria thoracic clinic for about four years
and left to take the position at the Sacre Coeur.
Of course I could have told you a good deal
more than you have written, most of it
laudatory and some of it condemnatory. He
was definitely abnormal, but not “ mental” ,
and not a genius nor a leader. He was clever,
especially in mechanical things, and could have
easily been one of these inventors of whose in
ventions nine fail and one succeeds enormous
ly. He was an egocentric. His vision was keen
but narrow. He wore blinders. He trod on
many toes, quite often without knowing or
without caring if he did know it. He had a
superiority complex and he was entirely
amoral. And yet it is not quite fair to say all
that, because I do give him credit for sincerity
in his social views. He was turning strongly to
the Left when he had the opportunity to take
a trip to Moscow, and came back an out and
out Communist and joined the communists
here. Nobody knows whether this circumstance
was the true cause o f his leaving the Sacre

The Chinese released a new movie of
Bethune and issued new Bethune com
memorative stamps, which, according to
Barootes,9 were sold out in 2 days. The
delegation visited two cemeteries with
tombs dedicated to Bethune, a major
military hospital and medical school
founded by him and dedicated to his
memory.
To see the friendship and affection exhibited
toward the Canadians, and especially to
Bethune’s nieces, by the families in the small
village where Bethune died was indeed a revela
tion, the manifestation of appreciation, love

The story of Norman Bethune has not
been completely told and perhaps it never
will be. The romantic spirit of the only
extensive biography of Bethune, The
Scalpel, the Sword, is mellowed a bit by
such personal testimonies to Bethune’s
character as are revealed in a letter to
Gabriel Nadeau. The letter was written by
Edward Archibald on Dec. 27, 1940. Ar
chibald was thanking Nadeau for the
reprint of an article he had written about
Bethune:

Appendix I—Mao Tse-tung’s Tribute to Norman Bethune, Dec. 21, 1939
Comrade Norman Bethune, a member of
the Communist Party of Canada, was
around 50 when he was sent by the com
munist parties of Canada and the United
States to China; he made light of travell
ing thousands of miles to help us in our war
of resistance against Japan. He arrived in
Yenan in the spring of last year, went to
work in the Wutai Mountains, and to our
great sorrow died a martyr at his post.
What kind of spirit is this that makes a
foreigner selflessly adopt the cause of the
Chinese people’s liberation as his own? It
is the spirit of internationalism, the spirit
of communism, from which every Chinese
communist must learn. Leninism teaches
that the world revolution can only succeed
if the proletariat of the capitalist countries
supports the struggle for liberation of the
colonial and semicolonial peoples and if the
proletariat of the colonies and semicolonies
supports that of the proletariat of the
capitalist countries. Comrade Bethune put
this Leninist line into practice. We must
unite with the proletariat of all the capitalist
countries, with the proletariat of Japan,
Britain, the United States, Germany, Italy
and all other capitalist countries, before it
is possible to overthrow imperialism, to

liberate our nation and people, and to
liberate the other nations and peoples of the
world. This is our internationalism, the in
ternationalism with which we oppose both
narrow nationalism and narrow patriotism.
Comrade Bethune’s spirit, his utter devo
tion to others without any thought of self,
was shown in his boundless sense of respon
sibility in his work and his boundless warm
heartedness towards all comrades and the
people. Every communist must learn from
him. There are not a few people who are
irresponsible in their work, preferring the
light to the heavy, shoving the heavy loads
on to others and choosing the easy ones for
themselves. At every turn they think of
themselves before others. When they make
some small contribution, they swell with
pride and brag about it for fear that others
will not know. They feel no warmth
towards comrades and the people but are
cold, indifferent and apathetic. In fact such
people are not communists, or at least can
not be counted as true communists. No one
who returned from the front failed to ex
press admiration for Bethune whenever his
name was mentioned, and none remained
unmoved by his spirit. In the ShansiChahar-Hopei border area, no soldier or ci-

vilian was unmoved who had been treated by
Dr. Bethune or had seen how he worked.
Every communist must learn this true com
munist spirit from Comrade Bethune.
Comrade Bethune was a doctor, the art
of healing was his profession and he was
constantly perfecting his skill, which stood
very high in the eighth route army’s medical
service. His example is an excellent lesson
for those people who wish to change their
work the moment they see something dif
ferent and for those who despise technical
work as of no consequence or as promis
ing no future.
Comrade Bethune and I met only once.
Afterwards he wrote me many letters. But
I was busy, and I wrote him only one
letter and do not even know if he ever re
ceived it. I am deeply grieved over his
death. Now we are all commemorating
him, which shows how profoundly his spi
rit inspires everyone. We must all learn the
spirit of absolute selflessness from him.
With this spirit everyone can be very use
ful to the people. A m an’s ability may be
great or small, but if he has this spirit, he
is already noble-minded and pure, a man
of moral integrity and above vulgar inte
rests, a man who is of value to the people.
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Coeur Hospital at the order of the controlling
nuns, or whether he resigned of his own mo
tion in order to take up the work in Spain, on
the Republican side, where it was known the
leaders had murdered many priests and nuns.
In any case his position at the Sacre Coeur had
become untenable. . . . I never really liked
him; our outlook on life was too dissimilar.
Nevertheless I recognized his ability and was
sincerely grateful for his enthusiastic work for
the clinic, and for the reputation of the hospital
and thereby for myself. And 1 was quite
sincerely grieved when the news came of his
death.10

Perhaps the most balanced evaluation
o f the life and work o f Norman Bethune
lies between the above testimony and the
BO O K R E V IE W S
continued from page 324
a concise and comprehensive fashion. This
book should be available to all residents in
urology programs and in libraries of hospitals
where a substantial amount of surgery for
urologic malignant conditions is being per
formed.
Said A. A wad, md, frcsjc]
Member,
Editorial Board.
Professor and head,
Department of urology,
Dalhousie University,
Halifax, NS
REPARATIVE AND CONSTRUCTIVE
SURGERY OF THE FEMALE GENE
RATIVE TRACT. Howard W. Jones, Jr.
and John A. Rock. 350 pp. Illust. Williams
& Wilkins, Baltimore, 1983. $60. ISBN
0-683-04470-2.
The senior author of this textbook has been
involved in the refinement o f surgical tech
niques for more than 30 years; the junior
author, his student, reflects a new generation
of specialists in reproductive medicine who
have devoted much of their energy to the
development of new skills in microsurgery.
The usefulness of this book lies not only in
its size, easy reading and consistent approach
to data collection, but also in presenting the
authors’ way of doing things. One cannot help
comparing it with the much smaller, now out
of print, book “ Surgical Gynecology” by J.P.
Greenhill that served as a surgical reference for
many would-be obstetricians and gynecologists
in the late 1950s and early 1960s. Explicit
graphics and careful dialogue in the text can
assist the gynecologic surgeon in his tasks.
The text has several highlights that enhance
its message. First, the authors provide a careful
evaluation of the diagnostic tests that lead up
to definitive surgery. For once, Rubin’s test is
given historical perspective and perhaps can
now be ruled out in terms o f the definitive
information received with regard to tubal
patency. The disparity between the results of
hysterosalpingography and laparoscopy are
clearly outlined. An extensive review of
hysteroscopy as a new and emerging diagnostic
technique is given. Culdoscopy, which was the
authors’ procedure of choice for the diagnosis
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book-length portrayal o f the man’s life.
On Dec. 21, 1939, Mao Tse-tung gave
a tribute (Appendix I) to Dr. Bethune’s
work for Chinese freedom in which he in
spired the people o f China to emulate the
dedication and enthusiasm o f a man
whose
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the publication date of the book, the authors
were not able to report on a larger series of
successful pregnancies resulting from this
program. Unfortunately, little time was spent
outlining the precautionary measures that
should be taken in founding such a program
designed to improve human fertility.
This book could be considered an adjunct
to the libraries of physicians-in-training, as well
as surgeons new to practice. The high
proportion of diagrammatic material and
photographs no doubt contributes to a
marketing impediment, the price. However,
since the information contained in this book
can be used over a number o f years, an
amortization of the initial cost may well be
justified.
J.E. T yson, md, frcsic]
Professor and head,
Department of obstetrics,
gynecology and reproductive sciences,
University of Manitoba,
Winnipeg, Man.
THE SURGICAL WOUND. Edited by
Peter Dineen and Gavin Hildick-Smith. 222
pp. Illust. Lea & Febiger, Philadelphia, 1981.
Price not stated. ISBN 0-8121-0799-3.
Multiauthored publications derived from sym
posia usually suffer from the weaknesses of
poor editing and organization. Fortunately,
this book is an exception. The uniformity of
the text, figures and separate bibliographies for
each chapter have resulted in an excellent
review of wound healing.
This book is divided into two sections. The
first deals with basic research in wound healing
and includes recently discovered facts about the
macrophage, complement and the role of
various chemical m ediators in acute
inflammation. Also included are interesting
chapters on the biosynthesis of collagen fibrils,
agents that inhibit excessive production of
collagen during wound healing and the biology
and treatment of keloid scars.
The second section of this book attempts to
integrate the- current state of investigative
knowledge into the clinical management of
wounds. Chapters discussing recent concepts
of wound infections, topical medicaments and
artificial skin provide practical information. A
section on stimulation of tissue repair by
therapeutic ultrasonography gives the reader
some hint of future modalities of treating
wounds.
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The arrangement of this book invites the
reader to browse through the pages of theory
and practice. I have become more informed
about the scientific basis of wound repair and
its aberrations. The clinician and basic scientist
should find this an enlightening and
informative book for both reading and
reference.

Although this textbook suffers from the
shortcomings of any large book by touching
on all major subjects and not discussing any
one in depth, it is a useful reference for the
student of cardiothoracic surgery and would
be a welcome addition to any library.

Ben M itmaker, md, frcsici

Division of cardiovascular surgery,
Victoria General Hospital,
Halifax, NS

6000 Cote des Neiges,
Montreal, PQ
THORACIC AND CARDIOVASCULAR
SURGERY. 4th ed. Edited by William W.L.
Glenn. 1667 pp. Illust. Appleton-CenturyCrofts, Norwalk, C onn., 1983. $145.
ISBN 0-8385-8956-1.

This book is not just a revision of its
predecessor “ Thoracic and Cardiovascular
Surgery with Related Pathology” but is a
completely new textbook. In contrast to the
third edition published in 1975, it provides
contributions from a number of authors, many
of them being well-recognized experts in
subspecialty areas.
The text has been divided into three main
sections on general thoracic surgery and
congenital and acquired heart disease. The
chapters in each section have been organized
in the format of a standard textbook: a
historical background, a discussion of the
pathophysiology, the n atu ral history,
indications for surgery, surgical techniques and
results of surgical intervention. This format
facilitates quick and easy reference to the
desired subject. Moreover, material from the
former textbook has been rewritten and
updated and new chapters have been added to
keep up with the ever-expanding knowledge of
cardiothoracic surgery.
The first portion of the book on general
thoracic surgery contains new chapters on
thoracic outlet syndrome, lung transplantation,
complications of thoracic surgery and bronchoplasty. Two chapters discuss recent advances
in immunotherapy and chemotherapy for lung
carcinoma and the management of pulmonary
metastatic disease. In the cardiac portion of the
textbook, the major additions are in the area
of acquired heart disease and include recent
developments in this area and fundamental
topics concerning the practice of cardiac
surgery. The chapters on cardiac surgical
anatom y, cardiovascular function and
physiology, and postoperative care of the
cardiac patient are welcome additions to this
text. Chapters on noninvasive cardiac
investigation include echocardiography and
nuclear imaging. The sections on the
management of surgical complications of
myocardial infarction, prosthetic heart valves
and thoracic aneurysms have been expanded
and improved greatly. Also, the book now
contains chapters on the surgical management
o f supraventricular and ventricular
tachyarrhythmias, a field that is new and
developing rapidly.
While it is impossible to review this large
textbook in great detail, the major differences
between this edition and the third edition are
the improved format, contributions by many
authors with particular expertise in subspecialty
fields, the updating of previous knowledge and
new chapters concerned with recent advances.

R.W. Landymore, md, FRCS1C)

TRAUM A. Surgery 1. Butterworths Inter
national Medical Reviews. Edited by David
C. Carter and Hiram C. Polk, Jr. 327 pp.
Illust. Butterworths & Co. (Publishers) Ltd.,
W oburn, M ass., 1981. $59.95. ISBN
0-407-02316-X.

This book, as introduced by its principal
authors in the preface, is the first in a series
of international medical reviews, to be followed
later by one on endocrine surgery and one on
gastrointestinal surgery.
The authors correctly state that the book is
intended to enhance the growth and develop
ment of the surgeon-in-training and that it will
stimulate and refresh the established surgical
practitioner. 1 heartily endorse this statement.
Those who work in hospitals, not wholly
committed to emergency surgical care, are well
aware of the confusion, organized and

unorganized, in the emergency department
when a number of major casualties suddenly
descend upon it. This volume will be of par
ticular value to personnel at all levels working
in general hospitals of no matter what size or
complexity.
All areas of the body are, from the point of
view of trauma, well covered. A particularly
good chapter is one dealing with pitfalls in
diagnosing and managing multiple injuries.
Here, the format o f the book is possibly best
illustrated: a detailed scientific assessment of
the individual subject is followed by a
comm entary, in many instances by an
experienced senior surgeon, emphasizing the
practical application of the points made.
The comment of Dr. Ben Eiseman, stress
ing how important it is that the surgeon-in
charge be left alone with the patient for a few
moments to assess the case and indicate
priorities after appropriate resuscitation, is
noted. This cannot be stressed too greatly, con
sidering the multispecialty approach that often
complicates the management of the multiple
traum a patient.
Two particularly good chapters are one on
the management of liver trauma and another
by H. Harlan Stone on the management of
wounds of the colon. The chapter on vascular
traum a in the extremities by Perry and Shires
is straightforward and of practical importance
to the nonvascular general surgeon.
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Perhaps the most important chapter in the
book is that on supportive care, dealing with
parameters emanating from the intensive care
unit, particularly in the vital areas of
pulm onary, vascular and renal support
systems.
While rather stark in its presentation, the
chapter on injuries associated with civil
hostilities, from the Royal Victoria Hospital
in Belfast, is perhaps the best practical chapter
in the book.
Johnson and Barros D’Sa describe the
management of a large number of violent in
cidents and experience with 9000 casualties, of
which over 3000 had gunshot wounds and
bomb injuries. Their emphasis is on the tried
and true principles: (a) the hospital-based doc
tor works best in the hospital; (b) triage must
be a continuing process; (c) a policy of selec
tive observation demands repeated clinical
assessment of the patient; (d) there is never a
place for primary suture of even low-velocity
wounds; (e) in vein injuries, as in arterial in
juries, ligation should be avoided at all costs;
(0 it is important to open the lesser sac to ex
clude holes in the posterior wall of the stomach
and (g) it is necessary to inspect the back,
perineum and limbs for small puncture
wounds. All represent the unchangeable
catechism of trauma management.
Aside from the data available, this book con
tains a remarkably extensive bibliography at
the end of each chapter that should be of great
value to the serious student looking for a de
tailed reference on any subject connected with
trauma.
R o b e r t M . L e v in e ,
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INTERNATIONAL MEETING ON THERAPEUTIC ENDO
SCOPY - Toronto, Canada. Hosted by the Division of

Gastroenterology, Wellesley Hospital, University of
Toronto, October 13-15, 1983, at The King Edward Hotel,
Toronto. The course will include lectures, live video
demonstrations, small seminar groups, case presentations
and commercial exhibits. Topics include: Sclerotherapy of
esophageal varices, Laser and electrocautery in bleeding
lesions, Laser tumour destruction, ERCP and sphinctero
tomy, Esophageal and pancreaticobiliary prostheses.
Percutaneous endoscopic gastrostomy, and Colonscopic
polypectomy. Guest faculty: Dr. I. Beck, Canada; Dr. J.
Geenen, USA; Dr. K. Huibregste, Holland; Dr. R. Hunt,
Canada; Dr. P. Kiefhaber, Germany; Dr. J. Papp, USA: Dr.
K. Schroeder, USA: Dr. N. Soehendra, Germany; Dr. J.
Waye, USA and Dr. Christopher Williams, England. Regis
tration Fee (Canadian funds): $325 physicians, $150 Resi
dents and Assistants. For further information please
contact: Doctor Norman E. Marcon, 121 Jones Building,
Wellesley Hospital, Toronto, Ont., Canada M4Y 1J3. Tel:
(416) 9 6 6 -5 7 1 0 or 966 -57 69.
-S 8 3-0 0 9

RESEARCH/CLINICAL FELLOW: PQ - We are accepting

applications for a urology graduate desiring a further year
or tw o in a urological research field, both experimental and
clinical, in the area of bladder physiology and urodynamics.
Please contact: Dr. Mostafa M. Elhilali, Director, Division
of Urology, McGill University, c/o Rm. S 6 .7 0 , Royal
Victoria Hospital, 687 Pine Ave. W ., Montreal, PQ H3A
1A1. Appointment will be made in accordance with
Canadian Immigration requirements.
S83-013

6000 Cote des Neiges,
Bureau 100,
Montreal, PQ
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GENERAL SURGEON: ALTA. - Holding or eligible for
FRCS(C), to associate with single surgeon in a very active
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is a very pleasant city of 54 000 located in southern
Alberta. Two excellent hospitals and a very large trading
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seeking a permament position. Additional information will
be provided on request. Please write to: Dr. H.
Prokopishyn, Haig Clinic, 601-6th Ave. S, Lethbridge, Alta.
T1J 0Z2. Tel.: (403) 328 -66 41.
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ing in colon and rectal surgery, with special emphasis and
expertise in outpatient anorectal surgery. Must be adapt
able, willing to learn, and adopt our new and successful
techniques. A well appointed and spacious environment.
A very rewarding practice w ith excellent patient
gratification, with a well trained and motivated support
staff of 10. Very private practice and patient care oriented.
Downtown Toronto. Reply: Box S102, Canadian Journal
of Surgery.
—S83-015
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PEDIATRIC UROLOGIST: PQ
Fully trained with
academic career as an objective. Previous research and
teaching experience preferred. Full-time appointment with
a group of very active, academically oriented pediatric
urologists. Please contact: Dr. Mostafa M. Elhilali, Director,
Division of Urology, McGill University, c/o Rm. S6.70,
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GENERAL SURGEON
with some
Emergency Orthopedic Experience
Required to relieve for a minimum of 6 months,
commencing Nov. 1, 1983. Joining a 10 family
physician/1 obstetrician/gynecologist group in
Whitehorse, Yukon Territory, servicing a population
of 24 000 people and 27 doctors. Excellent location
for someone who enjoys the outdoors. Remuneration
to be negotiated.
Please write giving complete resume or telephone:
J.L. Pollock
Clinic Administrator
The Medical Clinic
406 Lambert St.
Whitehorse, YT Y1A 1Z7
Tel: (403) 667-4421
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GENERAL SURGEON: ONT. — Six-physician clinic in
town of 7 000, service area 15 000, requires certified
general surgeon. Fully accredited 65-bed hospital; good
anesthetic back-up; shared call. Eligible for under serviced
area grant. Contact: Dr. J. Dove, 56 King St., Dryden, Ont.
P8N 1B6. Tel: (807) 223 -22 58.
S83-007

KIDNEY FOUNDATION
RESEARCH FELLOWSHIPS
ALBERTA. CANADA 1984-85
Applicants invited for Postdoctoral
Medical Fellowships in Nephrology
or Urology to run concurrently from
July 1, 1984 at the University of
Alberta, Edmonton and the Universi
ty of Calgary (Faculty of Medicine).

SURGEON: ONT. — to join three busy surgeons specializ

Ethicon Sutures Ltd.
PDS Suture

CERTIFIED

UROLOGIST: PQ — Fully trained with academic career
in mind, and having some research and teaching
experience for a full-time appointment with an active
academic urology group. Please contact: Dr. Mostafa M.
Elhilali, Director. Division of Urology, McGill University, c/o
Rm. S6.70, Royal Victoria Hospital, 687 Pine Ave. W .,
Montreal, PQ H3A 1A1. Appointment will be made in
accordance with Canadian Immigration requirements.
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Interdisciplinary training in basic
research and/or clinical investigation
available. Programs provide oppor
tunity for full enrolment in School of
Graduate Studies.
Salary concordant with qualifications
and prior training to maximum
$35 000 per annum.
Fellowship is for 1 year but second
year application anticipated. For ap
plication forms contact: Kidney
Foundation of Canada, Alberta
Branch, 103, 5920 - 1A St. SW,
Calgary, Alberta CANADA T2H
0G3.
APPLICATIONS POSTMARKED
AFTER OCTOBER 31, 1983 WILL
NOT BE ACCEPTED.
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An important
surgical tool:
Ensure*
complete nutrition

by mouth or by tube

ENSURE

Protein-calorie malnutrition threatens almost 50% of
hospitalized patients'. Its consequences - slow healing,
anemia, increased susceptibility to infection, wound
dehiscence - can compromise the outcome of treatment or
surgery and even jeopardize the patient’s life.
Ensure, complete nutrition for hospitalized patients
Before surgery, to help build up the patient’s strength and
immunocompetence2.
After surgery, to help restore a positive nitrogen balance
and help speed recovery3.
1. Bistrian BR et al. JAMA 1976; 235:15. • 2. Chandra RK et al. Nutrition Research 1982; 2:223-232.
3. Hoover C J e ta l. JPEN 1977; 14A(1).

complete liquid nutrition

Helps surgical patients
back to good health
*TM

Total commitment to nutrition
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